<?xml version='1.0' encoding='UTF-8'?>
<bill xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xml.house.gov/schemas/uslm/1.0 USLM-1.0.18.xsd" xml:lang="en"><?page 1?><meta><dc:title pagenum="1"> S1379 ENR: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</dc:title><dc:publisher>U.S. Senate</dc:publisher><dc:date/><dc:format>text/xml</dc:format><dc:language>EN</dc:language><dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights><dc:creator>Xcential BillDTD to USLM Converter v20200824</dc:creator><property role="congress">One Hundred Sixteenth Congress of the United States of America</property><property role="session">1st Session</property><property role="legis-type">AN ACT</property><property role="legis-num">S. 1379</property><property role="current-chamber">IN THE SENATE OF THE UNITED STATES</property><property role="official-title">To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and			 Cosmetic Act with respect to public health security and all-hazards preparedness and response, and for other purposes.</property><property role="docStage">ENR</property><property role="citableAs" value="116s1379enr">116 S. 1379 ENR</property></meta><main id="H2882C22B0CC811EB194409173F13E4C5" name="S1379"><longTitle><content><p>AN ACT</p><p>To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and			 Cosmetic Act with respect to public health security and all-hazards preparedness and response, and for other purposes.</p></content></longTitle><enactingFormula>Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</enactingFormula><section identifier="/s1" id="HC985029F7D7A4979A5D1343F3D2EBF9A" class="bill-dtd-OLC" pagenum="1"><num value="1">Section 1.</num><heading> Short title; table of contents.</heading><subsection identifier="/s1/a" id="HA24366F768F84747B726A4E81BD25A6E" class="bill-dtd-OLC" pagenum="1"><num value="a">(a)</num><heading> Short title.—</heading><content>This Act may be cited as the “<quotedText><shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle></quotedText>”.</content></subsection><subsection identifier="/s1/b" id="H432287A22D6B4902B77DFE6F1DF4CE03" class="bill-dtd-OLC" pagenum="1"><num value="b">(b)</num><heading> Table of contents.—</heading><content>The table of contents for this Act is as follows:</content><content><toc role="twoColumnTOC"><layout><tocItem><column class="twoColumnLeft"><ref idref="HC985029F7D7A4979A5D1343F3D2EBF9A">Sec. 1.</ref></column><column class="twoColumnRight"><ref idref="HC985029F7D7A4979A5D1343F3D2EBF9A">Short title; table of contents.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="id5431E22ECEED4A03937A79835A158E00">Sec. 2.</ref></column><column class="twoColumnRight"><ref idref="id5431E22ECEED4A03937A79835A158E00">References in Act.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H79F1B9D717924B48A0394729A99138FA">Title I—Strengthening the National Health Security Strategy </ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="HD4AFAAE037334B6C97FA38EF2E2824FD">Sec. 101.</ref></column><column class="twoColumnRight"><ref idref="HD4AFAAE037334B6C97FA38EF2E2824FD">National Health Security Strategy.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="HE0BD129810D24D6DA374522FF4DEE940">Title II—Improving Preparedness and Response</ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="HE5EF90F5EAC745BCBA7AC7D96A758DEB">Sec. 201.</ref></column><column class="twoColumnRight"><ref idref="HE5EF90F5EAC745BCBA7AC7D96A758DEB">Improving benchmarks and standards for preparedness and response.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HE9E14DD58A4F422A8DDB797D4B070556">Sec. 202.</ref></column><column class="twoColumnRight"><ref idref="HE9E14DD58A4F422A8DDB797D4B070556">Amendments to preparedness and response programs.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HF0100735318446FB83FB1D46FF1DF5D7">Sec. 203.</ref></column><column class="twoColumnRight"><ref idref="HF0100735318446FB83FB1D46FF1DF5D7">Regional health care emergency preparedness and response systems.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H26C830BFA6FF4D639A80C86C9B16950F">Sec. 204.</ref></column><column class="twoColumnRight"><ref idref="H26C830BFA6FF4D639A80C86C9B16950F">Military and civilian partnership for trauma readiness.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H02E2D82161744F9DA7AFFE2AA47D69A2">Sec. 205.</ref></column><column class="twoColumnRight"><ref idref="H02E2D82161744F9DA7AFFE2AA47D69A2">Public health and health care system situational awareness and biosurveillance capabilities.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H28CF2BD24EEA48FFA94C9E265F741AED">Sec. 206.</ref></column><column class="twoColumnRight"><ref idref="H28CF2BD24EEA48FFA94C9E265F741AED">Strengthening and supporting the public health emergency rapid response fund.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HD8317E7A7F2C4FEC8CADD91C3C629BBF">Sec. 207.</ref></column><column class="twoColumnRight"><ref idref="HD8317E7A7F2C4FEC8CADD91C3C629BBF">Improving all-hazards preparedness and response by public health emergency volunteers.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H5F18B19F14724A7995562D60B0C4C6DB">Sec. 208.</ref></column><column class="twoColumnRight"><ref idref="H5F18B19F14724A7995562D60B0C4C6DB">Clarifying State liability law for volunteer health care professionals.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H2543C033639144F1A8DE97C8C0EBFBEE">Sec. 209.</ref></column><column class="twoColumnRight"><ref idref="H2543C033639144F1A8DE97C8C0EBFBEE">Report on adequate national blood supply.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H9D018AF5CA814FC9B4A47D8CAFDCF04D">Sec. 210.</ref></column><column class="twoColumnRight"><ref idref="H9D018AF5CA814FC9B4A47D8CAFDCF04D">Report on the public health preparedness and response capabilities and capacities of hospitals, long-term care facilities, and other health care facilities.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H1EC01609C3F94A3C9D1AD494D5AE5905">Title III—Reaching All Communities</ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="H292F6AB7198A4224908AEC47B4EA04AF">Sec. 301.</ref></column><column class="twoColumnRight"><ref idref="H292F6AB7198A4224908AEC47B4EA04AF">Strengthening and assessing the emergency response workforce.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HDB4451B7F0D54DF8BED66A5A68E8E9B3">Sec. 302.</ref></column><column class="twoColumnRight"><ref idref="HDB4451B7F0D54DF8BED66A5A68E8E9B3">Health system infrastructure to improve preparedness and response.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H54BC8F5E97484C6E85DAABC19AB702DE">Sec. 303.</ref></column><column class="twoColumnRight"><ref idref="H54BC8F5E97484C6E85DAABC19AB702DE">Considerations for at-risk individuals.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H3857715C9AED473D9C32E256F7873E60">Sec. 304.</ref></column><column class="twoColumnRight"><ref idref="H3857715C9AED473D9C32E256F7873E60">Improving emergency preparedness and response considerations for children.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H45AFBE1BB8C543768B08D52DEA3037B7">Sec. 305.</ref></column><column class="twoColumnRight"><ref idref="H45AFBE1BB8C543768B08D52DEA3037B7">National advisory committees on disasters.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HE84903B8AA4542E4B1A1DB9806C6D841">Sec. 306.</ref></column><column class="twoColumnRight"><ref idref="HE84903B8AA4542E4B1A1DB9806C6D841">Guidance for participation in exercises and drills.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H60FE95B474BC424DBCB3AEE9DC1A1DE9">Title IV—Prioritizing a Threat-Based Approach </ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="H9AC515DEC02240F28005F056E1AC3F3B">Sec. 401.</ref></column><column class="twoColumnRight"><ref idref="H9AC515DEC02240F28005F056E1AC3F3B">Assistant Secretary for Preparedness and Response.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H7481C347809A42B58639F8CC0F727536">Sec. 402.</ref></column><column class="twoColumnRight"><ref idref="H7481C347809A42B58639F8CC0F727536">Public Health Emergency Medical Countermeasures Enterprise.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H786FB102DE174A7A87ECC275FA44DF0A">Sec. 403.</ref></column><column class="twoColumnRight"><ref idref="H786FB102DE174A7A87ECC275FA44DF0A">Strategic National Stockpile.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HA26BB6BF682F4DF4BB8BABC8C6CA51D6">Sec. 404.</ref></column><column class="twoColumnRight"><ref idref="HA26BB6BF682F4DF4BB8BABC8C6CA51D6">Preparing for pandemic influenza, antimicrobial resistance, and other significant threats.</ref></column></tocItem><?page 2?><tocItem><column class="twoColumnLeft"><ref idref="H963969CB69314CA3ABFB125C0149A249">Sec. 405.</ref></column><column class="twoColumnRight"><ref idref="H963969CB69314CA3ABFB125C0149A249">Reporting on the Federal Select Agent Program.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H3AAEF5881A214C89A16B29C59DA587F2">Title V—Increasing Communication in Medical Countermeasure Advanced Research and Development</ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="H0F22870BF2F04D4BB1E30561CC81BE84">Sec. 501.</ref></column><column class="twoColumnRight"><ref idref="H0F22870BF2F04D4BB1E30561CC81BE84">Medical countermeasure budget plan.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H370C043F223148078ED7CED7B2BAD3F9">Sec. 502.</ref></column><column class="twoColumnRight"><ref idref="H370C043F223148078ED7CED7B2BAD3F9">Material threat and medical countermeasure notifications.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H8F8B2D95A3874513A898A93525D1E92A">Sec. 503.</ref></column><column class="twoColumnRight"><ref idref="H8F8B2D95A3874513A898A93525D1E92A">Availability of regulatory management plans.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H4205E6DD2C7B43ECBE820E265AAE7D65">Sec. 504.</ref></column><column class="twoColumnRight"><ref idref="H4205E6DD2C7B43ECBE820E265AAE7D65">The Biomedical Advanced Research and Development Authority and the BioShield Special Reserve Fund.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HDC8ADA6672B44340AD814B489275674D">Sec. 505.</ref></column><column class="twoColumnRight"><ref idref="HDC8ADA6672B44340AD814B489275674D">Additional strategies for combating antibiotic resistance.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H3FA03E64B7FC49EAB049D51B121149CA">Title VI—Advancing Technologies for Medical Countermeasures</ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="H89125FDF70034C7680F645CCBAB8BFCD">Sec. 601.</ref></column><column class="twoColumnRight"><ref idref="H89125FDF70034C7680F645CCBAB8BFCD">Administration of countermeasures.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H8A29E30E5CAB4EF58601641121F5DB5D">Sec. 602.</ref></column><column class="twoColumnRight"><ref idref="H8A29E30E5CAB4EF58601641121F5DB5D">Updating definitions of other transactions.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H294417A5F9C44CC4ADA1232B8FF648C3">Sec. 603.</ref></column><column class="twoColumnRight"><ref idref="H294417A5F9C44CC4ADA1232B8FF648C3">Medical countermeasure master files.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H787617A9190C4E689E7BFF7AC4ACB0A2">Sec. 604.</ref></column><column class="twoColumnRight"><ref idref="H787617A9190C4E689E7BFF7AC4ACB0A2">Animal rule report.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H92B6EA998E544D9AB2CF02E60F06E87F">Sec. 605.</ref></column><column class="twoColumnRight"><ref idref="H92B6EA998E544D9AB2CF02E60F06E87F">Review of the benefits of genomic engineering technologies and their potential role in national security.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H4A34E42718264615AF1AB211A52AEAFB">Sec. 606.</ref></column><column class="twoColumnRight"><ref idref="H4A34E42718264615AF1AB211A52AEAFB">Report on vaccines development.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H6399FC744B6640D58EA7D07FB20D471D">Sec. 607.</ref></column><column class="twoColumnRight"><ref idref="H6399FC744B6640D58EA7D07FB20D471D">Strengthening mosquito abatement for safety and health.</ref></column></tocItem><header role="tocTitleHeader"><column><ref idref="H46A151F46D61417390689F0327B3380A">Title VII—Miscellaneous Provisions</ref></column></header><tocItem><column class="twoColumnLeft"><ref idref="H2E8A0472175A46288CFBA5B941F9127D">Sec. 701.</ref></column><column class="twoColumnRight"><ref idref="H2E8A0472175A46288CFBA5B941F9127D">Reauthorizations and extensions.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H3047AC7DC2E944C3B4FDC8864D11F427">Sec. 702.</ref></column><column class="twoColumnRight"><ref idref="H3047AC7DC2E944C3B4FDC8864D11F427">Location of materials in the stockpile.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="HE4843EADC74546319110DCF1D3E49433">Sec. 703.</ref></column><column class="twoColumnRight"><ref idref="HE4843EADC74546319110DCF1D3E49433">Cybersecurity.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H0B096551102E4875A89AA8BC4A1EDB48">Sec. 704.</ref></column><column class="twoColumnRight"><ref idref="H0B096551102E4875A89AA8BC4A1EDB48">Strategy and report.</ref></column></tocItem><tocItem><column class="twoColumnLeft"><ref idref="H3BC143D97CB94EB994B8B4A50C4DBC38">Sec. 705.</ref></column><column class="twoColumnRight"><ref idref="H3BC143D97CB94EB994B8B4A50C4DBC38">Technical amendments.</ref></column></tocItem></layout></toc></content></subsection></section><section identifier="/s2" id="id5431E22ECEED4A03937A79835A158E00" class="bill-dtd-OLC" pagenum="2"><num value="2">Sec. 2.</num><heading> References in Act.</heading><content class="indent0">Except as otherwise specified, amendments made by this Act to a section or other provision of law are amendments to such section or other provision of the Public Health Service Act (<ref href="/us/usc/42/201">42 U.S.C. 201</ref> et seq.).</content></section><title identifier="/tI" id="H79F1B9D717924B48A0394729A99138FA" class="bill-dtd-OLC" pagenum="2"><num value="I">Title I—</num><heading>Strengthening the National Health Security Strategy </heading><section identifier="/tI/s101" id="HD4AFAAE037334B6C97FA38EF2E2824FD" class="bill-dtd-OLC" pagenum="2"><num value="101">Sec. 101.</num><heading> National Health Security Strategy.</heading><chapeau class="block">Section 2802 (<ref href="/us/usc/42/300hh-1">42 U.S.C. 300hh–1</ref>) is amended—</chapeau><paragraph identifier="/tI/s101/1" id="HC9A235D486A04468B789E21C97D3F637" class="bill-dtd-OLC" pagenum="2"><num value="1">(1)</num><chapeau> in subsection (a)—</chapeau><subparagraph identifier="/tI/s101/1/A" id="H4883F5C3768B4A109C9874DB5187A53A" class="bill-dtd-OLC" pagenum="2"><num value="A">(A)</num><chapeau> in paragraph (1)—</chapeau><clause identifier="/tI/s101/1/A/i" id="H8D168999CA964D2FB52F3CA370A2FB54" class="bill-dtd-OLC" pagenum="2"><num value="i">(i)</num><content> by striking “<quotedText>2014</quotedText>” and inserting “<quotedText>2018</quotedText>”; and</content></clause><clause identifier="/tI/s101/1/A/ii" id="H649ED48CAF774FE4925B7C7C07959C68" class="bill-dtd-OLC" pagenum="2"><num value="ii">(ii)</num><content> by striking the second sentence and inserting the following: “<quotedText>Such National Health Security Strategy shall describe potential emergency health security threats and identify the process for achieving the preparedness goals described in subsection (b) to be prepared to identify and respond to such threats and shall be consistent with the national preparedness goal (as described in section 504(a)(19) of the Homeland Security Act of 2002), the National Incident Management System (as defined in section 501(7) of such Act), and the National Response Plan developed pursuant to section 504 of such Act, or any successor plan.</quotedText>”;</content></clause></subparagraph><subparagraph identifier="/tI/s101/1/B" id="H0B5794B9FFC94BFD9E90A5A2005360B6" class="bill-dtd-OLC" pagenum="2"><num value="B">(B)</num><content> in paragraph (2), by inserting before the period at the end of the second sentence the following: “<quotedText>, and an analysis of any changes to the evidence-based benchmarks and objective standards under sections 319C–1 and 319C–2</quotedText>”; and</content></subparagraph><?page 3?><subparagraph identifier="/tI/s101/1/C" id="HC91406962E2D4FDA99F28A133867530C" class="bill-dtd-OLC" pagenum="3"><num value="C">(C)</num><chapeau> in paragraph (3)—</chapeau><clause identifier="/tI/s101/1/C/i" id="H5C2CBF656B734B63B2E446628215CB5C" class="bill-dtd-OLC" pagenum="3"><num value="i">(i)</num><content> by striking “<quotedText>2009</quotedText>” and inserting “<quotedText>2022</quotedText>”;</content></clause><clause identifier="/tI/s101/1/C/ii" id="HAAC44583D48A4302B7FD1A0E413159AF" class="bill-dtd-OLC" pagenum="3"><num value="ii">(ii)</num><content> by inserting “<quotedText>(including gaps in the environmental health and animal health workforces, as applicable), describing the status of such workforce</quotedText>” after “<quotedText>gaps in such workforce</quotedText>”;</content></clause><clause identifier="/tI/s101/1/C/iii" id="H3F292BCBC57443059B37DF62DB3DC545" class="bill-dtd-OLC" pagenum="3"><num value="iii">(iii)</num><content> by striking “<quotedText>and identifying strategies</quotedText>” and inserting “<quotedText>identifying strategies</quotedText>”; and</content></clause><clause identifier="/tI/s101/1/C/iv" id="HA8DC49C8E5DF48C5B5F8B66DAEB47DCC" class="bill-dtd-OLC" pagenum="3"><num value="iv">(iv)</num><content> by inserting before the period at the end “<quotedText>, and identifying current capabilities to meet the requirements of section 2803</quotedText>”; and</content></clause></subparagraph></paragraph><paragraph identifier="/tI/s101/2" id="H82640ADCD9E24757B32335ACFD55AA6B" class="bill-dtd-OLC" pagenum="3"><num value="2">(2)</num><chapeau> in subsection (b)—</chapeau><subparagraph identifier="/tI/s101/2/A" id="HB9DCCCA773AB45E0B6602C85F5FDB44E" class="bill-dtd-OLC" pagenum="3"><num value="A">(A)</num><chapeau> in paragraph (2)—</chapeau><clause identifier="/tI/s101/2/A/i" id="H3C38917E5B584CAC93DF81B513624CD3" class="bill-dtd-OLC" pagenum="3"><num value="i">(i)</num><content> in subparagraph (A), by striking “<quotedText>and investigation</quotedText>” and inserting “<quotedText>investigation, and related information technology activities</quotedText>”;</content></clause><clause identifier="/tI/s101/2/A/ii" id="HDD3BF1D176034D3B9655511EB44FC56B" class="bill-dtd-OLC" pagenum="3"><num value="ii">(ii)</num><content> in subparagraph (B), by striking “<quotedText>and decontamination</quotedText>” and inserting “<quotedText>decontamination, relevant health care services and supplies, and transportation and disposal of medical waste</quotedText>”; and</content></clause><clause identifier="/tI/s101/2/A/iii" id="HC17FF325F3B34F58B7922059247884C6" class="bill-dtd-OLC" pagenum="3"><num value="iii">(iii)</num><content> by adding at the end the following:<quotedContent id="HBEBD7B2823C34B099F83FAEAAE2EC99A"><subparagraph identifier="/tI/s101/2/A/iii/qB/E" id="H44273B27C4DF4F9A93B02A9C4A91A69C" class="bill-dtd-OLC" pagenum="3"><num value="E">“(E)</num><content> Response to environmental hazards.”</content></subparagraph></quotedContent>;</content></clause></subparagraph><subparagraph identifier="/tI/s101/2/B" id="HF9878FD66F6F419EA474867978692F49" class="bill-dtd-OLC" pagenum="3"><num value="B">(B)</num><chapeau> in paragraph (3)—</chapeau><clause identifier="/tI/s101/2/B/i" id="H70E61A9F9D8745DB820726DF39B57802" class="bill-dtd-OLC" pagenum="3"><num value="i">(i)</num><content> in the matter preceding subparagraph (A), by striking “<quotedText>including mental health</quotedText>” and inserting “<quotedText>including pharmacies, mental health facilities,</quotedText>”; and</content></clause><clause identifier="/tI/s101/2/B/ii" id="HA17F2CBC26974D0E9D2923787D4BEA1E" class="bill-dtd-OLC" pagenum="3"><num value="ii">(ii)</num><content> in subparagraph (F), by inserting “<quotedText>or exposures to agents that could cause a public health emergency</quotedText>” before the period;</content></clause></subparagraph><subparagraph identifier="/tI/s101/2/C" id="H302507386E6D42CB86F8ECEAEB1D1E1B" class="bill-dtd-OLC" pagenum="3"><num value="C">(C)</num><content> in paragraph (5), by inserting “<quotedText>and other applicable compacts</quotedText>” after “<quotedText>Compact</quotedText>”; and</content></subparagraph><subparagraph identifier="/tI/s101/2/D" id="HA48EF41CB411410AB11F8459A17175B4" class="bill-dtd-OLC" pagenum="3"><num value="D">(D)</num><content> by adding at the end the following:<quotedContent id="H47376CB657484F188E75E25DF166D333"><paragraph identifier="/tI/s101/2/D/qB/9" id="H5261ED85D256442498F2B2AF11821DB2" class="bill-dtd-OLC" pagenum="3"><num value="9">“(9)</num><heading> Zoonotic disease, food, and agriculture.—</heading><content>Improving coordination among Federal, State, local, Tribal, and territorial entities (including through consultation with the Secretary of Agriculture) to prevent, detect, and respond to outbreaks of plant or animal disease (including zoonotic disease) that could compromise national security resulting from a deliberate attack, a naturally occurring threat, the intentional adulteration of food, or other public health threats, taking into account interactions between animal health, human health, and animals' and humans' shared environment as directly related to public health emergency preparedness and response capabilities, as applicable.</content></paragraph><paragraph identifier="/tI/s101/2/D/qB/10" id="H4C6CAE1C1F2247368C380710F8CFABA9" class="bill-dtd-OLC" pagenum="3"><num value="10">“(10)</num><heading> Global health security.—</heading><content>Assessing current or potential health security threats from abroad to inform domestic public health preparedness and response capabilities.”</content></paragraph></quotedContent>.</content></subparagraph></paragraph></section></title><title identifier="/tII" id="HE0BD129810D24D6DA374522FF4DEE940" class="bill-dtd-OLC" pagenum="3"><num value="II">Title II—</num><heading>Improving Preparedness and Response</heading><section identifier="/tII/s201" id="HE5EF90F5EAC745BCBA7AC7D96A758DEB" class="bill-dtd-OLC" pagenum="3"><num value="201">Sec. 201.</num><heading> Improving benchmarks and standards for preparedness and response.</heading><subsection identifier="/tII/s201/a" id="HEB80AE566FB24CF5BBB1A09347F5DBDB" class="bill-dtd-OLC" pagenum="3"><num value="a">(a)</num><heading> Evaluating measurable evidence-Based benchmarks and objective standards.—</heading><content>Section 319C–1 (<ref href="/us/usc/42/247d-3a">42 U.S.C. 247d–3a</ref>) is amended by inserting after subsection (j) the following:<?page 4?><quotedContent id="H5AEE07E669D2497AADDC9AB6F2611ED4"><subsection identifier="/tII/s201/a/qB/k" id="HA242859EE4AB4FB2B2E48457F2F6D54B" class="bill-dtd-OLC" pagenum="4"><num value="k">“(k)</num><heading> Evaluation.—</heading><paragraph identifier="/tII/s201/a/qB/k/1" id="H9BE4E50A088C4869AA3419B73AEB6722" class="bill-dtd-OLC" pagenum="4"><num value="1">“(1)</num><heading> In general.—</heading><content>Not later than 2 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle> and every 2 years thereafter, the Secretary shall conduct an evaluation of the evidence-based benchmarks and objective standards required under subsection (g). Such evaluation shall be submitted to the congressional committees of jurisdiction together with the National Health Security Strategy under section 2802, at such time as such strategy is submitted.</content></paragraph><paragraph identifier="/tII/s201/a/qB/k/2" id="H0456CD7D296C4CE3B5DE209A7572B2FD" class="bill-dtd-OLC" pagenum="4"><num value="2">“(2)</num><heading> Content.—</heading><chapeau>The evaluation under this paragraph shall include—</chapeau><subparagraph identifier="/tII/s201/a/qB/k/2/A" id="H9B7A576F3C624DD09DF3DDCCC9B59055" class="bill-dtd-OLC" pagenum="4"><num value="A">“(A)</num><content> a review of evidence-based benchmarks and objective standards, and associated metrics and targets;</content></subparagraph><subparagraph identifier="/tII/s201/a/qB/k/2/B" id="HE40EDFF585254BD8A68B6A251A2D23FD" class="bill-dtd-OLC" pagenum="4"><num value="B">“(B)</num><content> a discussion of changes to any evidence-based benchmarks and objective standards, and the effect of such changes on the ability to track whether entities are meeting or making progress toward the goals under this section and, to the extent practicable, the applicable goals of the National Health Security Strategy under section 2802;</content></subparagraph><subparagraph identifier="/tII/s201/a/qB/k/2/C" id="H3349CBD968374C908BC631BB2981478C" class="bill-dtd-OLC" pagenum="4"><num value="C">“(C)</num><content> a description of amounts received by eligible entities described in subsection (b) and section 319C–2(b), and amounts received by subrecipients and the effect of such funding on meeting evidence-based benchmarks and objective standards; and</content></subparagraph><subparagraph identifier="/tII/s201/a/qB/k/2/D" id="H4C128FDE97AA4B89A4920D98991AF7D1" class="bill-dtd-OLC" pagenum="4"><num value="D">“(D)</num><content> recommendations, as applicable and appropriate, to improve evidence-based benchmarks and objective standards to more accurately assess the ability of entities receiving awards under this section to better achieve the goals under this section and section 2802.”</content></subparagraph></paragraph></subsection></quotedContent>. </content></subsection><subsection identifier="/tII/s201/b" id="H6775F565711F462783A55759DAA27398" class="bill-dtd-OLC" pagenum="4"><num value="b">(b)</num><heading> Evaluating the partnership for State and regional hospital preparedness.—</heading><content>Section 319C–2(i)(1) (42 U.S.C. 247–3b(i)(1)) is amended by striking “<quotedText>section 319C–1(g), (i), and (j)</quotedText>” and inserting “<quotedText>section 319C–1(g), (i), (j), and (k)</quotedText>”.</content></subsection></section><section identifier="/tII/s202" id="HE9E14DD58A4F422A8DDB797D4B070556" class="bill-dtd-OLC" pagenum="4"><num value="202">Sec. 202.</num><heading> Amendments to preparedness and response programs.</heading><subsection identifier="/tII/s202/a" id="H3E88947AF7C6437787C9116B9D61F0D4" class="bill-dtd-OLC" pagenum="4"><num value="a">(a)</num><heading> Cooperative agreement applications for improving State and local public health security.—</heading><chapeau>Section 319C–1 (<ref href="/us/usc/42/247d-3a">42 U.S.C. 247d–3a</ref>) is amended—</chapeau><paragraph identifier="/tII/s202/a/1" id="H92A80CA4D4A3458FA4CA566B6F39346A" class="bill-dtd-OLC" pagenum="4"><num value="1">(1)</num><content> in subsection (a), by inserting “<quotedText>, acting through the Director of the Centers for Disease Control and Prevention,</quotedText>” after “<quotedText>the Secretary</quotedText>”; and</content></paragraph><paragraph identifier="/tII/s202/a/2" id="H99AC2782F9584E379DDB9020C2EC1724" class="bill-dtd-OLC" pagenum="4"><num value="2">(2)</num><chapeau> in subsection (b)(2)(A)—</chapeau><subparagraph identifier="/tII/s202/a/2/A" id="H08D6AEE1449C47948B00DF361DD11929" class="bill-dtd-OLC" pagenum="4"><num value="A">(A)</num><content> in clause (vi), by inserting “<quotedText>, including public health agencies with specific expertise that may be relevant to public health security, such as environmental health agencies,</quotedText>” after “<quotedText>stakeholders</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s202/a/2/B" id="H78318CD2C7C74F21B876F2A8434EFB0B" class="bill-dtd-OLC" pagenum="4"><num value="B">(B)</num><content> by redesignating clauses (vii) through (ix) as clauses (viii) through (x);</content></subparagraph><subparagraph identifier="/tII/s202/a/2/C" id="HF2A902F439C44B0E94ABB794AE9101CC" class="bill-dtd-OLC" pagenum="4"><num value="C">(C)</num><content> by inserting after clause (vi) the following:<quotedContent id="H10DFEEA5ABC04A948DCE56017CA3C7AA"><clause identifier="/tII/s202/a/2/C/qB/vii" id="HE875F28AA2304AA3AA5A5E1CF2E0D27F" class="bill-dtd-OLC" pagenum="4"><num value="vii">“(vii)</num><content> a description of how, as applicable, such entity may integrate information to account for individuals with behavioral health needs following a public health emergency;”</content></clause></quotedContent>;</content></subparagraph><subparagraph identifier="/tII/s202/a/2/D" id="H032A6C1751A849C3972506044F880CF7" class="bill-dtd-OLC" pagenum="4"><num value="D">(D)</num><content> in clause (ix), as so redesignated, by striking “<quotedText>; and</quotedText>” and inserting a semicolon; and</content></subparagraph><?page 5?><subparagraph identifier="/tII/s202/a/2/E" id="HB0CFEA3B552B47D08E50C7ED1C75D0CB" class="bill-dtd-OLC" pagenum="5"><num value="E">(E)</num><content> by adding at the end the following:<quotedContent id="H937D8EB971D44CE0AADACD32771F4176"><clause identifier="/tII/s202/a/2/E/qB/xi" id="H02CEC3EA0F044C3BBF35F57E6B0505C3" class="bill-dtd-OLC" pagenum="5"><num value="xi">“(xi)</num><content> a description of how the entity will partner with health care facilities, including hospitals and nursing homes and other long-term care facilities, to promote and improve public health preparedness and response; and</content></clause><clause identifier="/tII/s202/a/2/E/qB/xii" id="H21E5DEA2EA95447B8CA2BAFDAA42B4F5" class="bill-dtd-OLC" pagenum="5"><num value="xii">“(xii)</num><content> a description of how, as appropriate and practicable, the entity will include critical infrastructure partners, such as utility companies within the entity’s jurisdiction, in planning pursuant to this subparagraph to help ensure that critical infrastructure will remain functioning during, or return to function as soon as practicable after, a public health emergency;”</content></clause></quotedContent>.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s202/b" id="HEA161E9549514DDBA580522647E746AF" class="bill-dtd-OLC" pagenum="5"><num value="b">(b)</num><heading> Exception relating to application of certain requirements.—</heading><paragraph identifier="/tII/s202/b/1" id="HC045D0BB69DD494393F009C529D082E2" class="bill-dtd-OLC" pagenum="5"><num value="1">(1)</num><heading> In general.—</heading><chapeau>Section 319C–1(g) (42 U.S.C. 247d–3a(g)) is amended—</chapeau><subparagraph identifier="/tII/s202/b/1/A" id="H12DF93A124A54127AB268A20DBC1ABCC" class="bill-dtd-OLC" pagenum="5"><num value="A">(A)</num><chapeau> in paragraph (5)—</chapeau><clause identifier="/tII/s202/b/1/A/i" id="H14A63A960BAF4B82B872B1344A29A39F" class="bill-dtd-OLC" pagenum="5"><num value="i">(i)</num><content> in the matter preceding subparagraph (A), by striking “<quotedText>Beginning with fiscal year 2009</quotedText>” and inserting “<quotedText>Beginning with fiscal year 2019</quotedText>”; and</content></clause><clause identifier="/tII/s202/b/1/A/ii" id="HB2696D328DB243E08966F29ECBBECF06" class="bill-dtd-OLC" pagenum="5"><num value="ii">(ii)</num><chapeau> in subparagraph (A)—</chapeau><subclause identifier="/tII/s202/b/1/A/ii/I" id="H1E840D763FEF4403B56DBA4EA797FB75" class="bill-dtd-OLC" pagenum="5"><num value="I">(I)</num><content> by striking “<quotedText>for the immediately preceding fiscal year</quotedText>” and inserting “<quotedText>for either of the 2 immediately preceding fiscal years</quotedText>”; and</content></subclause><subclause identifier="/tII/s202/b/1/A/ii/II" id="HB85B8B992C3E47B8825356F3C5D6ED75" class="bill-dtd-OLC" pagenum="5"><num value="II">(II)</num><content> by striking “<quotedText>2008</quotedText>” and inserting “<quotedText>2018</quotedText>”; and</content></subclause></clause></subparagraph><subparagraph identifier="/tII/s202/b/1/B" id="H9789B3E532F0437B939D829BE46023EB" class="bill-dtd-OLC" pagenum="5"><num value="B">(B)</num><content> in paragraph (6), by amending subparagraph (A) to read as follows:<quotedContent id="HB7A83FF8622242D080A8FF70C474DA1E"><subparagraph identifier="/tII/s202/b/1/B/qB/A" id="H0B4EB41712AD43779260965E5197CE60" class="bill-dtd-OLC" pagenum="5"><num value="A">“(A)</num><heading> In general.—</heading><chapeau>The amounts described in this paragraph are the following amounts that are payable to an entity for activities described in this section or section 319C–2:</chapeau><clause identifier="/tII/s202/b/1/B/qB/A/i" id="H70308EA651584F03B35F8E98A81328AE" class="bill-dtd-OLC" pagenum="5"><num value="i">“(i)</num><content> For no more than one of each of the first 2 fiscal years immediately following a fiscal year in which an entity experienced a failure described in subparagraph (A) or (B) of paragraph (5), an amount equal to 10 percent of the amount the entity was eligible to receive for the respective fiscal year.</content></clause><clause identifier="/tII/s202/b/1/B/qB/A/ii" id="HFC652A0BC8B640469ADC94158023CC4E" class="bill-dtd-OLC" pagenum="5"><num value="ii">“(ii)</num><content> For no more than one of the first 2 fiscal years immediately following the third consecutive fiscal year in which an entity experienced such a failure, in lieu of applying clause (i), an amount equal to 15 percent of the amount the entity was eligible to receive for the respective fiscal year.”</content></clause></subparagraph></quotedContent>.</content></subparagraph></paragraph><paragraph identifier="/tII/s202/b/2" id="H110C952B18E44C339F265E13F133B2DF" class="bill-dtd-OLC" pagenum="5"><num value="2">(2)</num><heading> Effective date.—</heading><content>The amendments made by paragraph (1) shall apply with respect to cooperative agreements awarded on or after the date of enactment of this Act.</content></paragraph></subsection><subsection identifier="/tII/s202/c" id="HE31126CCF2F8437C84646A9911645CAD" class="bill-dtd-OLC" pagenum="5"><num value="c">(c)</num><heading> Partnership for State and regional hospital preparedness To improve surge capacity.—</heading><chapeau>Section 319C–2 (<ref href="/us/usc/42/247d-3b">42 U.S.C. 247d–3b</ref>) is amended—</chapeau><paragraph identifier="/tII/s202/c/1" id="HFFDF128A4D3844E1B5F7E32BE2243E7E" class="bill-dtd-OLC" pagenum="5"><num value="1">(1)</num><chapeau> in subsection (a)—</chapeau><subparagraph identifier="/tII/s202/c/1/A" id="H98A900A538AC41149C6D26239D5139BF" class="bill-dtd-OLC" pagenum="5"><num value="A">(A)</num><content> by inserting “<quotedText>, acting through the Assistant Secretary for Preparedness and Response,</quotedText>” after “<quotedText>The Secretary</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s202/c/1/B" id="H770A861C4A4D4E6EA2A52F971F645ED8" class="bill-dtd-OLC" pagenum="5"><num value="B">(B)</num><content> by striking “<quotedText>preparedness for public health emergencies</quotedText>” and inserting “<quotedText>preparedness for, and response to, <?page 6?>public health emergencies in accordance with subsection (c)</quotedText>”;</content></subparagraph></paragraph><paragraph identifier="/tII/s202/c/2" id="H289FA098D04142EB9961B866AE0C88FE" class="bill-dtd-OLC" pagenum="6"><num value="2">(2)</num><chapeau> in subsection (b)(1)(A)—</chapeau><subparagraph identifier="/tII/s202/c/2/A" id="H520206F8D16441A89C49E81070116654" class="bill-dtd-OLC" pagenum="6"><num value="A">(A)</num><content> by striking “<quotedText>partnership consisting of</quotedText>” and inserting “<quotedText>coalition that includes</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s202/c/2/B" id="H00EEADD3EEEC4B1A873E857AC5140194" class="bill-dtd-OLC" pagenum="6"><num value="B">(B)</num><content> in clause (ii), by striking “<quotedText>; and</quotedText>” and inserting a semicolon; and</content></subparagraph><subparagraph identifier="/tII/s202/c/2/C" id="H7B44BA9976F74CD1A6D61173D783978A" class="bill-dtd-OLC" pagenum="6"><num value="C">(C)</num><content> by adding at the end the following:<quotedContent id="HA1502EDB91F54C36AE417AC5BE07FE08"><clause identifier="/tII/s202/c/2/C/qB/iv" id="H6D472317D1814AD5BDC833B0CDBC0C39" class="bill-dtd-OLC" pagenum="6"><num value="iv">“(iv)</num><content> one or more emergency medical service organizations or emergency management organizations; and”</content></clause></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tII/s202/c/3" id="HC3E72A6B61BA435BB357052785B9A527" class="bill-dtd-OLC" pagenum="6"><num value="3">(3)</num><chapeau> in subsection (d)—</chapeau><subparagraph identifier="/tII/s202/c/3/A" id="HFC2972F6C2B04B88B49D1D1DEFFA6FCC" class="bill-dtd-OLC" pagenum="6"><num value="A">(A)</num><content> in paragraph (1)(B), by striking “<quotedText>partnership</quotedText>” each place it appears and inserting “<quotedText>coalition</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s202/c/3/B" id="HEC034E32F8924FF3B6A39AC168354F1C" class="bill-dtd-OLC" pagenum="6"><num value="B">(B)</num><content> in paragraph (2)(C), by striking “<quotedText>medical preparedness</quotedText>” and inserting “<quotedText>preparedness and response</quotedText>”;</content></subparagraph></paragraph><paragraph identifier="/tII/s202/c/4" id="H0E19BB44584848CE9717AB7B8BF209AF" class="bill-dtd-OLC" pagenum="6"><num value="4">(4)</num><content> in subsection (f), by striking “<quotedText>partnership</quotedText>” and inserting “<quotedText>coalition</quotedText>”;</content></paragraph><paragraph identifier="/tII/s202/c/5" id="HC92C24F03580482A89CE906654091C9D" class="bill-dtd-OLC" pagenum="6"><num value="5">(5)</num><chapeau> in subsection (g)(2)—</chapeau><subparagraph identifier="/tII/s202/c/5/A" id="H5CB0B2E1078F4186AAAA8F5EA7F63CE7" class="bill-dtd-OLC" pagenum="6"><num value="A">(A)</num><content> by striking “<quotedText>Partnerships</quotedText>” and inserting “<quotedText>Coalitions</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s202/c/5/B" id="H9EA34EBD93CD42A682F83913F6273240" class="bill-dtd-OLC" pagenum="6"><num value="B">(B)</num><content> by striking “<quotedText>partnerships</quotedText>” and inserting “<quotedText>coalitions</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s202/c/5/C" id="HBE9B546876C14C9BB55AC930F7816539" class="bill-dtd-OLC" pagenum="6"><num value="C">(C)</num><content> by inserting “<quotedText>and response</quotedText>” after “<quotedText>preparedness</quotedText>”; and</content></subparagraph></paragraph><paragraph identifier="/tII/s202/c/6" id="H02CEC3347E6748078D57564BCA1F3327" class="bill-dtd-OLC" pagenum="6"><num value="6">(6)</num><chapeau> in subsection (i)(1)—</chapeau><subparagraph identifier="/tII/s202/c/6/A" id="H50BCF689122F4952BB39EA4EAABE6691" class="bill-dtd-OLC" pagenum="6"><num value="A">(A)</num><content> by striking “<quotedText>An entity</quotedText>” and inserting “<quotedText>A coalition</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s202/c/6/B" id="HEECDFDCB88304BF2916E4C7565033C57" class="bill-dtd-OLC" pagenum="6"><num value="B">(B)</num><content> by striking “<quotedText>such partnership</quotedText>” and inserting “<quotedText>such coalition</quotedText>”.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s202/d" id="H5A28975DCC54466FA0D059C8543A8B3F" class="bill-dtd-OLC" pagenum="6"><num value="d">(d)</num><heading> Public health security grants authorization of appropriations.—</heading><content>Section 319C–1(h)(1)(A) (42 U.S.C. 247d–3a(h)(1)(A)) is amended by striking “<quotedText>$641,900,000 for fiscal year 2014</quotedText>” and all that follows through the period at the end and inserting “<quotedText>$685,000,000 for each of fiscal years 2019 through 2023 for awards pursuant to paragraph (3) (subject to the authority of the Secretary to make awards pursuant to paragraphs (4) and (5)).</quotedText>”.</content></subsection><subsection identifier="/tII/s202/e" id="H0CDFB7C1EF7B4868A47AB1961505F96F" class="bill-dtd-OLC" pagenum="6"><num value="e">(e)</num><heading> Partnership for State and regional hospital preparedness authorization of appropriations.—</heading><chapeau>Section 319C–2(j) (42 U.S.C. 247d–3b(j)) is amended—</chapeau><paragraph identifier="/tII/s202/e/1" id="H8B053B5CD85046E898C030B1FE2C8E80" class="bill-dtd-OLC" pagenum="6"><num value="1">(1)</num><content> by amending paragraph (1) to read as follows:<quotedContent id="H4A6E3F7290EC43739C360A9A7CAE33E2"><paragraph identifier="/tII/s202/e/1/qB/1" id="H33717060569D41118C391495D4737E50" class="bill-dtd-OLC" pagenum="6"><num value="1">“(1)</num><heading> In general.—</heading><subparagraph identifier="/tII/s202/e/1/qB/1/A" id="HE8596316A6754ABAA74A7F732734FE4E" class="bill-dtd-OLC" pagenum="6"><num value="A">“(A)</num><heading> Authorization of appropriations.—</heading><content>For purposes of carrying out this section and section 319C–3, in accordance with subparagraph (B), there is authorized to be appropriated $385,000,000 for each of fiscal years 2019 through 2023.</content></subparagraph><subparagraph identifier="/tII/s202/e/1/qB/1/B" id="H6D487DFA504E4D9AADFEE48BA6C4C101" class="bill-dtd-OLC" pagenum="6"><num value="B">“(B)</num><heading> Reservation of amounts for regional systems.—</heading><clause identifier="/tII/s202/e/1/qB/1/B/i" id="HA7B7936E58E3493987C884393392AED0" class="bill-dtd-OLC" pagenum="6"><num value="i">“(i)</num><heading> In general.—</heading><content>Subject to clause (ii), of the amount appropriated under subparagraph (A) for a fiscal year, the Secretary may reserve up to 5 percent for the purpose of carrying out section 319C–3.</content></clause><clause identifier="/tII/s202/e/1/qB/1/B/ii" id="HE31B7C96B2D241EBB674D304680C859E" class="bill-dtd-OLC" pagenum="6"><num value="ii">“(ii)</num><heading> Reservation contingent on continued appropriations for this section.—</heading><content>If for fiscal year 2019 or a subsequent fiscal year, the amount appropriated under subparagraph (A) is such that, after <?page 7?>application of clause (i), the amount remaining for the purpose of carrying out this section would be less than the amount available for such purpose for the previous fiscal year, the amount that may be reserved under clause (i) shall be reduced such that the amount remaining for the purpose of carrying out this section is not less than the amount available for such purpose for the previous fiscal year.</content></clause><clause identifier="/tII/s202/e/1/qB/1/B/iii" id="HCCFC63278F3B4D409ADE73B99A6DC427" class="bill-dtd-OLC" pagenum="7"><num value="iii">“(iii)</num><heading> Sunset.—</heading><content>The authority to reserve amounts under clause (i) shall expire on September 30, 2023.”</content></clause></subparagraph></paragraph></quotedContent>;</content></paragraph><paragraph identifier="/tII/s202/e/2" id="H9434B117A91847C6871377D44251D42E" class="bill-dtd-OLC" pagenum="7"><num value="2">(2)</num><content> in paragraph (2), by striking “<quotedText>paragraph (1) for a fiscal year</quotedText>” and inserting “<quotedText>paragraph (1)(A) for a fiscal year and not reserved for the purpose described in paragraph (1)(B)(i)</quotedText>”; and</content></paragraph><paragraph identifier="/tII/s202/e/3" id="H1386021518534E15BDB1DB23C24A9477" class="bill-dtd-OLC" pagenum="7"><num value="3">(3)</num><content> in paragraph (3)(A), by striking “<quotedText>paragraph (1) and not reserved under paragraph (2)</quotedText>” and inserting “<quotedText>paragraph (1)(A) and not reserved under paragraph (1)(B)(i) or (2)</quotedText>”.</content></paragraph></subsection></section><section identifier="/tII/s203" id="HF0100735318446FB83FB1D46FF1DF5D7" class="bill-dtd-OLC" pagenum="7"><num value="203">Sec. 203.</num><heading> Regional health care emergency preparedness and response systems.</heading><subsection identifier="/tII/s203/a" id="H4E7494157AF54D2595373C282D5D84AE" class="bill-dtd-OLC" pagenum="7"><num value="a">(a)</num><heading> In general.—</heading><content>Part B of title III (<ref href="/us/usc/42/243">42 U.S.C. 243</ref> et seq.) is amended by inserting after section 319C–2 the following:<quotedContent id="H847E82D38F1D416B933D6E59D098047C"><section identifier="/tII/s203/a/qB/s319C–3" id="H540DAEF0C12943FA9EFCFC61C351FF20" class="bill-dtd-OLC" pagenum="7"><num value="319C–3">“Sec. 319C–3.</num><heading> Guidelines for regional health care emergency preparedness and response systems.</heading><subsection identifier="/tII/s203/a/qB/s319C–3/a" id="H85A7F70142D14FE3A64929DD0AF0351D" class="bill-dtd-OLC" pagenum="7"><num value="a">“(a)</num><heading> Purpose.—</heading><content>It is the purpose of this section to identify and provide guidelines for regional systems of hospitals, health care facilities, and other public and private sector entities, with varying levels of capability to treat patients and increase medical surge capacity during, in advance of, and immediately following a public health emergency, including threats posed by one or more chemical, biological, radiological, or nuclear agents, including emerging infectious diseases.</content></subsection><subsection identifier="/tII/s203/a/qB/s319C–3/b" id="HFB9D25AAE3CE4312AC22247983F18650" class="bill-dtd-OLC" pagenum="7"><num value="b">“(b)</num><heading> Guidelines.—</heading><chapeau>The Assistant Secretary for Preparedness and Response, in consultation with the Director of the Centers for Disease Control and Prevention, the Administrator of the Centers for Medicare &amp; Medicaid Services, the Administrator of the Health Resources and Services Administration, the Commissioner of Food and Drugs, the Assistant Secretary for Mental Health and Substance Use, the Assistant Secretary of Labor for Occupational Safety and Health, the Secretary of Veterans Affairs, the heads of such other Federal agencies as the Secretary determines to be appropriate, and State, local, Tribal, and territorial public health officials, shall, not later than 2 years after the date of enactment of this section—</chapeau><paragraph identifier="/tII/s203/a/qB/s319C–3/b/1" id="HF3005D0F04BA44F79E406A38E09AF986" class="bill-dtd-OLC" pagenum="7"><num value="1">“(1)</num><chapeau> identify and develop a set of guidelines relating to practices and protocols for all-hazards public health emergency preparedness and response for hospitals and health care facilities to provide appropriate patient care during, in advance of, or immediately following, a public health emergency, resulting from one or more chemical, biological, radiological, or nuclear agents, including emerging infectious diseases (which may include existing practices, such as trauma care and medical surge capacity and capabilities), with respect to—</chapeau><subparagraph identifier="/tII/s203/a/qB/s319C–3/b/1/A" id="HC8415570CDBF4FD6A0D76079E7F34099" class="bill-dtd-OLC" pagenum="7"><num value="A">“(A)</num><chapeau> a regional approach to identifying hospitals and health care facilities based on varying capabilities and capacity to treat patients affected by such emergency, including—</chapeau><?page 8?><clause identifier="/tII/s203/a/qB/s319C–3/b/1/A/i" id="H8B51D16D23C241CF98E156666D52DB00" class="bill-dtd-OLC" pagenum="8"><num value="i">“(i)</num><content> the manner in which the system will coordinate with and integrate the partnerships and health care coalitions established under section 319C–2(b); and</content></clause><clause identifier="/tII/s203/a/qB/s319C–3/b/1/A/ii" id="H5BA3B19D11F64057BAC889C8EF1CDF15" class="bill-dtd-OLC" pagenum="8"><num value="ii">“(ii)</num><content> informing and educating appropriate first responders and health care supply chain partners of the regional emergency preparedness and response capabilities and medical surge capacity of such hospitals and health care facilities in the community;</content></clause></subparagraph><subparagraph identifier="/tII/s203/a/qB/s319C–3/b/1/B" id="H575FBABCD34043D4B989E1A25B34BE8D" class="bill-dtd-OLC" pagenum="8"><num value="B">“(B)</num><content> physical and technological infrastructure, laboratory capacity, staffing, blood supply, and other supply chain needs, taking into account resiliency, geographic considerations, and rural considerations;</content></subparagraph><subparagraph identifier="/tII/s203/a/qB/s319C–3/b/1/C" id="HA0E3AAFC25D544A88E3516B75C47306D" class="bill-dtd-OLC" pagenum="8"><num value="C">“(C)</num><content> protocols or best practices for the safety and personal protection of workers who handle human remains and health care workers (including with respect to protective equipment and supplies, waste management processes, and decontamination), sharing of specialized experience among the health care workforce, behavioral health, psychological resilience, and training of the workforce, as applicable;</content></subparagraph><subparagraph identifier="/tII/s203/a/qB/s319C–3/b/1/D" id="HF9DBFBECF6764C30B94DCCDE176DCF59" class="bill-dtd-OLC" pagenum="8"><num value="D">“(D)</num><content> in a manner that allows for disease containment (within the meaning of section 2802(b)(2)(B)), coordinated medical triage, treatment, and transportation of patients, based on patient medical need (including patients in rural areas), to the appropriate hospitals or health care facilities within the regional system or, as applicable and appropriate, between systems in different States or regions; and</content></subparagraph><subparagraph identifier="/tII/s203/a/qB/s319C–3/b/1/E" id="H66C98E65EA1947148DEDC32A5F210208" class="bill-dtd-OLC" pagenum="8"><num value="E">“(E)</num><content> the needs of children and other at-risk individuals;</content></subparagraph></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/b/2" id="HD3E086D5423041219DCF3C3CEFB64C79" class="bill-dtd-OLC" pagenum="8"><num value="2">“(2)</num><content> make such guidelines available on the internet website of the Department of Health and Human Services in a manner that does not compromise national security; and</content></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/b/3" id="HBF14D611C1F348CCAD1B52BB39A9E831" class="bill-dtd-OLC" pagenum="8"><num value="3">“(3)</num><content> update such guidelines as appropriate, including based on input received pursuant to subsections (c) and (e) and information resulting from applicable reports required under the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle> (including any amendments made by such Act), to address new and emerging public health threats.</content></paragraph></subsection><subsection identifier="/tII/s203/a/qB/s319C–3/c" id="H3FEE9C7D9D9849AAA23A7325578BB18B" class="bill-dtd-OLC" pagenum="8"><num value="c">“(c)</num><heading> Considerations.—</heading><chapeau>In identifying, developing, and updating guidelines under subsection (b), the Assistant Secretary for Preparedness and Response shall—</chapeau><paragraph identifier="/tII/s203/a/qB/s319C–3/c/1" id="HF932A3DE977348909926DE97568B503E" class="bill-dtd-OLC" pagenum="8"><num value="1">“(1)</num><content> include input from hospitals and health care facilities (including health care coalitions under section 319C–2), State, local, Tribal, and territorial public health departments, and health care or subject matter experts (including experts with relevant expertise in chemical, biological, radiological, or nuclear threats, including emerging infectious diseases), as the Assistant Secretary determines appropriate, to meet the goals under section 2802(b)(3);</content></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/c/2" id="H1119F5D3516A48FEB54B6097A81E6BE8" class="bill-dtd-OLC" pagenum="8"><num value="2">“(2)</num><content> consult and engage with appropriate health care providers and professionals, including physicians, nurses, first responders, health care facilities (including hospitals, primary care clinics, community health centers, mental health facilities, ambulatory care facilities, and dental health facilities), pharmacies, emergency medical providers, trauma care providers, environmental health agencies, public health laboratories, poison control centers, blood banks, tissue banks, and other experts <?page 9?>that the Assistant Secretary determines appropriate, to meet the goals under section 2802(b)(3);</content></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/c/3" id="H83216F2B5A5445BA8313634739DCFED0" class="bill-dtd-OLC" pagenum="9"><num value="3">“(3)</num><content> consider feedback related to financial implications for hospitals, health care facilities, public health agencies, laboratories, blood banks, tissue banks, and other entities engaged in regional preparedness planning to implement and follow such guidelines, as applicable; and</content></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/c/4" id="H2833EFD33045417FAF9D792A1F2E6125" class="bill-dtd-OLC" pagenum="9"><num value="4">“(4)</num><content> consider financial requirements and potential incentives for entities to prepare for, and respond to, public health emergencies as part of the regional health care emergency preparedness and response system.</content></paragraph></subsection><subsection identifier="/tII/s203/a/qB/s319C–3/d" id="H228456790ACA4132AD46B66D6F58E2AD" class="bill-dtd-OLC" pagenum="9"><num value="d">“(d)</num><heading> Technical assistance.—</heading><content>The Assistant Secretary for Preparedness and Response, in consultation with the Director of the Centers for Disease Control and Prevention and the Assistant Secretary of Labor for Occupational Safety and Health, may provide technical assistance and consultation toward meeting the guidelines described in subsection (b).</content></subsection><subsection identifier="/tII/s203/a/qB/s319C–3/e" id="HED0709A97A27450E9EE37438BAD525D2" class="bill-dtd-OLC" pagenum="9"><num value="e">“(e)</num><heading> Demonstration project for regional health care preparedness and response systems.—</heading><paragraph identifier="/tII/s203/a/qB/s319C–3/e/1" id="H5D8C1DF5440F4459A7CEA884C83F6026" class="bill-dtd-OLC" pagenum="9"><num value="1">“(1)</num><heading> In general.—</heading><content>The Assistant Secretary for Preparedness and Response may establish a demonstration project pursuant to the development and implementation of guidelines under subsection (b) to award grants to improve medical surge capacity for all hazards, build and integrate regional medical response capabilities, improve specialty care expertise for all-hazards response, and coordinate medical preparedness and response across State, local, Tribal, territorial, and regional jurisdictions.</content></paragraph><paragraph identifier="/tII/s203/a/qB/s319C–3/e/2" id="H75A8876C781B433E8A431A5E7629F8E3" class="bill-dtd-OLC" pagenum="9"><num value="2">“(2)</num><heading> Sunset.—</heading><content>The authority under this subsection shall expire on September 30, 2023.”</content></paragraph></subsection></section></quotedContent>. </content></subsection><subsection identifier="/tII/s203/b" id="H6230F054F2E744FE8B051791B99BDAC2" class="bill-dtd-OLC" pagenum="9"><num value="b">(b)</num><heading> GAO report to Congress.—</heading><paragraph identifier="/tII/s203/b/1" id="H3C9AF706B25844FCB7D75FA19079EF05" class="bill-dtd-OLC" pagenum="9"><num value="1">(1)</num><heading> Report.—</heading><content>Not later than 3 years after the date of enactment of this Act, the Comptroller General of the United States (referred to in this subsection as the “<quotedText>Comptroller General</quotedText>”) shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate and the Committee on Energy and Commerce and the Committee on Ways and Means of the House of Representatives, a report on the extent to which hospitals and health care facilities have implemented the recommended guidelines under section 319C–3(b) of the Public Health Service Act (as added by subsection (a)), including an analysis and evaluation of any challenges hospitals or health care facilities experienced in implementing such guidelines.</content></paragraph><paragraph identifier="/tII/s203/b/2" id="HC3DFD62014D4489F9E235991A3978146" class="bill-dtd-OLC" pagenum="9"><num value="2">(2)</num><heading> Content.—</heading><chapeau>The Comptroller General shall include in the report under paragraph (1)—</chapeau><subparagraph identifier="/tII/s203/b/2/A" id="HE2018826CDD44C87994398CD50C9B424" class="bill-dtd-OLC" pagenum="9"><num value="A">(A)</num><content> data on the preparedness and response capabilities that have been informed by the guidelines under section 319C–3(b) of the Public Health Service Act to improve regional emergency health care preparedness and response capability, including hospital and health care facility capacity and medical surge capabilities to prepare for, and respond to, public health emergencies; and</content></subparagraph><subparagraph identifier="/tII/s203/b/2/B" id="H30F9D1DFEB5445DE959A772ADF4E87B8" class="bill-dtd-OLC" pagenum="9"><num value="B">(B)</num><content> recommendations to reduce gaps in incentives for regional health partners, including hospitals and health care facilities, to improve capacity and medical surge capabilities to prepare for, and respond to, public health <?page 10?>emergencies, consistent with subsection (a), which may include consideration of facilities participating in programs under section 319C–2 of the Public Health Service Act (<ref href="/us/usc/42/247d-3b">42 U.S.C. 247d–3b</ref>) or in programs under the Centers for Medicare &amp; Medicaid Services (including innovative health care delivery and payment models), and input from private sector financial institutions.</content></subparagraph></paragraph><paragraph identifier="/tII/s203/b/3" id="H06410A692C8F40ADBC33DE8CD96AB1E0" class="bill-dtd-OLC" pagenum="10"><num value="3">(3)</num><heading> Consultation.—</heading><chapeau>In carrying out paragraphs (1) and (2), the Comptroller General shall consult with the heads of appropriate Federal agencies, including—</chapeau><subparagraph identifier="/tII/s203/b/3/A" id="H33D05641D5054FA6B22246D2A7813C9B" class="bill-dtd-OLC" pagenum="10"><num value="A">(A)</num><content> the Assistant Secretary for Preparedness and Response;</content></subparagraph><subparagraph identifier="/tII/s203/b/3/B" id="H7558654272304041A97889CC4BC8C1E9" class="bill-dtd-OLC" pagenum="10"><num value="B">(B)</num><content> the Director of the Centers for Disease Control and Prevention;</content></subparagraph><subparagraph identifier="/tII/s203/b/3/C" id="H5ED7F5A079DB493396A558258775684B" class="bill-dtd-OLC" pagenum="10"><num value="C">(C)</num><content> the Administrator of the Centers for Medicare &amp; Medicaid Services;</content></subparagraph><subparagraph identifier="/tII/s203/b/3/D" id="HC3679366EF1F4A178951FBD5D78DBDF5" class="bill-dtd-OLC" pagenum="10"><num value="D">(D)</num><content> the Assistant Secretary for Mental Health and Substance Use;</content></subparagraph><subparagraph identifier="/tII/s203/b/3/E" id="HCAB990003AC34DA4BC87E365AF687BA5" class="bill-dtd-OLC" pagenum="10"><num value="E">(E)</num><content> the Assistant Secretary of Labor for Occupational Safety and Health; and</content></subparagraph><subparagraph identifier="/tII/s203/b/3/F" id="H782137881F1E44708428C12A347E31E1" class="bill-dtd-OLC" pagenum="10"><num value="F">(F)</num><content> the Secretary of Veterans Affairs.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s203/c" id="HC8AC17AFFADC488FB483BC87A6B71DD2" class="bill-dtd-OLC" pagenum="10"><num value="c">(c)</num><heading> Annual reports.—</heading><content>Section 319C–2(i)(1) (42 U.S.C. 247d–3b(i)(1)) is amended by inserting after the first sentence the following: “<quotedText>In submitting reports under this paragraph, a coalition shall include information on the progress that the coalition has made toward the implementation of section 319C–3 (or barriers to progress, if any).</quotedText>”.</content></subsection><subsection identifier="/tII/s203/d" id="H68B6DE6A14534C4AA79550BE3EFFA843" class="bill-dtd-OLC" pagenum="10"><num value="d">(d)</num><heading> National Health Security Strategy Incorporation of Regionalized Emergency Preparedness and Response.—</heading><content>Subparagraph (G) of section 2802(b)(3) (<ref href="/us/usc/42/300hh-1">42 U.S.C. 300hh–1(b)(3)</ref>) is amended to read as follows:<quotedContent id="HF399B95D3D5F4351BF5C860260E4DA4E"><subparagraph identifier="/tII/s203/d/qB/G" id="H4E45FDDD34B64BCE8FBCDB82F0EFC4BB" class="bill-dtd-OLC" pagenum="10"><num value="G">“(G)</num><content> Optimizing a coordinated and flexible approach to the emergency response and medical surge capacity of hospitals, other health care facilities, critical care, trauma care (which may include trauma centers), and emergency medical systems.”</content></subparagraph></quotedContent>. </content></subsection><subsection identifier="/tII/s203/e" id="H35ACE1E7F900409F87C24D4E8BF2FCDE" class="bill-dtd-OLC" pagenum="10"><num value="e">(e)</num><heading> Improving State and local public health security.—</heading><paragraph identifier="/tII/s203/e/1" id="H1E1E184137AF4DF4806FD1D17054DA10" class="bill-dtd-OLC" pagenum="10"><num value="1">(1)</num><heading> State and local security.—</heading><content>Section 319C–1(e) (42 U.S.C. 247d–3a(e)) is amended by striking “<quotedText>, and local emergency plans.</quotedText>” and inserting “<quotedText>, local emergency plans, and any regional health care emergency preparedness and response system established pursuant to the applicable guidelines under section 319C–3.</quotedText>”.</content></paragraph><paragraph identifier="/tII/s203/e/2" id="HC5CD179BC4E8467CAACD2F14112BD5B3" class="bill-dtd-OLC" pagenum="10"><num value="2">(2)</num><heading> Partnerships.—</heading><chapeau>Section 319C–2(d)(1)(A) (42 U.S.C. 247d–3b(d)(1)(A)) is amended—</chapeau><subparagraph identifier="/tII/s203/e/2/A" id="H6AD06F567438413E9BFBC3721362681E" class="bill-dtd-OLC" pagenum="10"><num value="A">(A)</num><content> in clause (i), by striking “<quotedText>; and</quotedText>” and inserting “<quotedText>;</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s203/e/2/B" id="H84A7C6D09B93421CAD2DA72451149ADE" class="bill-dtd-OLC" pagenum="10"><num value="B">(B)</num><content> by redesignating clause (ii) as clause (iii); and</content></subparagraph><subparagraph identifier="/tII/s203/e/2/C" id="H2219F7DEE9E7436E99FA59A7C14E05A8" class="bill-dtd-OLC" pagenum="10"><num value="C">(C)</num><content> by inserting after clause (i) the following:<quotedContent id="HD76050E0C6F043EB9302D813CA5010DC"><clause identifier="/tII/s203/e/2/C/qB/ii" id="HC4971754EFEB48A0BFA8039EFA1F0585" class="bill-dtd-OLC" pagenum="10"><num value="ii">“(ii)</num><content> among one or more facilities in a regional health care emergency system under section 319C–3; and”</content></clause></quotedContent>.</content></subparagraph></paragraph></subsection></section><section identifier="/tII/s204" id="H26C830BFA6FF4D639A80C86C9B16950F" class="bill-dtd-OLC" pagenum="10"><num value="204">Sec. 204.</num><heading> Military and civilian partnership for trauma readiness.</heading><content><p class="indent0">Title XII (<ref href="/us/usc/42/300d">42 U.S.C. 300d</ref> et seq.) is amended by adding at the end the following new part:</p><?page 11?><quotedContent id="HAB8B9A54466B47149D78C9A10849C65D"><part identifier="/tII/s204/qB/ptI" id="H7B072A4C7312480F90CE6D217B3741E8" class="bill-dtd-OLC" pagenum="11"><num value="I">“Part I—</num><heading>Military and Civilian Partnership for Trauma Readiness Grant Program</heading><section identifier="/tII/s204/qB/ptI/s1291" id="H68D8814364EB489EA99A2C21F6AA6C0A" class="bill-dtd-OLC" pagenum="11"><num value="1291">“Sec. 1291.</num><heading> Military and Civilian Partnership for Trauma Readiness Grant Program.</heading><subsection identifier="/tII/s204/qB/ptI/s1291/a" id="H9690B2EF7A7C452CA1700658E6D009C1" class="bill-dtd-OLC" pagenum="11"><num value="a">“(a)</num><heading> Military trauma team placement program.—</heading><paragraph identifier="/tII/s204/qB/ptI/s1291/a/1" id="H15A2E264E0DE4B2E9BDA0D8E363298CA" class="bill-dtd-OLC" pagenum="11"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary, acting through the Assistant Secretary for Preparedness and Response and in consultation with the Secretary of Defense, shall award grants to not more than 20 eligible high-acuity trauma centers to enable military trauma teams to provide, on a full-time basis, trauma care and related acute care at such trauma centers.</content></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/a/2" id="H701C4E7165204F7591B2E5E4BD8EA347" class="bill-dtd-OLC" pagenum="11"><num value="2">“(2)</num><heading> Limitations.—</heading><chapeau>In the case of a grant awarded under paragraph (1) to an eligible high-acuity trauma center, such grant—</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/a/2/A" id="HF2644BEE8FFF4A4687D58889C78FE2A0" class="bill-dtd-OLC" pagenum="11"><num value="A">“(A)</num><content> shall be for a period of at least 3 years and not more than 5 years (and may be renewed at the end of such period); and</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/a/2/B" id="H651E7F2A7AEA4D3187C9AE3C61036F7C" class="bill-dtd-OLC" pagenum="11"><num value="B">“(B)</num><content> shall be in an amount that does not exceed $1,000,000 per year.</content></subparagraph></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/a/3" id="H2271798177BF4FB084FB79B8C64D5404" class="bill-dtd-OLC" pagenum="11"><num value="3">“(3)</num><heading> Availability of funds.—</heading><content>Notwithstanding section 1552 of title 31, United States Code, or any other provision of law, funds available to the Secretary for obligation for a grant under this subsection shall remain available for expenditure for 100 days after the last day of the performance period of such grant.</content></paragraph></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/b" id="H1B803E5B1A61441EB1E55EE7E5663F46" class="bill-dtd-OLC" pagenum="11"><num value="b">“(b)</num><heading> Military trauma care provider placement program.—</heading><paragraph identifier="/tII/s204/qB/ptI/s1291/b/1" id="H62126643DF764D618BD71376E71A7F3D" class="bill-dtd-OLC" pagenum="11"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary, acting through the Assistant Secretary for Preparedness and Response and in consultation with the Secretary of Defense, shall award grants to eligible trauma centers to enable military trauma care providers to provide trauma care and related acute care at such trauma centers.</content></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/b/2" id="HD88FD3F5970D4997BEA765D23C54159E" class="bill-dtd-OLC" pagenum="11"><num value="2">“(2)</num><heading> Limitations.—</heading><chapeau>In the case of a grant awarded under paragraph (1) to an eligible trauma center, such grant—</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/b/2/A" id="H58191EA36CD64DEBB8E19AD8913E0BD5" class="bill-dtd-OLC" pagenum="11"><num value="A">“(A)</num><content> shall be for a period of at least 1 year and not more than 3 years (and may be renewed at the end of such period); and</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/b/2/B" id="H8B848539AD9A4AE691A786B717944FAA" class="bill-dtd-OLC" pagenum="11"><num value="B">“(B)</num><chapeau> shall be in an amount that does not exceed, in a year—</chapeau><clause identifier="/tII/s204/qB/ptI/s1291/b/2/B/i" id="H69E65A55FF644A2697A1C1F8E06CDF5D" class="bill-dtd-OLC" pagenum="11"><num value="i">“(i)</num><content> $100,000 for each military trauma care provider that is a physician at such eligible trauma center; and</content></clause><clause identifier="/tII/s204/qB/ptI/s1291/b/2/B/ii" id="H363585E50F874B87AE505699CE2CA251" class="bill-dtd-OLC" pagenum="11"><num value="ii">“(ii)</num><content> $50,000 for each other military trauma care provider at such eligible trauma center.</content></clause></subparagraph></paragraph></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/c" id="H4F396005F4EE434A82BD23B1FC65A3EC" class="bill-dtd-OLC" pagenum="11"><num value="c">“(c)</num><heading> Grant requirements.—</heading><paragraph identifier="/tII/s204/qB/ptI/s1291/c/1" id="H7820018F048F472995D55FA7F4142555" class="bill-dtd-OLC" pagenum="11"><num value="1">“(1)</num><heading> Deployment and public health emergencies.—</heading><chapeau>As a condition of receipt of a grant under this section, a grant recipient shall agree to allow military trauma care providers providing care pursuant to such grant to—</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/c/1/A" id="H5FCF3CFF23924283A97A9180F47D12D1" class="bill-dtd-OLC" pagenum="11"><num value="A">“(A)</num><content> be deployed by the Secretary of Defense for military operations, for training, or for response to a mass casualty incident; and</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/c/1/B" id="H89271EFEF1724FFE91076E9EF00BBBF9" class="bill-dtd-OLC" pagenum="11"><num value="B">“(B)</num><content> be deployed by the Secretary of Defense, in consultation with the Secretary of Health and Human Services, <?page 12?>for response to a public health emergency pursuant to section 319.</content></subparagraph></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/c/2" id="H59F2107FE6DC4CA58487AF12642052B2" class="bill-dtd-OLC" pagenum="12"><num value="2">“(2)</num><heading> Use of funds.—</heading><content>Grants awarded under this section to an eligible trauma center may be used to train and incorporate military trauma care providers into such trauma center, including incorporation into operational exercises and training drills related to public health emergencies, expenditures for malpractice insurance, office space, information technology, specialty education and supervision, trauma programs, research, and applicable license fees for such military trauma care providers.</content></paragraph></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/d" id="HFBAC5B557F0D416A8BAD43051E436164" class="bill-dtd-OLC" pagenum="12"><num value="d">“(d)</num><heading> Rule of construction.—</heading><content>Nothing in this section shall be construed to affect any other provision of law that preempts State licensing requirements for health care professionals, including with respect to military trauma care providers.</content></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/e" id="H9E7F70584AB7493B9806A98C17AE392C" class="bill-dtd-OLC" pagenum="12"><num value="e">“(e)</num><heading> Reporting requirements.—</heading><paragraph identifier="/tII/s204/qB/ptI/s1291/e/1" id="HC415890655E0431197C775EF53902334" class="bill-dtd-OLC" pagenum="12"><num value="1">“(1)</num><heading> Report to the Secretary and the Secretary of Defense.—</heading><chapeau>Each eligible trauma center or eligible high-acuity trauma center awarded a grant under subsection (a) or (b) for a year shall submit to the Secretary and the Secretary of Defense a report for such year that includes information on—</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/1/A" id="H6187ECF7A1C24AFD9BC81EB5D6988DB6" class="bill-dtd-OLC" pagenum="12"><num value="A">“(A)</num><content> the number and types of trauma cases managed by military trauma teams or military trauma care providers pursuant to such grant during such year;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/1/B" id="H2E0EBB57E5CA41DFAB8BABFCA9EBFD0C" class="bill-dtd-OLC" pagenum="12"><num value="B">“(B)</num><content> the ability to maintain the integration of the military trauma providers or teams of providers as part of the trauma center, including the financial effect of such grant on the trauma center;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/1/C" id="HD990C9FF79694E1BA15803A1165549B2" class="bill-dtd-OLC" pagenum="12"><num value="C">“(C)</num><content> the educational effect on resident trainees in centers where military trauma teams are assigned;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/1/D" id="HF3A5DB39520D4E0C88A925C5958B1B38" class="bill-dtd-OLC" pagenum="12"><num value="D">“(D)</num><content> any research conducted during such year supported by such grant; and</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/1/E" id="H8CA31A27DD5547EF9164773B3C7F8D1D" class="bill-dtd-OLC" pagenum="12"><num value="E">“(E)</num><content> any other information required by the Secretaries for the purpose of evaluating the effect of such grant.</content></subparagraph></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/e/2" id="H5DAE1A182779419CA3B95FB30E785D1F" class="bill-dtd-OLC" pagenum="12"><num value="2">“(2)</num><heading> Report to Congress.—</heading><chapeau>Not less than once every 2 years, the Secretary, in consultation with the Secretary of Defense, shall submit a report to the congressional committees of jurisdiction that includes information on the effect of placing military trauma care providers in trauma centers awarded grants under this section on—</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/A" id="HBFFAF32A7EAE44AEB3BFB66ED71909BA" class="bill-dtd-OLC" pagenum="12"><num value="A">“(A)</num><content> maintaining military trauma care providers’ readiness and ability to respond to and treat battlefield injuries;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/B" id="H0F391D008AFE45F692D43F53BCE637AD" class="bill-dtd-OLC" pagenum="12"><num value="B">“(B)</num><content> providing health care to civilian trauma patients in urban and rural settings;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/C" id="H124BD885A966440E8708E5C1BFF13BA6" class="bill-dtd-OLC" pagenum="12"><num value="C">“(C)</num><content> the capability of trauma centers and military trauma care providers to increase medical surge capacity, including as a result of a large-scale event;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/D" id="H0F14354DE8444E469AB9794D140734DC" class="bill-dtd-OLC" pagenum="12"><num value="D">“(D)</num><content> the ability of grant recipients to maintain the integration of the military trauma providers or teams of providers as part of the trauma center;</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/E" id="HDAC65EB256F541F580F0A0F29A0F5767" class="bill-dtd-OLC" pagenum="12"><num value="E">“(E)</num><content> efforts to incorporate military trauma care providers into operational exercises and training and drills for public health emergencies; and</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/e/2/F" id="H1A1C26A58EA54412836AAB81B3FB1C7F" class="bill-dtd-OLC" pagenum="12"><num value="F">“(F)</num><content> the capability of military trauma care providers to participate as part of a medical response during or <?page 13?>in advance of a public health emergency, as determined by the Secretary, or a mass casualty incident.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/f" id="H9799C108F33A4337AAA15B61DF74677B" class="bill-dtd-OLC" pagenum="13"><num value="f">“(f)</num><heading> Definitions.—</heading><chapeau>For purposes of this part:</chapeau><paragraph identifier="/tII/s204/qB/ptI/s1291/f/1" id="H9E50173721DA4808A22C7E2E4459A3C6" class="bill-dtd-OLC" pagenum="13"><num value="1">“(1)</num><heading> Eligible high-acuity trauma center.—</heading><chapeau>The term ‘<term>eligible high-acuity trauma center</term>’ means a Level I trauma center that satisfies each of the following:</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/1/A" id="H2E7E44FF688240BE9FFECDD8B5FFA4AB" class="bill-dtd-OLC" pagenum="13"><num value="A">“(A)</num><content> Such trauma center has an agreement with the Secretary of Defense to enable military trauma teams to provide trauma care and related acute care at such trauma center.</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/1/B" id="H091FF3C4A205405DB44C93D648E1A25D" class="bill-dtd-OLC" pagenum="13"><num value="B">“(B)</num><content> At least 20 percent of patients treated at such trauma center in the most recent 3-month period for which data are available are treated for a major trauma at such trauma center.</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/1/C" id="H25DE2C53F4124B17AA9619AB6D2A8D43" class="bill-dtd-OLC" pagenum="13"><num value="C">“(C)</num><content> Such trauma center utilizes a risk-adjusted benchmarking system and metrics to measure performance, quality, and patient outcomes.</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/1/D" id="H6389DE1F5B4F405F89C39B5A30E9604C" class="bill-dtd-OLC" pagenum="13"><num value="D">“(D)</num><chapeau> Such trauma center is an academic training center—</chapeau><clause identifier="/tII/s204/qB/ptI/s1291/f/1/D/i" id="HCE2E8348C08747F98F5396F64EDED5CB" class="bill-dtd-OLC" pagenum="13"><num value="i">“(i)</num><content> affiliated with a medical school;</content></clause><clause identifier="/tII/s204/qB/ptI/s1291/f/1/D/ii" id="HC33A139FF55F488397C7092410686EDD" class="bill-dtd-OLC" pagenum="13"><num value="ii">“(ii)</num><content> that maintains residency programs and fellowships in critical trauma specialties and subspecialties, and provides education and supervision of military trauma team members according to those specialties and subspecialties; and</content></clause><clause identifier="/tII/s204/qB/ptI/s1291/f/1/D/iii" id="HE95DB3AC644346CEB2C622FD57EEAB72" class="bill-dtd-OLC" pagenum="13"><num value="iii">“(iii)</num><content> that undertakes research in the prevention and treatment of traumatic injury.</content></clause></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/1/E" id="H9A4632C4B3F54B3F90C93B36A3263BC0" class="bill-dtd-OLC" pagenum="13"><num value="E">“(E)</num><content> Such trauma center serves as a medical and public health preparedness and response leader for its community, such as by participating in a partnership for State and regional hospital preparedness established under section 319C–2 or 319C–3.</content></subparagraph></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/f/2" id="H8247FD49DBF745E7A340277B7DF11C69" class="bill-dtd-OLC" pagenum="13"><num value="2">“(2)</num><heading> Eligible trauma center.—</heading><chapeau>The term ‘<term>eligible trauma center</term>’ means a Level I, II, or III trauma center that satisfies each of the following:</chapeau><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/2/A" id="H3B6373CBE2B34440A6CDA7F2452D4014" class="bill-dtd-OLC" pagenum="13"><num value="A">“(A)</num><content> Such trauma center has an agreement with the Secretary of Defense to enable military trauma care providers to provide trauma care and related acute care at such trauma center.</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/2/B" id="H84404C89836A4B30B1D0D7C539F47C39" class="bill-dtd-OLC" pagenum="13"><num value="B">“(B)</num><content> Such trauma center utilizes a risk-adjusted benchmarking system and metrics to measure performance, quality, and patient outcomes.</content></subparagraph><subparagraph identifier="/tII/s204/qB/ptI/s1291/f/2/C" id="H79AC863F95D248BC8AC6DCAC83A8EA55" class="bill-dtd-OLC" pagenum="13"><num value="C">“(C)</num><content> Such trauma center demonstrates a need for integrated military trauma care providers to maintain or improve the trauma clinical capability of such trauma center.</content></subparagraph></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/f/3" id="HF6FC7CA090D94243BF86300F73A7483F" class="bill-dtd-OLC" pagenum="13"><num value="3">“(3)</num><heading> Major trauma.—</heading><content>The term ‘<term>major trauma</term>’ means an injury that is greater than or equal to 15 on the injury severity score.</content></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/f/4" id="H4DC23BF370F544CB8ECB5C467A8F8904" class="bill-dtd-OLC" pagenum="13"><num value="4">“(4)</num><heading> Military trauma team.—</heading><content>The term ‘<term>military trauma team</term>’ means a complete military trauma team consisting of military trauma care providers.</content></paragraph><paragraph identifier="/tII/s204/qB/ptI/s1291/f/5" id="HFDE5B7BA887140E38FDC2D366E98F119" class="bill-dtd-OLC" pagenum="13"><num value="5">“(5)</num><heading> Military trauma care provider.—</heading><content>The term ‘<term>military trauma care provider</term>’ means a member of the Armed Forces who furnishes emergency, critical care, and other trauma acute <?page 14?>care services (including a physician, surgeon, physician assistant, nurse, nurse practitioner, respiratory therapist, flight paramedic, combat medic, or enlisted medical technician) or other military trauma care provider as the Secretary determines appropriate.</content></paragraph></subsection><subsection identifier="/tII/s204/qB/ptI/s1291/g" id="H20798C68000C4B48A0525C4DEAB0017F" class="bill-dtd-OLC" pagenum="14"><num value="g">“(g)</num><heading> Authorization of appropriations.—</heading><content>To carry out this section, there is authorized to be appropriated $11,500,000 for each of fiscal years 2019 through 2023.”</content></subsection></section></part></quotedContent>.</content></section><section identifier="/tII/s205" id="H02E2D82161744F9DA7AFFE2AA47D69A2" class="bill-dtd-OLC" pagenum="14"><num value="205">Sec. 205.</num><heading> Public health and health care system situational awareness and biosurveillance capabilities.</heading><subsection identifier="/tII/s205/a" id="H64315BC139654372A593EA1518C51967" class="bill-dtd-OLC" pagenum="14"><num value="a">(a)</num><heading> Facilities, capacities, and biosurveillance capabilities.—</heading><chapeau>Section 319D (<ref href="/us/usc/42/247d-4">42 U.S.C. 247d–4</ref>) is amended—</chapeau><paragraph identifier="/tII/s205/a/1" id="H3326BB2316CD442DBB9EF1C623E09689" class="bill-dtd-OLC" pagenum="14"><num value="1">(1)</num><content> in the section heading, by striking “<quotedText><inline class="allCaps"><b>Revitalizing</b></inline></quotedText>” and inserting “<quotedText><inline class="allCaps"><b>Facilities and capacities of</b></inline></quotedText>”;</content></paragraph><paragraph identifier="/tII/s205/a/2" id="H870BE98C00294B9D9890DC8E239E0531" class="bill-dtd-OLC" pagenum="14"><num value="2">(2)</num><chapeau> in subsection (a)—</chapeau><subparagraph identifier="/tII/s205/a/2/A" id="HE746766CB3B8401492671812FADE328A" class="bill-dtd-OLC" pagenum="14"><num value="A">(A)</num><content> in the subsection heading, by striking “<quotedText><inline class="smallCaps">Facilities; capacities</inline></quotedText>” and inserting “<quotedText><inline class="smallCaps">In general</inline></quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s205/a/2/B" id="HB02751AC3F13467585CC7D507DD5F46D" class="bill-dtd-OLC" pagenum="14"><num value="B">(B)</num><content> in paragraph (1), by striking “<quotedText>and improved</quotedText>” and inserting “<quotedText>, improved, and appropriately maintained</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s205/a/2/C" id="H9D23AEFABD204FFF8CAFFFCBFA4957E4" class="bill-dtd-OLC" pagenum="14"><num value="C">(C)</num><content> in paragraph (3), in the matter preceding subparagraph (A), by striking “<quotedText>expand, enhance, and improve</quotedText>” and inserting “<quotedText>expand, improve, enhance, and appropriately maintain</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s205/a/2/D" id="H7E31C02F0E7B4ABD81873D65929A2D5E" class="bill-dtd-OLC" pagenum="14"><num value="D">(D)</num><content> by adding at the end the following:<quotedContent id="H1D412836E58A444C9EEFAF47E2288565"><paragraph identifier="/tII/s205/a/2/D/qB/4" id="H888524711B92452D9C83EE5F172DF2B2" class="bill-dtd-OLC" pagenum="14"><num value="4">“(4)</num><heading> Study of resources for facilities and capacities.—</heading><content>Not later than June 1, 2022, the Comptroller General of the United States shall conduct a study on Federal spending in fiscal years 2013 through 2018 for activities authorized under this subsection. Such study shall include a review and assessment of obligations and expenditures directly related to each activity under paragraphs (2) and (3), including a specific accounting of, and delineation between, obligations and expenditures incurred for the construction, renovation, equipping, and security upgrades of facilities and associated contracts under this subsection, and the obligations and expenditures incurred to establish and improve the situational awareness and biosurveillance network under subsection (b), and shall identify the agency or agencies incurring such obligations and expenditures.”</content></paragraph></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tII/s205/a/3" id="H59B95E9048E946F59E128FEE19490DF3" class="bill-dtd-OLC" pagenum="14"><num value="3">(3)</num><chapeau> in subsection (b)—</chapeau><subparagraph identifier="/tII/s205/a/3/A" id="HCD86645D833045F4A39CA4170B76E29A" class="bill-dtd-OLC" pagenum="14"><num value="A">(A)</num><content> in the subsection heading, by striking “<quotedText><inline class="smallCaps">national</inline></quotedText>” and inserting “<quotedText><inline class="smallCaps">Establishment of systems of public health</inline></quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s205/a/3/B" id="H7E56761CAE7E4BA6A42AEEC5775DBBE6" class="bill-dtd-OLC" pagenum="14"><num value="B">(B)</num><content> in paragraph (1)(B), by inserting “<quotedText>immunization information systems,</quotedText>” after “<quotedText>centers,</quotedText>”;</content></subparagraph><subparagraph identifier="/tII/s205/a/3/C" id="H56B842FE4F804C89BCB59F4C19490F76" class="bill-dtd-OLC" pagenum="14"><num value="C">(C)</num><chapeau> in paragraph (2)—</chapeau><clause identifier="/tII/s205/a/3/C/i" id="HF9595B9E249249FBA749683FD577450A" class="bill-dtd-OLC" pagenum="14"><num value="i">(i)</num><content> by inserting “<quotedText>develop a plan to, and</quotedText>” after “<quotedText>The Secretary shall</quotedText>”; and</content></clause><clause identifier="/tII/s205/a/3/C/ii" id="H00EFD7C065034D98ADBBCBE04C1E4B2D" class="bill-dtd-OLC" pagenum="14"><num value="ii">(ii)</num><content> by inserting “<quotedText>and in a form readily usable for analytical approaches</quotedText>” after “<quotedText>in a secure manner</quotedText>”; and</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/3/D" id="HB9F82DE97066490DB8CE72B71BE39A61" class="bill-dtd-OLC" pagenum="14"><num value="D">(D)</num><content> by amending paragraph (3) to read as follows:<quotedContent id="HDD6C2162CAEF4F4F829007649AC27DE3"><paragraph identifier="/tII/s205/a/3/D/qB/3" id="H195B80DD1B1D46AAB47DD2A5229DE306" class="bill-dtd-OLC" pagenum="14"><num value="3">“(3)</num><heading> Standards.—</heading><subparagraph identifier="/tII/s205/a/3/D/qB/3/A" id="HE699E7EC667C476F9034F834089E48AD" class="bill-dtd-OLC" pagenum="14"><num value="A">“(A)</num><heading> In general.—</heading><content>Not later than 1 year after the date of the enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the <?page 15?>Secretary, in cooperation with health care providers, State, local, Tribal, and territorial public health officials, and relevant Federal agencies (including the Office of the National Coordinator for Health Information Technology and the National Institute of Standards and Technology), shall, as necessary, adopt technical and reporting standards, including standards for interoperability as defined by section 3000, for networks under paragraph (1) and update such standards as necessary. Such standards shall be made available on the internet website of the Department of Health and Human Services, in a manner that does not compromise national security.</content></subparagraph><subparagraph identifier="/tII/s205/a/3/D/qB/3/B" id="H8AA32C594F9446B9B683083D94BD7E85" class="bill-dtd-OLC" pagenum="15"><num value="B">“(B)</num><heading> Deference to standards development organizations.—</heading><content>In adopting and implementing standards under this subsection and subsection (c), the Secretary shall give deference to standards published by standards development organizations and voluntary consensus-based standards entities.”</content></subparagraph></paragraph></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tII/s205/a/4" id="H5F9E0C5AB0054D8AB72D1EDA9ED51823" class="bill-dtd-OLC" pagenum="15"><num value="4">(4)</num><chapeau> in subsection (c)—</chapeau><subparagraph identifier="/tII/s205/a/4/A" id="H0A03375690394BC7A115BBB823928C7F" class="bill-dtd-OLC" pagenum="15"><num value="A">(A)</num><chapeau> in paragraph (1)—</chapeau><clause identifier="/tII/s205/a/4/A/i" id="HAA8B3B2869B14D7D909F6FA729AC8F41" class="bill-dtd-OLC" pagenum="15"><num value="i">(i)</num><content> by striking “<quotedText>Not later than 2 years after the date of enactment of the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, the Secretary</quotedText>” and inserting “<quotedText>The Secretary</quotedText>”;</content></clause><clause identifier="/tII/s205/a/4/A/ii" id="H125A936BB46C463A8830D7B45E3DA7B9" class="bill-dtd-OLC" pagenum="15"><num value="ii">(ii)</num><content> by inserting “<quotedText>, and improve as applicable and appropriate,</quotedText>” after “<quotedText>shall establish</quotedText>”;</content></clause><clause identifier="/tII/s205/a/4/A/iii" id="H421BA8E5C2824415BFFCF12E2C24DD47" class="bill-dtd-OLC" pagenum="15"><num value="iii">(iii)</num><content> by striking “<quotedText>of rapid</quotedText>” and inserting “<quotedText>of, rapid</quotedText>”; and</content></clause><clause identifier="/tII/s205/a/4/A/iv" id="H9FFE62F66941489FB996AFDB4C18E780" class="bill-dtd-OLC" pagenum="15"><num value="iv">(iv)</num><content> by striking “<quotedText>such connectivity</quotedText>” and inserting “<quotedText>such interoperability</quotedText>”;</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/4/B" id="H7BC778347A0242F8B0B543EF18A4FF40" class="bill-dtd-OLC" pagenum="15"><num value="B">(B)</num><content> by amending paragraph (2) to read as follows:<quotedContent id="H3AAB05B00AD442F8A250D50FA3F8F47B"><paragraph identifier="/tII/s205/a/4/B/qB/2" id="H3817F27402F94AC1B9F9BC32A19A2EBC" class="bill-dtd-OLC" pagenum="15"><num value="2">“(2)</num><heading> Coordination and consultation.—</heading><chapeau>In establishing and improving the network under paragraph (1), the Secretary shall—</chapeau><subparagraph identifier="/tII/s205/a/4/B/qB/2/A" id="H3AB146192C4749FC840D270026181DFC" class="bill-dtd-OLC" pagenum="15"><num value="A">“(A)</num><content> facilitate coordination among agencies within the Department of Health and Human Services that provide, or have the potential to provide, information and data to, and analyses for, the situational awareness and biosurveillance network under paragraph (1), including coordination among relevant agencies related to health care services, the facilitation of health information exchange (including the Office of the National Coordinator for Health Information Technology), and public health emergency preparedness and response; and</content></subparagraph><subparagraph identifier="/tII/s205/a/4/B/qB/2/B" id="H585E3A11AD684C6D9E1D291475817D8C" class="bill-dtd-OLC" pagenum="15"><num value="B">“(B)</num><content> consult with the Secretary of Agriculture, the Secretary of Commerce (and the Director of the National Institute of Standards and Technology), the Secretary of Defense, the Secretary of Homeland Security, the Secretary of Veterans Affairs, and the heads of other Federal agencies, as the Secretary determines appropriate.”</content></subparagraph></paragraph></quotedContent>;</content></subparagraph><subparagraph identifier="/tII/s205/a/4/C" id="H3ADBBF9B6B184360A5F008E2B194C3CA" class="bill-dtd-OLC" pagenum="15"><num value="C">(C)</num><chapeau> in paragraph (3)—</chapeau><clause identifier="/tII/s205/a/4/C/i" id="H7DDD8F81F47E4FE2864FA290296F86D2" class="bill-dtd-OLC" pagenum="15"><num value="i">(i)</num><content> by redesignating subparagraphs (A) through (E) as clauses (i) through (v), respectively, and adjusting the margins accordingly;</content></clause><clause identifier="/tII/s205/a/4/C/ii" id="H64B73A81BC4F41D9A6D590580BA96EAD" class="bill-dtd-OLC" pagenum="15"><num value="ii">(ii)</num><chapeau> in clause (iv), as so redesignated—</chapeau><subclause identifier="/tII/s205/a/4/C/ii/I" id="HAE544BD497BE4E64BD8F9D8EA9F23536" class="bill-dtd-OLC" pagenum="15"><num value="I">(I)</num><content> by inserting “<quotedText>immunization information systems,</quotedText>” after “<quotedText>poison control,</quotedText>”; and</content></subclause><?page 16?><subclause identifier="/tII/s205/a/4/C/ii/II" id="H1D2E6DA8B1864814BA40B7EBA2D70263" class="bill-dtd-OLC" pagenum="16"><num value="II">(II)</num><content> by striking “<quotedText>and clinical laboratories</quotedText>” and inserting “<quotedText>, clinical laboratories, and public environmental health agencies</quotedText>”;</content></subclause></clause><clause identifier="/tII/s205/a/4/C/iii" id="H6F86B7B6FB4543BC8511BE7AF3761899" class="bill-dtd-OLC" pagenum="16"><num value="iii">(iii)</num><content> by striking “<quotedText>The network</quotedText>” and inserting the following:<quotedContent id="HADC0D55CC63842C3B5DD91BB60464B17"><subparagraph identifier="/tII/s205/a/4/C/iii/qB/A" id="HED0AB5C329614329ABE81A05652DA00D" class="bill-dtd-OLC" pagenum="16"><num value="A">“(A)</num><heading> In general.—</heading><content>The network”</content></subparagraph></quotedContent>; and</content></clause><clause identifier="/tII/s205/a/4/C/iv" id="H841AD7A0DA574B3EB858F4101FA2863F" class="bill-dtd-OLC" pagenum="16"><num value="iv">(iv)</num><content> by adding at the end the following:<quotedContent id="HA12FBB9080A846B9AF5C14BDD194A9C4"><subparagraph identifier="/tII/s205/a/4/C/iv/qB/B" id="H66CAA5AA489740E896022F659C50C51E" class="bill-dtd-OLC" pagenum="16"><num value="B">“(B)</num><heading> Review.—</heading><content>Not later than 2 years after the date of the enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle> and every 6 years thereafter, the Secretary shall conduct a review of the elements described in subparagraph (A). Such review shall include a discussion of the addition of any elements pursuant to clause (v), including elements added to advancing new technologies, and identify any challenges in the incorporation of elements under subparagraph (A). The Secretary shall provide such review to the congressional committees of jurisdiction.”</content></subparagraph></quotedContent>; </content></clause></subparagraph><subparagraph identifier="/tII/s205/a/4/D" id="H486B89443BEA49A4A98B991023117D18" class="bill-dtd-OLC" pagenum="16"><num value="D">(D)</num><chapeau> in paragraph (5)—</chapeau><clause identifier="/tII/s205/a/4/D/i" id="HB93BB29284D440B688337E0D0215DBB9" class="bill-dtd-OLC" pagenum="16"><num value="i">(i)</num><content> by redesignating subparagraphs (A) through (D) as clauses (i) through (iv), respectively, and adjusting the margins accordingly;</content></clause><clause identifier="/tII/s205/a/4/D/ii" id="H1F15FA2EFA2E42A88E3CF08C3ECEAE9F" class="bill-dtd-OLC" pagenum="16"><num value="ii">(ii)</num><content> by striking “<quotedText>In establishing</quotedText>” and inserting the following:<quotedContent id="HF91144F8A6DA4CBF86B1B179681311CE"><subparagraph identifier="/tII/s205/a/4/D/ii/qB/A" id="H43C603E1A64F453F996A92670C973E98" class="bill-dtd-OLC" pagenum="16"><num value="A">“(A)</num><heading> In general.—</heading><content>In establishing”</content></subparagraph></quotedContent>; </content></clause><clause identifier="/tII/s205/a/4/D/iii" id="HC8455CF8F07441178CB54AE0B33AD6FE" class="bill-dtd-OLC" pagenum="16"><num value="iii">(iii)</num><content> by adding at the end the following:<quotedContent id="HA11E18E27B2F4FC8859FC9BBC9B77BF1"><subparagraph identifier="/tII/s205/a/4/D/iii/qB/B" id="H98B0FD135FA44FF88E0224DD96DE14C2" class="bill-dtd-OLC" pagenum="16"><num value="B">“(B)</num><heading> Public meeting.—</heading><clause identifier="/tII/s205/a/4/D/iii/qB/B/i" id="H3F778358E6E24893B301D2CA14E7CE29" class="bill-dtd-OLC" pagenum="16"><num value="i">“(i)</num><heading> In general.—</heading><content>Not later than 180 days after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Secretary shall convene a public meeting for purposes of discussing and providing input on the potential goals, functions, and uses of the network described in paragraph (1) and incorporating the elements described in paragraph (3)(A).</content></clause><clause identifier="/tII/s205/a/4/D/iii/qB/B/ii" id="HCC671CB265534915B8A9F09E99F69ABB" class="bill-dtd-OLC" pagenum="16"><num value="ii">“(ii)</num><heading> Experts.—</heading><content>The public meeting shall include representatives of relevant Federal agencies (including representatives from the Office of the National Coordinator for Health Information Technology and the National Institute of Standards and Technology); State, local, Tribal, and territorial public health officials; stakeholders with expertise in biosurveillance and situational awareness; stakeholders with expertise in capabilities relevant to biosurveillance and situational awareness, such as experts in informatics and data analytics (including experts in prediction, modeling, or forecasting); and other representatives as the Secretary determines appropriate.</content></clause><clause identifier="/tII/s205/a/4/D/iii/qB/B/iii" id="HCF9C1ED0C9944D6899747F24A51B77BC" class="bill-dtd-OLC" pagenum="16"><num value="iii">“(iii)</num><heading> Topics.—</heading><chapeau>Such public meeting shall include a discussion of—</chapeau><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/I" id="HDB946B43C4B6460A8A848727AB1BF998" class="bill-dtd-OLC" pagenum="16"><num value="I">“(I)</num><content> data elements, including minimal or essential data elements, that are voluntarily provided for such network, which may include elements from public health and public and private health care entities, to the extent practicable;</content></subclause><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/II" id="HC6E4785F422045F68F0A36EE94B8CAB8" class="bill-dtd-OLC" pagenum="16"><num value="II">“(II)</num><content> standards and implementation specifications that may improve the collection, analysis, <?page 17?>and interpretation of data during a public health emergency;</content></subclause><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/III" id="H951692740EC5448CA09B7B80FADCCA07" class="bill-dtd-OLC" pagenum="17"><num value="III">“(III)</num><content> strategies to encourage the access, exchange, and use of information;</content></subclause><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/IV" id="H6B03B52A9C2B4721BD0453486A8670A5" class="bill-dtd-OLC" pagenum="17"><num value="IV">“(IV)</num><content> considerations for State, local, Tribal, and territorial capabilities and infrastructure related to data exchange and interoperability;</content></subclause><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/V" id="HEBEF3EBE907847F48E9036E03DD7889D" class="bill-dtd-OLC" pagenum="17"><num value="V">“(V)</num><content> privacy and security protections provided at the Federal, State, local, Tribal, and territorial levels, and by nongovernmental stakeholders; and</content></subclause><subclause identifier="/tII/s205/a/4/D/iii/qB/B/iii/VI" id="HD2E16BC40E0543E6AC11A7F06C63ED2B" class="bill-dtd-OLC" pagenum="17"><num value="VI">“(VI)</num><content> opportunities for the incorporation of innovative technologies to improve the network.”</content></subclause></clause></subparagraph></quotedContent>; and</content></clause><clause identifier="/tII/s205/a/4/D/iv" id="H1181F4A7187F4F17854CA44296B24BEA" class="bill-dtd-OLC" pagenum="17"><num value="iv">(iv)</num><chapeau> in subparagraph (A), as so designated by clause (ii)—</chapeau><subclause identifier="/tII/s205/a/4/D/iv/I" id="H99693E052B494BCC82B9222ED06D706F" class="bill-dtd-OLC" pagenum="17"><num value="I">(I)</num><chapeau> in clause (i), as so redesignated—</chapeau><item identifier="/tII/s205/a/4/D/iv/I/aa" id="HBE02FDB09D4544BFAC037C1038715192" class="bill-dtd-OLC" pagenum="17"><num value="aa">(aa)</num><content> by striking “<quotedText>as determined</quotedText>” and inserting “<quotedText>as adopted</quotedText>”; and</content></item><item identifier="/tII/s205/a/4/D/iv/I/bb" id="HF5541513B1D746779EBE1628D561B111" class="bill-dtd-OLC" pagenum="17"><num value="bb">(bb)</num><content> by inserting “<quotedText>and the National Institute of Standards and Technology</quotedText>” after “<quotedText>Office of the National Coordinator for Health Information Technology</quotedText>”;</content></item></subclause><subclause identifier="/tII/s205/a/4/D/iv/II" id="H9C8E287AB20944B9A52CAD73DA1E1009" class="bill-dtd-OLC" pagenum="17"><num value="II">(II)</num><content> in clause (iii), as so redesignated, by striking “<quotedText>; and</quotedText>” and inserting a semicolon;</content></subclause><subclause identifier="/tII/s205/a/4/D/iv/III" id="HC4F7E5415A8140F5B389E39DAA0BAFEE" class="bill-dtd-OLC" pagenum="17"><num value="III">(III)</num><content> in clause (iv), as so redesignated, by striking the period and inserting “<quotedText>; and</quotedText>”; and</content></subclause><subclause identifier="/tII/s205/a/4/D/iv/IV" id="H78111672BCD344029F45A5EC40BCD77A" class="bill-dtd-OLC" pagenum="17"><num value="IV">(IV)</num><content> by adding at the end the following:<quotedContent id="H8F96CD652C4746EBA1F03550AB3F36D6"><clause identifier="/tII/s205/a/4/D/iv/IV/qB/v" id="HEA9505695C244DC4AC9658F70266F86E" class="bill-dtd-OLC" pagenum="17"><num value="v">“(v)</num><content> pilot test standards and implementation specifications, consistent with the process described in section 3002(b)(3)(C), which State, local, Tribal, and territorial public health entities may utilize, on a voluntary basis, as a part of the network.”</content></clause></quotedContent>; </content></subclause></clause></subparagraph><subparagraph identifier="/tII/s205/a/4/E" id="HEBF734E9802A4047982C41718F6CCA55" class="bill-dtd-OLC" pagenum="17"><num value="E">(E)</num><content> by redesignating paragraph (6) as paragraph (7);</content></subparagraph><subparagraph identifier="/tII/s205/a/4/F" id="H1B68CAD6F1F0472480BF9FA80F2FF222" class="bill-dtd-OLC" pagenum="17"><num value="F">(F)</num><content> by inserting after paragraph (5) the following:<quotedContent id="H325154D05BBE45E8A9A2EB231E90378D"><paragraph identifier="/tII/s205/a/4/F/qB/6" id="HEEA6405819D04CA58B2D28574BE31290" class="bill-dtd-OLC" pagenum="17"><num value="6">“(6)</num><heading> Strategy and implementation plan.—</heading><subparagraph identifier="/tII/s205/a/4/F/qB/6/A" id="H8DD4878F404F4A3BA0950AA7C4EE082D" class="bill-dtd-OLC" pagenum="17"><num value="A">“(A)</num><heading> In general.—</heading><chapeau>Not later than 18 months after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Secretary shall submit to the congressional committees of jurisdiction a coordinated strategy and an accompanying implementation plan that—</chapeau><clause identifier="/tII/s205/a/4/F/qB/6/A/i" id="H1EC869E2F59D4977BC79F67B64F5D025" class="bill-dtd-OLC" pagenum="17"><num value="i">“(i)</num><content> is informed by the public meeting under paragraph (5)(B);</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/A/ii" id="HD83E948F026A4BFE80159E95759BABFE" class="bill-dtd-OLC" pagenum="17"><num value="ii">“(ii)</num><content> includes a review and assessment of existing capabilities of the network and related infrastructure, including input provided by the public meeting under paragraph (5)(B);</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/A/iii" id="H096D91834A9744C8BE08248B41B07434" class="bill-dtd-OLC" pagenum="17"><num value="iii">“(iii)</num><chapeau> identifies and demonstrates the measurable steps the Secretary will carry out to—</chapeau><subclause identifier="/tII/s205/a/4/F/qB/6/A/iii/I" id="H0C70BB3D40B64D2D9421C83549DE7192" class="bill-dtd-OLC" pagenum="17"><num value="I">“(I)</num><content> develop, implement, and evaluate the network described in paragraph (1), utilizing elements described in paragraph (3)(A);</content></subclause><subclause identifier="/tII/s205/a/4/F/qB/6/A/iii/II" id="H19A55992502741A6B88F138C43DBA3F8" class="bill-dtd-OLC" pagenum="17"><num value="II">“(II)</num><content> modernize and enhance biosurveillance activities, including strategies to include innovative technologies and analytical approaches (including prediction and forecasting for pandemics and all-hazards) from public and private entities;</content></subclause><?page 18?><subclause identifier="/tII/s205/a/4/F/qB/6/A/iii/III" id="HE9E7B6D20CA048AE9E7BDA4C7C77599B" class="bill-dtd-OLC" pagenum="18"><num value="III">“(III)</num><content> improve information sharing, coordination, and communication among disparate biosurveillance systems supported by the Department of Health and Human Services, including the identification of methods to improve accountability, better utilize resources and workforce capabilities, and incorporate innovative technologies within and across agencies; and</content></subclause><subclause identifier="/tII/s205/a/4/F/qB/6/A/iii/IV" id="H143003DFE9FA4A3395EA25ABB0A60F2C" class="bill-dtd-OLC" pagenum="18"><num value="IV">“(IV)</num><content> test and evaluate capabilities of the interoperable network of systems to improve situational awareness and biosurveillance capabilities;</content></subclause></clause><clause identifier="/tII/s205/a/4/F/qB/6/A/iv" id="HC66344F2FC394FE0826D2968F066A640" class="bill-dtd-OLC" pagenum="18"><num value="iv">“(iv)</num><content> includes performance measures and the metrics by which performance measures will be assessed with respect to the measurable steps under clause (iii); and</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/A/v" id="HDFE037B449D24D7E9439B285B99CC9D3" class="bill-dtd-OLC" pagenum="18"><num value="v">“(v)</num><content> establishes dates by which each measurable step under clause (iii) will be implemented.</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/4/F/qB/6/B" id="HD628BC9A6CBC4B02897BB4F3B1E0EEBF" class="bill-dtd-OLC" pagenum="18"><num value="B">“(B)</num><heading> Annual budget plan.—</heading><chapeau>Not later than 2 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle> and on an annual basis thereafter, in accordance with the strategy and implementation plan under this paragraph, the Secretary shall, taking into account recommendations provided by the National Biodefense Science Board, develop a budget plan based on the strategy and implementation plan under this section. Such budget plan shall include—</chapeau><clause identifier="/tII/s205/a/4/F/qB/6/B/i" id="HAE908724A14848E8817F5A22166386AE" class="bill-dtd-OLC" pagenum="18"><num value="i">“(i)</num><content> a summary of resources previously expended to establish, improve, and utilize the nationwide public health situational awareness and biosurveillance network under paragraph (1);</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/B/ii" id="HC8368FAF2ABB40AABEFC2E709BE01186" class="bill-dtd-OLC" pagenum="18"><num value="ii">“(ii)</num><content> estimates of costs and resources needed to establish and improve the network under paragraph (1) according to the strategy and implementation plan under subparagraph (A);</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/B/iii" id="H22013CF5F98F4C99917EFD422F61CE18" class="bill-dtd-OLC" pagenum="18"><num value="iii">“(iii)</num><content> the identification of gaps and inefficiencies in nationwide public health situational awareness and biosurveillance capabilities, resources, and authorities needed to address such gaps; and</content></clause><clause identifier="/tII/s205/a/4/F/qB/6/B/iv" id="H309E9652B29E45E3BE1D5EDE6E062AE6" class="bill-dtd-OLC" pagenum="18"><num value="iv">“(iv)</num><content> a strategy to minimize and address such gaps and improve inefficiencies.”</content></clause></subparagraph></paragraph></quotedContent>;</content></subparagraph><subparagraph identifier="/tII/s205/a/4/G" id="H32E5C3D46DE44EB5A2F88EF4FAB9036A" class="bill-dtd-OLC" pagenum="18"><num value="G">(G)</num><chapeau> in paragraph (7), as so redesignated—</chapeau><clause identifier="/tII/s205/a/4/G/i" id="H1A13B56DAD044012BC33C19719778DAD" class="bill-dtd-OLC" pagenum="18"><num value="i">(i)</num><content> in subparagraph (A), by inserting “<quotedText>(taking into account zoonotic disease, including gaps in scientific understanding of the interactions between human, animal, and environmental health)</quotedText>” after “<quotedText>human health</quotedText>”;</content></clause><clause identifier="/tII/s205/a/4/G/ii" id="HD26AA923FFD54444B5B51B8BFF474094" class="bill-dtd-OLC" pagenum="18"><num value="ii">(ii)</num><chapeau> in subparagraph (B)—</chapeau><subclause identifier="/tII/s205/a/4/G/ii/I" id="HCA88F91F24E44B9AA002EEB429BE1D1C" class="bill-dtd-OLC" pagenum="18"><num value="I">(I)</num><content> by inserting “<quotedText>and gaps in surveillance programs</quotedText>” after “<quotedText>surveillance programs</quotedText>”; and</content></subclause><subclause identifier="/tII/s205/a/4/G/ii/II" id="H79F50725F4D14CA99F1F63115C5A4F13" class="bill-dtd-OLC" pagenum="18"><num value="II">(II)</num><content> by striking “<quotedText>; and</quotedText>” and inserting a semicolon;</content></subclause></clause><clause identifier="/tII/s205/a/4/G/iii" id="H03200F21482D42DFA3012901955E4229" class="bill-dtd-OLC" pagenum="18"><num value="iii">(iii)</num><chapeau> in subparagraph (C)—</chapeau><subclause identifier="/tII/s205/a/4/G/iii/I" id="H5E2EC547A31644C494BD54E05A88D723" class="bill-dtd-OLC" pagenum="18"><num value="I">(I)</num><content> by inserting “<quotedText>, animal health organizations related to zoonotic disease,</quotedText>” after “<quotedText>health care entities</quotedText>”; and</content></subclause><?page 19?><subclause identifier="/tII/s205/a/4/G/iii/II" id="H20478D21B2D54B57A983DD16EC2DAF39" class="bill-dtd-OLC" pagenum="19"><num value="II">(II)</num><content> by striking the period and inserting “<quotedText>; and</quotedText>”; and</content></subclause></clause><clause identifier="/tII/s205/a/4/G/iv" id="H11BB0B19DDCF4F0494297791C741CAA0" class="bill-dtd-OLC" pagenum="19"><num value="iv">(iv)</num><content> by adding at the end the following:<quotedContent id="HB6810FB3C9D44C318EDC30AA44EF2B60"><subparagraph identifier="/tII/s205/a/4/G/iv/qB/D" id="HA26F6ABE0AA9488193897DB3B0418566" class="bill-dtd-OLC" pagenum="19"><num value="D">“(D)</num><content> provide recommendations to the Secretary on policies and procedures to complete the steps described in this paragraph in a manner that is consistent with section 2802.”</content></subparagraph></quotedContent>; and</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/4/H" id="H4D1620A1AD6B44E89E70A952CB68E098" class="bill-dtd-OLC" pagenum="19"><num value="H">(H)</num><content> by adding at the end the following:<quotedContent id="H3230122EF7E64389A11E3739081C9967"><paragraph identifier="/tII/s205/a/4/H/qB/8" id="HF87FACD54D434E1495A8A476DA526C90" class="bill-dtd-OLC" pagenum="19"><num value="8">“(8)</num><heading> Situational awareness and biosurveillance as a national security priority.—</heading><content>The Secretary, on a periodic basis as applicable and appropriate, shall meet with the Director of National Intelligence to inform the development and capabilities of the nationwide public health situational awareness and biosurveillance network.”</content></paragraph></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tII/s205/a/5" id="HBE37A067059A436AB7D7DAFF55D0A073" class="bill-dtd-OLC" pagenum="19"><num value="5">(5)</num><chapeau> in subsection (d)—</chapeau><subparagraph identifier="/tII/s205/a/5/A" id="H4034138DB6A54F71AEA74E7CC1FF57A6" class="bill-dtd-OLC" pagenum="19"><num value="A">(A)</num><chapeau> in paragraph (1)—</chapeau><clause identifier="/tII/s205/a/5/A/i" id="H40831FEBB0BA4E35913D03CC208C714E" class="bill-dtd-OLC" pagenum="19"><num value="i">(i)</num><content> by inserting “<quotedText>environmental health agencies,</quotedText>” after “<quotedText>public health agencies,</quotedText>”; and</content></clause><clause identifier="/tII/s205/a/5/A/ii" id="H313DDFB13AA64B67AE5CB487BD139F8C" class="bill-dtd-OLC" pagenum="19"><num value="ii">(ii)</num><content> by inserting “<quotedText>immunization programs,</quotedText>” after “<quotedText>poison control centers,</quotedText>”;</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/5/B" id="H5570218F1C1341F1A1F7689A16A4AE8A" class="bill-dtd-OLC" pagenum="19"><num value="B">(B)</num><chapeau> in paragraph (2)—</chapeau><clause identifier="/tII/s205/a/5/B/i" id="HCC5875726FD242F0B536BB2ACBB9E50B" class="bill-dtd-OLC" pagenum="19"><num value="i">(i)</num><content> in subparagraph (B), by striking “<quotedText>and</quotedText>” at the end;</content></clause><clause identifier="/tII/s205/a/5/B/ii" id="H25B2CDDB64654B1D8F0054C25914B56E" class="bill-dtd-OLC" pagenum="19"><num value="ii">(ii)</num><content> in subparagraph (C), by striking the period and inserting “<quotedText>; and</quotedText>”; and</content></clause><clause identifier="/tII/s205/a/5/B/iii" id="HEA895F0E2F0149A08615FDFCC46A0F7C" class="bill-dtd-OLC" pagenum="19"><num value="iii">(iii)</num><content> by adding after subparagraph (C) the following:<quotedContent id="HBF1C859700E943C99E7F01A495D9EE41"><subparagraph identifier="/tII/s205/a/5/B/iii/qB/D" id="H952136526683429A891B9FC6769438B4" class="bill-dtd-OLC" pagenum="19"><num value="D">“(D)</num><content> an implementation plan that may include measurable steps to achieve the purposes described in paragraph (1).”</content></subparagraph></quotedContent>; and</content></clause></subparagraph><subparagraph identifier="/tII/s205/a/5/C" id="H573157C375534A0383BEF69EF4E565D2" class="bill-dtd-OLC" pagenum="19"><num value="C">(C)</num><content> by striking paragraph (5) and inserting the following:<quotedContent id="HD49C139B9DEE462499170AE2724FC4FE"><paragraph identifier="/tII/s205/a/5/C/qB/5" id="H6F8EC3909E0C4DCDAE05F0AFCD7647D8" class="bill-dtd-OLC" pagenum="19"><num value="5">“(5)</num><heading> Technical assistance.—</heading><content>The Secretary may provide technical assistance to States, localities, Tribes, and territories or a consortium of States, localities, Tribes, and territories receiving an award under this subsection regarding interoperability and the technical standards set forth by the Secretary.”</content></paragraph></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tII/s205/a/6" id="H264CBE36B4E042EF8A6A2675BB1A2992" class="bill-dtd-OLC" pagenum="19"><num value="6">(6)</num><content> by redesignating subsections (f) and (g) as subsections (i) and (j), respectively; and</content></paragraph><paragraph identifier="/tII/s205/a/7" id="H9D2E26E9DFDE4BB387C7B4D2B8F0D6B1" class="bill-dtd-OLC" pagenum="19"><num value="7">(7)</num><content> by inserting after subsection (e) the following:<quotedContent id="HE74D26946D5B41F5BE740764A2895908"><subsection identifier="/tII/s205/a/7/qB/f" id="H24B445A8D7BE479286F391B36CB6E49F" class="bill-dtd-OLC" pagenum="19"><num value="f">“(f)</num><heading> Personnel authorities.—</heading><paragraph identifier="/tII/s205/a/7/qB/f/1" id="HC8236E422F5249CAA89FB8130CF4D6F3" class="bill-dtd-OLC" pagenum="19"><num value="1">“(1)</num><heading> Specially qualified personnel.—</heading><chapeau>In addition to any other personnel authorities, to carry out subsections (b) and (c), the Secretary may—</chapeau><subparagraph identifier="/tII/s205/a/7/qB/f/1/A" id="HA7D88A00BE93409A917A780897A322CC" class="bill-dtd-OLC" pagenum="19"><num value="A">“(A)</num><content> appoint highly qualified individuals to scientific or professional positions at the Centers for Disease Control and Prevention, not to exceed 30 such employees at any time (specific to positions authorized by this subsection), with expertise in capabilities relevant to biosurveillance and situational awareness, such as experts in informatics and data analytics (including experts in prediction, modeling, or forecasting), and other related scientific or technical fields; and</content></subparagraph><subparagraph identifier="/tII/s205/a/7/qB/f/1/B" id="H17DCCA848436407CAA8BCB8E3E7AB917" class="bill-dtd-OLC" pagenum="19"><num value="B">“(B)</num><content> compensate individuals appointed under subparagraph (A) in the same manner and subject to the same terms and conditions in which individuals appointed under <?page 20?>9903 of title 5, United States Code, are compensated, without regard to the provisions of chapter 51 and subchapter III of chapter 53 of such title relating to classification and General Schedule pay rates.</content></subparagraph></paragraph><paragraph identifier="/tII/s205/a/7/qB/f/2" id="H13BD82473AA64BDDAA3494066B2A1F7F" class="bill-dtd-OLC" pagenum="20"><num value="2">“(2)</num><heading> Limitations.—</heading><content>The Secretary shall exercise the authority under paragraph (1) in a manner that is consistent with the limitations described in section 319F–1(e)(2).</content></paragraph></subsection><subsection identifier="/tII/s205/a/7/qB/g" id="H056FED5F27F54C3F87FCF77E94B68017" class="bill-dtd-OLC" pagenum="20"><num value="g">“(g)</num><heading> Timeline.—</heading><content>The Secretary shall accomplish the purposes under subsections (b) and (c) no later than September 30, 2023, and shall provide a justification to the congressional committees of jurisdiction for any missed or delayed implementation of measurable steps identified under subsection (c)(6)(A)(iii).</content></subsection><subsection identifier="/tII/s205/a/7/qB/h" id="HAC903901D3F84D9698C2AB3DA4BEBBAA" class="bill-dtd-OLC" pagenum="20"><num value="h">“(h)</num><heading> Independent evaluation.—</heading><content>Not later than 3 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Comptroller General of the United States shall conduct an independent evaluation and submit to the Secretary and the congressional committees of jurisdiction a report concerning the activities conducted under subsections (b) and (c), and provide recommendations, as applicable and appropriate, on necessary improvements to the biosurveillance and situational awareness network.”</content></subsection></quotedContent>.</content></paragraph></subsection><subsection identifier="/tII/s205/b" id="HF995EAF2A7A34F42931FFF884A1F50AC" class="bill-dtd-OLC" pagenum="20"><num value="b">(b)</num><heading> Authorization of appropriations.—</heading><content>Subsection (i) of section 319D (<ref href="/us/usc/42/247d-4">42 U.S.C. 247d–4</ref>), as redesignated by subsection (a)(6), is amended by striking “<quotedText>$138,300,000 for each of fiscal years 2014 through 2018</quotedText>” and inserting “<quotedText>$161,800,000 for each of fiscal years 2019 through 2023</quotedText>”.</content></subsection><subsection identifier="/tII/s205/c" id="HFA8AD43AB22C418F8F05B6C77254D67F" class="bill-dtd-OLC" pagenum="20"><num value="c">(c)</num><heading> Biological threat detection report.—</heading><chapeau>The Secretary of Health and Human Services shall, in coordination with the Secretary of Defense and the Secretary of Homeland Security, not later than 180 days after the date of enactment of this Act, report to the Committee on Energy and Commerce, the Committee on Armed Services, and the Committee on Homeland Security of the House of Representatives and the Committee on Health, Education, Labor, and Pensions, the Committee on Armed Services, and the Committee on Homeland Security and Governmental Affairs of the Senate on the state of Federal biological threat detection efforts, including the following:</chapeau><paragraph identifier="/tII/s205/c/1" id="H0B40EA4C51BF4DC9A7F8B1E8D8DBB309" class="bill-dtd-OLC" pagenum="20"><num value="1">(1)</num><content> An identification of technological, operational, and programmatic successes and failures of domestic detection programs supported by Federal departments and agencies for intentionally introduced or accidentally released biological threat agents and naturally occurring infectious diseases.</content></paragraph><paragraph identifier="/tII/s205/c/2" id="H65CE3F45BBCD4792978910FE681DDC2B" class="bill-dtd-OLC" pagenum="20"><num value="2">(2)</num><content> A description of Federal efforts to facilitate the exchange of information related to the information described in paragraph (1) among Federal departments and agencies that utilize biological threat detection technology.</content></paragraph><paragraph identifier="/tII/s205/c/3" id="H8CA6EFADE38F46448CFD539C7480D486" class="bill-dtd-OLC" pagenum="20"><num value="3">(3)</num><chapeau> A description of the capabilities of detection systems in use by Federal departments and agencies including the capability to—</chapeau><subparagraph identifier="/tII/s205/c/3/A" id="HA7FB9D450EC44272BC8A5FCB4811DEA0" class="bill-dtd-OLC" pagenum="20"><num value="A">(A)</num><content> rapidly detect, identify, characterize, and confirm the presence of biological threat agents;</content></subparagraph><subparagraph identifier="/tII/s205/c/3/B" id="HA0603688B4CC412B9D4772E218EC3221" class="bill-dtd-OLC" pagenum="20"><num value="B">(B)</num><content> recover live biological agents from collection devices;</content></subparagraph><subparagraph identifier="/tII/s205/c/3/C" id="H6B11884FDB104069BDC5C39E92C2AD45" class="bill-dtd-OLC" pagenum="20"><num value="C">(C)</num><content> determine the geographical distribution of biological agents;</content></subparagraph><subparagraph identifier="/tII/s205/c/3/D" id="HC1B0447276BD42D6A89C81DA01ED4E09" class="bill-dtd-OLC" pagenum="20"><num value="D">(D)</num><content> determine the extent of environmental contamination and persistence of biological agents; and</content></subparagraph><?page 21?><subparagraph identifier="/tII/s205/c/3/E" id="H8CB989925E1F47368B490A4903EDAE64" class="bill-dtd-OLC" pagenum="21"><num value="E">(E)</num><content> provide advanced molecular diagnostics to State, local, Tribal, and territorial public health and other laboratories that support biological threat detection activities.</content></subparagraph></paragraph><paragraph identifier="/tII/s205/c/4" id="H1BD42302AA114F00B681DBBF669AAE89" class="bill-dtd-OLC" pagenum="21"><num value="4">(4)</num><content> A description of Federal interagency coordination related to biological threat detection.</content></paragraph><paragraph identifier="/tII/s205/c/5" id="H09C83DF6005A43C396DA5629B00BED5E" class="bill-dtd-OLC" pagenum="21"><num value="5">(5)</num><chapeau> A description of efforts by Federal departments and agencies that utilize biological threat detection technology to collaborate with State, local, Tribal, and territorial public health laboratories and other users of biological threat detection systems, including collaboration regarding the development of—</chapeau><subparagraph identifier="/tII/s205/c/5/A" id="H51096EF3FEF54C258D25E9411F5F078E" class="bill-dtd-OLC" pagenum="21"><num value="A">(A)</num><content> biological threat detection requirements or standards;</content></subparagraph><subparagraph identifier="/tII/s205/c/5/B" id="HE20FAA8D021144F58F54BF9B959499F4" class="bill-dtd-OLC" pagenum="21"><num value="B">(B)</num><content> a standardized integration strategy;</content></subparagraph><subparagraph identifier="/tII/s205/c/5/C" id="H1861EFDEB1D14A67B0EAA7D07A36F158" class="bill-dtd-OLC" pagenum="21"><num value="C">(C)</num><content> training requirements or guidelines;</content></subparagraph><subparagraph identifier="/tII/s205/c/5/D" id="H9B7BA75792104686BE1A34A9C482FBE7" class="bill-dtd-OLC" pagenum="21"><num value="D">(D)</num><content> guidelines for a coordinated public health response, including preparedness capabilities, and, as applicable, for coordination with public health surveillance systems; and</content></subparagraph><subparagraph identifier="/tII/s205/c/5/E" id="H1A44A1198F7F4F10AC436E17AFC5E939" class="bill-dtd-OLC" pagenum="21"><num value="E">(E)</num><content> a coordinated environmental remediation plan, as applicable.</content></subparagraph></paragraph><paragraph identifier="/tII/s205/c/6" id="HA08E6DD91E7C485A991B6333A182DBDE" class="bill-dtd-OLC" pagenum="21"><num value="6">(6)</num><content> Recommendations related to research, advanced research, development, and procurement for Federal departments and agencies to improve and enhance biological threat detection systems, including recommendations on the transfer of biological threat detection technology among Federal departments and agencies, as necessary and appropriate.</content></paragraph></subsection></section><section identifier="/tII/s206" id="H28CF2BD24EEA48FFA94C9E265F741AED" class="bill-dtd-OLC" pagenum="21"><num value="206">Sec. 206.</num><heading> Strengthening and supporting the public health emergency rapid response fund.</heading><chapeau class="block">Section 319 (<ref href="/us/usc/42/247d">42 U.S.C. 247d</ref>) is amended—</chapeau><paragraph identifier="/tII/s206/1" id="HEE59E28EDC014B978C41FFEEE1A154AE" class="bill-dtd-OLC" pagenum="21"><num value="1">(1)</num><chapeau> in subsection (b)—</chapeau><subparagraph identifier="/tII/s206/1/A" id="HE78AA57C96784225B43800EED147A8E0" class="bill-dtd-OLC" pagenum="21"><num value="A">(A)</num><chapeau> in paragraph (1)—</chapeau><clause identifier="/tII/s206/1/A/i" id="H34D28A1DF4AE4627A026E800954375E3" class="bill-dtd-OLC" pagenum="21"><num value="i">(i)</num><content> in the first sentence, by inserting “<quotedText>or if the Secretary determines there is the significant potential for a public health emergency, to allow the Secretary to rapidly respond to the immediate needs resulting from such public health emergency or potential public health emergency</quotedText>” before the period; and</content></clause><clause identifier="/tII/s206/1/A/ii" id="HE5400DEA137747CD94F9774B26B4FD35" class="bill-dtd-OLC" pagenum="21"><num value="ii">(ii)</num><content> by inserting “<quotedText>The Secretary shall plan for the expedited distribution of funds to appropriate agencies and entities.</quotedText>” after the first sentence;</content></clause></subparagraph><subparagraph identifier="/tII/s206/1/B" id="H29A01964189E425B8E67DC6A92984482" class="bill-dtd-OLC" pagenum="21"><num value="B">(B)</num><content> by redesignating paragraph (2) as paragraph (3);</content></subparagraph><subparagraph identifier="/tII/s206/1/C" id="HF257D1309CF64D2DBC90D9AF345E1C87" class="bill-dtd-OLC" pagenum="21"><num value="C">(C)</num><content> by inserting after paragraph (1) the following:<quotedContent id="H4BA02994A2A54A358D0C4D5C8E210232"><paragraph identifier="/tII/s206/1/C/qB/2" id="H427D1D08D5D8425A9E010231900EA76A" class="bill-dtd-OLC" pagenum="21"><num value="2">“(2)</num><heading> Uses.—</heading><chapeau>The Secretary may use amounts in the Fund established under paragraph (1), to—</chapeau><subparagraph identifier="/tII/s206/1/C/qB/2/A" id="HD549FF31875748148B6E355696B75C91" class="bill-dtd-OLC" pagenum="21"><num value="A">“(A)</num><content> facilitate coordination between and among Federal, State, local, Tribal, and territorial entities and public and private health care entities that the Secretary determines may be affected by a public health emergency or potential public health emergency referred to in paragraph (1) (including communication of such entities with relevant international entities, as applicable);</content></subparagraph><subparagraph identifier="/tII/s206/1/C/qB/2/B" id="HAE7EC540F6F94BBE8B67B9068E5E89D3" class="bill-dtd-OLC" pagenum="21"><num value="B">“(B)</num><content> make grants, provide for awards, enter into contracts, and conduct supportive investigations pertaining to a public health emergency or potential public health emergency, including further supporting programs under section 319C–1, 319C–2, or 319C–3;</content></subparagraph><?page 22?><subparagraph identifier="/tII/s206/1/C/qB/2/C" id="HB3AF4EFD81544094B14FC7278E74C63A" class="bill-dtd-OLC" pagenum="22"><num value="C">“(C)</num><content> facilitate and accelerate, as applicable, advanced research and development of security countermeasures (as defined in section 319F–2), qualified countermeasures (as defined in section 319F–1), or qualified pandemic or epidemic products (as defined in section 319F–3), that are applicable to the public health emergency or potential public health emergency under paragraph (1);</content></subparagraph><subparagraph identifier="/tII/s206/1/C/qB/2/D" id="H3C25DA353CC74A2E80E9B97675DDAB73" class="bill-dtd-OLC" pagenum="22"><num value="D">“(D)</num><content> strengthen biosurveillance capabilities and laboratory capacity to identify, collect, and analyze information regarding such public health emergency or potential public health emergency, including the systems under section 319D;</content></subparagraph><subparagraph identifier="/tII/s206/1/C/qB/2/E" id="H5FDC403559A749D4A6F6F279E65D9313" class="bill-dtd-OLC" pagenum="22"><num value="E">“(E)</num><content> support initial emergency operations and assets related to preparation and deployment of intermittent disaster response personnel under section 2812 and the Medical Reserve Corps under section 2813; and</content></subparagraph><subparagraph identifier="/tII/s206/1/C/qB/2/F" id="H15E32D55E6EF497E8B3C0EF12313477B" class="bill-dtd-OLC" pagenum="22"><num value="F">“(F)</num><content> carry out other activities, as the Secretary determines applicable and appropriate.”</content></subparagraph></paragraph></quotedContent>; and </content></subparagraph><subparagraph identifier="/tII/s206/1/D" id="H32C4BD0EC6434CFE9E3ED532EBC3F3B0" class="bill-dtd-OLC" pagenum="22"><num value="D">(D)</num><content> by inserting after paragraph (3), as so redesignated, the following:<quotedContent id="H6370EF657BD146D0BD58E268904C80A2"><paragraph identifier="/tII/s206/1/D/qB/4" id="H38F089E86A994E5891F55BB4556F41B7" class="bill-dtd-OLC" pagenum="22"><num value="4">“(4)</num><heading> Review.—</heading><content>Not later than 2 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Secretary, in coordination with the Assistant Secretary for Preparedness and Response, shall conduct a review of the Fund under this section and provide recommendations to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives on policies to improve such Fund for the uses described in paragraph (2).</content></paragraph><paragraph identifier="/tII/s206/1/D/qB/5" id="H81FED0915C574657A8A2F6FB3F8BFBA5" class="bill-dtd-OLC" pagenum="22"><num value="5">“(5)</num><heading> GAO report.—</heading><chapeau>Not later than 4 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Comptroller General of the United States shall—</chapeau><subparagraph identifier="/tII/s206/1/D/qB/5/A" id="HBCB60C014F454529A4C7598D4912F69F" class="bill-dtd-OLC" pagenum="22"><num value="A">“(A)</num><content> conduct a review of the Fund under this section, including its uses and the resources available in the Fund; and</content></subparagraph><subparagraph identifier="/tII/s206/1/D/qB/5/B" id="H8C7211C458DF4DD188B75F543B7B70EC" class="bill-dtd-OLC" pagenum="22"><num value="B">“(B)</num><content> submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on such review, including recommendations related to such review, as applicable.”</content></subparagraph></paragraph></quotedContent>; and </content></subparagraph></paragraph><paragraph identifier="/tII/s206/2" id="H022412920A244AD996687829BB46F82D" class="bill-dtd-OLC" pagenum="22"><num value="2">(2)</num><chapeau> in subsection (c)—</chapeau><subparagraph identifier="/tII/s206/2/A" id="HCD22C47DD2874C19B9EC95570CD82F14" class="bill-dtd-OLC" pagenum="22"><num value="A">(A)</num><content> by inserting “<quotedText>rapidly respond to public health emergencies or potential public health emergencies and</quotedText>” after “<quotedText>used to</quotedText>”; and</content></subparagraph><subparagraph identifier="/tII/s206/2/B" id="HB42085AFBF254F67BBE191BE189EF109" class="bill-dtd-OLC" pagenum="22"><num value="B">(B)</num><content> by striking “<quotedText>section.</quotedText>” and inserting “<quotedText>Act or funds otherwise provided for emergency response.</quotedText>”.</content></subparagraph></paragraph></section><section identifier="/tII/s207" id="HD8317E7A7F2C4FEC8CADD91C3C629BBF" class="bill-dtd-OLC" pagenum="22"><num value="207">Sec. 207.</num><heading> Improving all-hazards preparedness and response by public health emergency volunteers.</heading><subsection identifier="/tII/s207/a" id="H7862BFA3639D40B9A8CA9D2F1249A966" class="bill-dtd-OLC" pagenum="22"><num value="a">(a)</num><heading> In general.—</heading><chapeau>Section 319I (<ref href="/us/usc/42/247d-7b">42 U.S.C. 247d–7b</ref>) is amended—</chapeau><paragraph identifier="/tII/s207/a/1" id="H2A7CC15CFEDE4385933596ACA8216F25" class="bill-dtd-OLC" pagenum="22"><num value="1">(1)</num><content> in the section heading, by striking “<quotedText><inline class="allCaps"><b>Health Professions Volunteers</b></inline></quotedText>” and inserting “<quotedText><inline class="allCaps"><b>Volunteer Health Professional</b></inline></quotedText>”;</content></paragraph><?page 23?><paragraph identifier="/tII/s207/a/2" id="H0BCE5ADC03874D4DAF8090857D4A65A8" class="bill-dtd-OLC" pagenum="23"><num value="2">(2)</num><content> in subsection (a), by adding at the end the following: “<quotedText>Such health care professionals may include members of the National Disaster Medical System, members of the Medical Reserve Corps, and individual health care professionals.</quotedText>”;</content></paragraph><paragraph identifier="/tII/s207/a/3" id="HC879F3AB87ED4899B79FC567B99F7E8B" class="bill-dtd-OLC" pagenum="23"><num value="3">(3)</num><content> in subsection (i), by adding at the end the following: “<quotedText>In order to inform the development of such mechanisms by States, the Secretary shall make available information and material provided by States that have developed mechanisms to waive the application of licensing requirements to applicable health professionals seeking to provide medical services during a public health emergency. Such information shall be made publicly available in a manner that does not compromise national security.</quotedText>”; and</content></paragraph><paragraph identifier="/tII/s207/a/4" id="HCA868E733B97468785C9ABD69E79D9C0" class="bill-dtd-OLC" pagenum="23"><num value="4">(4)</num><content> in subsection (k), by striking “<quotedText>2014 through 2018</quotedText>” and inserting “<quotedText>2019 through 2023</quotedText>”.</content></paragraph></subsection><subsection identifier="/tII/s207/b" id="H92B7B80F2E5A4104A20894BE1C7E8449" class="bill-dtd-OLC" pagenum="23"><num value="b">(b)</num><heading> All-Hazards Public Health Emergency Preparedness and Response Plan.—</heading><content>Section 319C–1(b)(2)(A)(iv) (42 U.S.C. 247d–3a(b)(2)(A)(iv)) is amended to read as follows:<quotedContent id="HF02D737ED0A844E9918060F9A91CF5DC"><clause identifier="/tII/s207/b/qB/iv" id="H4910C67255604CB9B264E3620C10A26A" class="bill-dtd-OLC" pagenum="23"><num value="iv">“(iv)</num><chapeau> a description of the mechanism the entity will implement to utilize the Emergency Management Assistance Compact, or other mutual aid agreement, for medical and public health mutual aid, and, as appropriate, the activities such entity will implement pursuant to section 319I to improve enrollment and coordination of volunteer health care professionals seeking to provide medical services during a public health emergency, which may include—</chapeau><subclause identifier="/tII/s207/b/qB/iv/I" id="HEA11C3FFAEC043A49B4FB16B70EA9BEB" class="bill-dtd-OLC" pagenum="23"><num value="I">“(I)</num><content> providing a public method of communication for purposes of volunteer coordination (such as a phone number);</content></subclause><subclause identifier="/tII/s207/b/qB/iv/II" id="HF64F399CF99048F284B93D4B75584275" class="bill-dtd-OLC" pagenum="23"><num value="II">“(II)</num><content> providing for optional registration to participate in volunteer services during processes related to State medical licensing, registration, or certification or renewal of such licensing, registration, or certification; or</content></subclause><subclause identifier="/tII/s207/b/qB/iv/III" id="HE329F776669442558438ED8C8DC99EF7" class="bill-dtd-OLC" pagenum="23"><num value="III">“(III)</num><content> other mechanisms as the State determines appropriate;”</content></subclause></clause></quotedContent>.</content></subsection></section><section identifier="/tII/s208" id="H5F18B19F14724A7995562D60B0C4C6DB" class="bill-dtd-OLC" pagenum="23"><num value="208">Sec. 208.</num><heading> Clarifying State liability law for volunteer health care professionals.</heading><subsection identifier="/tII/s208/a" id="H4C60D0EEABA84C5081D1FE98B684E7D3" class="bill-dtd-OLC" pagenum="23"><num value="a">(a)</num><heading> In general.—</heading><content>Title II (<ref href="/us/usc/42/202">42 U.S.C. 202</ref> et seq.) is amended by inserting after section 224 the following:<quotedContent id="HE2EA53373EA2439E8E190C8F68595473"><section identifier="/tII/s208/a/qB/s225" id="H585738C7BBC3468D8A567C5FD89BC077" class="bill-dtd-OLC" pagenum="23"><num value="225">“Sec. 225.</num><heading> Health care professionals assisting during a public health emergency.</heading><subsection identifier="/tII/s208/a/qB/s225/a" id="HDA5FFAA015514DCB88879547085E0476" class="bill-dtd-OLC" pagenum="23"><num value="a">“(a)</num><heading> Limitation on liability.—</heading><chapeau>Notwithstanding any other provision of law, a health care professional who is a member of the Medical Reserve Corps under section 2813 or who is included in the Emergency System for Advance Registration of Volunteer Health Professionals under section 319I and who—</chapeau><paragraph identifier="/tII/s208/a/qB/s225/a/1" id="HA1692591D3144C5E8DA108241FA56CD9" class="bill-dtd-OLC" pagenum="23"><num value="1">“(1)</num><chapeau> is responding—</chapeau><subparagraph identifier="/tII/s208/a/qB/s225/a/1/A" id="H67768A7CBC344C5C8FE44D5BBC05CFA1" class="bill-dtd-OLC" pagenum="23"><num value="A">“(A)</num><content> to a public health emergency determined under section 319(a), during the initial period of not more than 90 days (as determined by the Secretary) of the public health emergency determination (excluding any period covered by a renewal of such determination); or</content></subparagraph><subparagraph identifier="/tII/s208/a/qB/s225/a/1/B" id="HFBEE5EE27E064632BFAE2088595E88B4" class="bill-dtd-OLC" pagenum="23"><num value="B">“(B)</num><content> to a major disaster or an emergency as declared by the President under section 401 of the Robert T. Stafford Disaster Relief and Emergency Assistance Act (<ref href="/us/usc/42/5170">42 U.S.C. <?page 24?>5170</ref>) or under section 201 of the National Emergencies Act (<ref href="/us/usc/50/1621">50 U.S.C. 1621</ref>) during the initial period of such declaration;</content></subparagraph></paragraph><paragraph identifier="/tII/s208/a/qB/s225/a/2" id="H0B7506C60C63481B81C6737515C4D59D" class="bill-dtd-OLC" pagenum="24"><num value="2">“(2)</num><chapeau> is alleged to be liable for an act or omission—</chapeau><subparagraph identifier="/tII/s208/a/qB/s225/a/2/A" id="HD0CFF988C9D34AC9B31409CC7913FE4D" class="bill-dtd-OLC" pagenum="24"><num value="A">“(A)</num><content> during the initial period of a determination or declaration described in paragraph (1) and related to the treatment of individuals in need of health care services due to such public health emergency, major disaster, or emergency;</content></subparagraph><subparagraph identifier="/tII/s208/a/qB/s225/a/2/B" id="H20469DCBDED74C239EF4FAE320EB542B" class="bill-dtd-OLC" pagenum="24"><num value="B">“(B)</num><content> in the State or States for which such determination or declaration is made;</content></subparagraph><subparagraph identifier="/tII/s208/a/qB/s225/a/2/C" id="H4C12E4F3663446AFB3C3A3C3F8425148" class="bill-dtd-OLC" pagenum="24"><num value="C">“(C)</num><content> in the health care professional’s capacity as a member of the Medical Reserve Corps or a professional included in the Emergency System for Advance Registration of Volunteer Health Professionals under section 319I; and</content></subparagraph><subparagraph identifier="/tII/s208/a/qB/s225/a/2/D" id="H9C97FD92D30442738EAD2587849BCBC3" class="bill-dtd-OLC" pagenum="24"><num value="D">“(D)</num><content> in the course of providing services that are within the scope of the license, registration, or certification of the professional, as defined by the State of licensure, registration, or certification; and</content></subparagraph></paragraph><paragraph identifier="/tII/s208/a/qB/s225/a/3" id="HFFE2D12D7AD14C90B6D1F3BAE1ECC345" class="bill-dtd-OLC" pagenum="24"><num value="3">“(3)</num><content> prior to the rendering of such act or omission, was authorized by the State’s authorization of deploying such State’s Emergency System for Advance Registration of Volunteer Health Professionals described in section 319I or the Medical Reserve Corps established under section 2813, to provide health care services,</content></paragraph><continuation class="indent0 firstIndent0">shall be subject only to the State liability laws of the State in which such act or omission			 occurred, in the same manner and to the same extent as a similar health			 care professional who is a resident of such State would be subject to such			 State laws, except with respect to the licensure, registration, and certification of such individual.</continuation></subsection><subsection identifier="/tII/s208/a/qB/s225/b" id="HA4419484C87946898ECF790290C5A036" class="bill-dtd-OLC" pagenum="24"><num value="b">“(b)</num><heading> Volunteer protection act.—</heading><content>Nothing in this section shall be construed to affect an individual's right to protections under the Volunteer Protection Act of 1997.</content></subsection><subsection identifier="/tII/s208/a/qB/s225/c" id="H037C56E7E3FF42B0BBB47F8C49DDC4D7" class="bill-dtd-OLC" pagenum="24"><num value="c">“(c)</num><heading> Preemption.—</heading><content>This section shall supersede the laws of any State that would subject a health care professional described in subsection (a) to the liability laws of any State other than the State liability laws to which such individual is subject pursuant to such subsection.</content></subsection><subsection identifier="/tII/s208/a/qB/s225/d" id="H7303ABAE57AC4819BD85964083784B6E" class="bill-dtd-OLC" pagenum="24"><num value="d">“(d)</num><heading> Definitions.—</heading><chapeau>In this section:</chapeau><paragraph identifier="/tII/s208/a/qB/s225/d/1" id="H73A8980AE2E14485B2B221FDA0C46123" class="bill-dtd-OLC" pagenum="24"><num value="1">“(1)</num><content> The term ‘<term>health care professional</term>’ means an individual licensed, registered, or certified under Federal or State laws or regulations to provide health care services.</content></paragraph><paragraph identifier="/tII/s208/a/qB/s225/d/2" id="H5058BE4F5F96473086AE90B71403DF99" class="bill-dtd-OLC" pagenum="24"><num value="2">“(2)</num><chapeau> The term ‘<term>health care services</term>’ means any services provided by a health care professional, or by any individual working under the supervision of a health care professional, that relate to—</chapeau><subparagraph identifier="/tII/s208/a/qB/s225/d/2/A" id="H20EF65CD424B4749B40AA5FDED945F6C" class="bill-dtd-OLC" pagenum="24"><num value="A">“(A)</num><content> the diagnosis, prevention, or treatment of any human disease or impairment; or</content></subparagraph><subparagraph identifier="/tII/s208/a/qB/s225/d/2/B" id="H351CDCE3935E4DF3A3001507FBBD47BF" class="bill-dtd-OLC" pagenum="24"><num value="B">“(B)</num><content> the assessment or care of the health of human beings.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s208/a/qB/s225/e" id="H08E8C4009E284025831F3158A05CD9EE" class="bill-dtd-OLC" pagenum="24"><num value="e">“(e)</num><heading> Effective date.—</heading><paragraph identifier="/tII/s208/a/qB/s225/e/1" id="HEC050818C6EB48768FBE69617FB20D7E" class="bill-dtd-OLC" pagenum="24"><num value="1">“(1)</num><heading> In general.—</heading><content>This section shall take effect 90 days after the date of the enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>.</content></paragraph><?page 25?><paragraph identifier="/tII/s208/a/qB/s225/e/2" id="H8D91E853828C4AA2A65ADFC1C9EFA99B" class="bill-dtd-OLC" pagenum="25"><num value="2">“(2)</num><heading> Application.—</heading><content>This section shall apply to a claim for harm only if the act or omission that caused such harm occurred on or after the effective date described in paragraph (1).”</content></paragraph></subsection></section></quotedContent>.</content></subsection><subsection identifier="/tII/s208/b" id="HC90B4BCE703442128F44C47E9267C7ED" class="bill-dtd-OLC" pagenum="25"><num value="b">(b)</num><heading> GAO study.—</heading><chapeau>Not later than one year after the date of enactment of this Act, the Comptroller General of the United States shall conduct a review of—</chapeau><paragraph identifier="/tII/s208/b/1" id="HCEC4154F092E4C6C935FD0ECFDCED6FF" class="bill-dtd-OLC" pagenum="25"><num value="1">(1)</num><content> the number of health care providers who register under the Emergency System for Advance Registration of Volunteer Health Professionals under section 319I of the Public Health Service Act (<ref href="/us/usc/42/247d-7b">42 U.S.C. 247d–7b</ref>) in advance to provide services during a public health emergency;</content></paragraph><paragraph identifier="/tII/s208/b/2" id="H3C0C8210E092483DA02DC08F673AED41" class="bill-dtd-OLC" pagenum="25"><num value="2">(2)</num><content> the number of health care providers who are credentialed to provide services during the period of a public health emergency declaration, including those who are credentialed though programs established in the Emergency System for Advance Registration of Volunteer Health Professionals under such section 319I and those credentialed by authorities within the State in which the emergency occurred;</content></paragraph><paragraph identifier="/tII/s208/b/3" id="H808FC9C6AE7A4D6BA6F46635C7947E07" class="bill-dtd-OLC" pagenum="25"><num value="3">(3)</num><content> the average time to verify the credentials of a health care provider during the period of a public health emergency declaration, including the average time pursuant to the Emergency System for Advance Registration of Volunteer Health Professionals under such section 319I and for an individual’s credentials to be verified by an authority within the State; and</content></paragraph><paragraph identifier="/tII/s208/b/4" id="H560D5315663F43BBA79A789CE022A110" class="bill-dtd-OLC" pagenum="25"><num value="4">(4)</num><content> the Emergency System for Advance Registration of Volunteer Health Professionals program in States, including whether physician or medical groups, associations, or other relevant provider organizations utilize such program for purposes of volunteering during public health emergencies.</content></paragraph></subsection></section><section identifier="/tII/s209" id="H2543C033639144F1A8DE97C8C0EBFBEE" class="bill-dtd-OLC" pagenum="25"><num value="209">Sec. 209.</num><heading> Report on adequate national blood supply.</heading><chapeau class="block">Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report containing recommendations related to maintaining an adequate national blood supply, including—</chapeau><paragraph identifier="/tII/s209/1" id="HB3CC4605507D49B7AEEA3DE8A2D9549A" class="bill-dtd-OLC" pagenum="25"><num value="1">(1)</num><content> challenges associated with the continuous recruitment of blood donors (including those newly eligible to donate);</content></paragraph><paragraph identifier="/tII/s209/2" id="H29FAA9501E9040FB8A993DA716E51083" class="bill-dtd-OLC" pagenum="25"><num value="2">(2)</num><content> ensuring the adequacy of the blood supply in the case of public health emergencies;</content></paragraph><paragraph identifier="/tII/s209/3" id="H477BDB88726144339D221DDFC985B86E" class="bill-dtd-OLC" pagenum="25"><num value="3">(3)</num><content> implementation of the transfusion transmission monitoring system; and</content></paragraph><paragraph identifier="/tII/s209/4" id="H4096130B3771406A9B7D9496B91D2E59" class="bill-dtd-OLC" pagenum="25"><num value="4">(4)</num><content> other measures to promote safety and innovation, such as the development, use, or implementation of new technologies, processes, and procedures to improve the safety and reliability of the blood supply.</content></paragraph></section><section identifier="/tII/s210" id="H9D018AF5CA814FC9B4A47D8CAFDCF04D" class="bill-dtd-OLC" pagenum="25"><num value="210">Sec. 210.</num><heading> Report on the public health preparedness and response capabilities and capacities of hospitals, long-term care facilities, and other health care facilities.</heading><subsection identifier="/tII/s210/a" id="H1AABDCA107DD4696ADF4DAFB0590EAE4" class="bill-dtd-OLC" pagenum="25"><num value="a">(a)</num><heading> Study.—</heading><paragraph identifier="/tII/s210/a/1" id="H2A1841CBCB6E4AE2A198F004B67552BA" class="bill-dtd-OLC" pagenum="25"><num value="1">(1)</num><heading> In general.—</heading><content>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall enter into an agreement with an appropriate entity to conduct a study regarding the public health preparedness and response capabilities and medical surge capacities of hospitals, long-term care facilities, and other health care <?page 26?>facilities to prepare for, and respond to, public health emergencies, including natural disasters.</content></paragraph><paragraph identifier="/tII/s210/a/2" id="HC6A406BBD9974023A9E6E76D6D11499E" class="bill-dtd-OLC" pagenum="26"><num value="2">(2)</num><heading> Consultation.—</heading><content>In conducting the study under paragraph (1), the entity shall consult with Federal, State, local, Tribal, and territorial public health officials (as appropriate), and health care providers and facilities with experience in public health preparedness and response activities.</content></paragraph><paragraph identifier="/tII/s210/a/3" id="HD475B2E20B56489DB17D223DAA4D06DB" class="bill-dtd-OLC" pagenum="26"><num value="3">(3)</num><heading> Evaluation.—</heading><chapeau>The study under paragraph (1) shall include—</chapeau><subparagraph identifier="/tII/s210/a/3/A" id="H291E8F687E714F7881195DEE6757222A" class="bill-dtd-OLC" pagenum="26"><num value="A">(A)</num><content> an evaluation of the current benchmarks and objective standards, as applicable, related to programs that support hospitals, long-term care facilities, and other health care facilities, and their effect on improving public health preparedness and response capabilities and medical surge capacities, including the Hospital Preparedness Program, the Public Health Emergency Preparedness cooperative agreements, and the Regional Health Care Emergency Preparedness and Response Systems under section 319C–3 of the Public Health Service Act (as added by section 203);</content></subparagraph><subparagraph identifier="/tII/s210/a/3/B" id="H3C3F5BCA45EC4A68B9D2BDAF2F64DCC1" class="bill-dtd-OLC" pagenum="26"><num value="B">(B)</num><content> the identification of gaps in preparedness, including with respect to such benchmarks and objective standards, such as those identified during recent public health emergencies, for hospitals, long-term care facilities, and other health care facilities to address future potential public health threats;</content></subparagraph><subparagraph identifier="/tII/s210/a/3/C" id="H46D045AFAE29410A85974303C41867BA" class="bill-dtd-OLC" pagenum="26"><num value="C">(C)</num><content> an evaluation of coordination efforts between the recipients of Federal funding for programs described in subparagraph (A) and entities with expertise in emergency power systems and other critical infrastructure partners during a public health emergency, to ensure a functioning critical infrastructure, to the greatest extent practicable, during a public health emergency;</content></subparagraph><subparagraph identifier="/tII/s210/a/3/D" id="HADF8BB48845641489BEC8B42FA118A0F" class="bill-dtd-OLC" pagenum="26"><num value="D">(D)</num><content> an evaluation of coordination efforts between the recipients of Federal funding for programs described in subparagraph (A) and environmental health agencies with expertise in emergency preparedness and response planning for hospitals, long-term care facilities, and other health care facilities; and</content></subparagraph><subparagraph identifier="/tII/s210/a/3/E" id="H59487135609B48D2A45EC1F544DBDE4B" class="bill-dtd-OLC" pagenum="26"><num value="E">(E)</num><content> an evaluation of current public health preparedness and response capabilities and medical surge capacities related to at-risk individuals during public health emergencies, including an identification of gaps in such preparedness as they relate to such individuals.</content></subparagraph></paragraph></subsection><subsection identifier="/tII/s210/b" id="HED99FFAFEC554DA99C3C626E10DC97A7" class="bill-dtd-OLC" pagenum="26"><num value="b">(b)</num><heading> Report.—</heading><paragraph identifier="/tII/s210/b/1" id="H6560C32AC1BE4363B2283831939AA1DC" class="bill-dtd-OLC" pagenum="26"><num value="1">(1)</num><heading> In general.—</heading><content>The agreement under subsection (a) shall require the entity to submit to the Secretary of Health and Human Services and the congressional committees of jurisdiction, not later than 3 years after the date of enactment of this Act, a report on the results of the study conducted pursuant to this section.</content></paragraph><paragraph identifier="/tII/s210/b/2" id="HE36B71A9C68B4394B7CC82010AC5CEB5" class="bill-dtd-OLC" pagenum="26"><num value="2">(2)</num><heading> Contents.—</heading><chapeau>The report under paragraph (1) shall—</chapeau><subparagraph identifier="/tII/s210/b/2/A" id="HE0E4EF6A98284CD6AC6B37F5E1EB826D" class="bill-dtd-OLC" pagenum="26"><num value="A">(A)</num><content> describe the findings and conclusions of the evaluation conducted pursuant to subsection (a); and</content></subparagraph><subparagraph identifier="/tII/s210/b/2/B" id="HCE745107F9934D3E8003D93BC4678574" class="bill-dtd-OLC" pagenum="26"><num value="B">(B)</num><chapeau> provide recommendations for improving public health preparedness and response capability and medical <?page 27?>surge capacity for hospitals, long-term care facilities, and other health care facilities, including—</chapeau><clause identifier="/tII/s210/b/2/B/i" id="H16B1D06B8FC84F6481887B6A59B11A1A" class="bill-dtd-OLC" pagenum="27"><num value="i">(i)</num><content> improving the existing benchmarks and objective standards for the Federal grant programs described in subsection (a)(3)(A) or developing new benchmarks and standards for such programs; and</content></clause><clause identifier="/tII/s210/b/2/B/ii" id="H305A8D9B901A47C9BD1DE088D93EB4A2" class="bill-dtd-OLC" pagenum="27"><num value="ii">(ii)</num><content> identifying best practices for improving public health preparedness and response programs and medical surge capacity at hospitals, long-term care facilities, and other health care facilities, including recommendations for the evaluation under subparagraphs (C) and (D) of subsection (a)(3).</content></clause></subparagraph></paragraph></subsection></section></title><title identifier="/tIII" id="H1EC01609C3F94A3C9D1AD494D5AE5905" class="bill-dtd-OLC" pagenum="27"><num value="III">Title III—</num><heading>Reaching All Communities</heading><section identifier="/tIII/s301" id="H292F6AB7198A4224908AEC47B4EA04AF" class="bill-dtd-OLC" pagenum="27"><num value="301">Sec. 301.</num><heading> Strengthening and assessing the emergency response workforce.</heading><subsection identifier="/tIII/s301/a" id="H19B30DD3FE444408BC5FD7EAC4B49807" class="bill-dtd-OLC" pagenum="27"><num value="a">(a)</num><heading> National Disaster Medical System.—</heading><paragraph identifier="/tIII/s301/a/1" id="HF1CB9EBB97F743FE977B1607DD3FA3F7" class="bill-dtd-OLC" pagenum="27"><num value="1">(1)</num><heading> Strengthening the National Disaster Medical System.—</heading><content>Clause (ii) of section 2812(a)(3)(A) (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11(a)(3)(A)</ref>) is amended to read as follows:<quotedContent id="HCBB4E34ED6ED44C399363210D1624EFA"><clause identifier="/tIII/s301/a/1/qB/ii" id="H2FB33CE3C8024D9FBF97A28F76EA9693" class="bill-dtd-OLC" pagenum="27"><num value="ii">“(ii)</num><content> be present at locations, and for limited periods of time, specified by the Secretary on the basis that the Secretary has determined that a location is at risk of a public health emergency during the time specified, or there is a significant potential for a public health emergency.”</content></clause></quotedContent>. </content></paragraph><paragraph identifier="/tIII/s301/a/2" id="HBFEF7C58DE8943EF8B403040F8F287B1" class="bill-dtd-OLC" pagenum="27"><num value="2">(2)</num><heading> Review of the National Disaster Medical System.—</heading><content>Section 2812(b)(2) (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11(b)(2)</ref>) is amended to read as follows:<quotedContent id="H1867CF7671584E4897C4E1E1E28A5E23"><paragraph identifier="/tIII/s301/a/2/qB/2" id="H01EE29F38C9F4FE99DCE3678E42773F7" class="bill-dtd-OLC" pagenum="27"><num value="2">“(2)</num><heading> Joint review and medical surge capacity strategic plan.—</heading><subparagraph identifier="/tIII/s301/a/2/qB/2/A" id="HC5DBF282615B463F9F44502602078EBD" class="bill-dtd-OLC" pagenum="27"><num value="A">“(A)</num><heading> Review.—</heading><chapeau>Not later than 180 days after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Secretary, in coordination with the Secretary of Homeland Security, the Secretary of Defense, and the Secretary of Veterans Affairs, shall conduct a joint review of the National Disaster Medical System. Such review shall include—</chapeau><clause identifier="/tIII/s301/a/2/qB/2/A/i" id="H9C2DBFB411AA489BA75977A9B11D8C16" class="bill-dtd-OLC" pagenum="27"><num value="i">“(i)</num><content> an evaluation of medical surge capacity, as described in section 2803(a);</content></clause><clause identifier="/tIII/s301/a/2/qB/2/A/ii" id="H643FE18274A6466EACBC2341164A744E" class="bill-dtd-OLC" pagenum="27"><num value="ii">“(ii)</num><content> an assessment of the available workforce of the intermittent disaster response personnel described in subsection (c);</content></clause><clause identifier="/tIII/s301/a/2/qB/2/A/iii" id="H20D68A2AED164DC4B788EE16927A9E21" class="bill-dtd-OLC" pagenum="27"><num value="iii">“(iii)</num><content> the capacity of the workforce described in clause (ii) to respond to all hazards, including capacity to simultaneously respond to multiple public health emergencies and the capacity to respond to a nationwide public health emergency;</content></clause><clause identifier="/tIII/s301/a/2/qB/2/A/iv" id="H7857BDDADDD646809D01B4111AF670FE" class="bill-dtd-OLC" pagenum="27"><num value="iv">“(iv)</num><content> the effectiveness of efforts to recruit, retain, and train such workforce; and</content></clause><clause identifier="/tIII/s301/a/2/qB/2/A/v" id="HE502A4C851304F5DB538F2D65BDAB8B2" class="bill-dtd-OLC" pagenum="27"><num value="v">“(v)</num><content> gaps that may exist in such workforce and recommendations for addressing such gaps.</content></clause></subparagraph><subparagraph identifier="/tIII/s301/a/2/qB/2/B" id="H3D9FC6E7711C415ABD5A68D9A9B46093" class="bill-dtd-OLC" pagenum="27"><num value="B">“(B)</num><heading> Updates.—</heading><content>As part of the National Health Security Strategy under section 2802, the Secretary shall update <?page 28?>the findings from the review under subparagraph (A) and provide recommendations to modify the policies of the National Disaster Medical System as necessary.”</content></subparagraph></paragraph></quotedContent>. </content></paragraph><paragraph identifier="/tIII/s301/a/3" id="HBB4AAFE3012144CA9568128508482406" class="bill-dtd-OLC" pagenum="28"><num value="3">(3)</num><heading> Notification of shortage.—</heading><content>Section 2812(c) (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11(c)</ref>) is amended by adding at the end the following:<quotedContent id="HD6D7941F150D420F942C215CB4639FCF"><paragraph identifier="/tIII/s301/a/3/qB/3" id="HBBD6EF427BD743B7828C0635E9EE6284" class="bill-dtd-OLC" pagenum="28"><num value="3">“(3)</num><heading> Notification.—</heading><chapeau>Not later than 30 days after the date on which the Secretary determines the number of intermittent disaster-response personnel of the National Disaster Medical System is insufficient to address a public health emergency or potential public health emergency, the Secretary shall submit to the congressional committees of jurisdiction a notification detailing—</chapeau><subparagraph identifier="/tIII/s301/a/3/qB/3/A" id="HD4F44F6A11964B1BAB837FBF2BDE75CD" class="bill-dtd-OLC" pagenum="28"><num value="A">“(A)</num><content> the impact such shortage could have on meeting public health needs and emergency medical personnel needs during a public health emergency; and</content></subparagraph><subparagraph identifier="/tIII/s301/a/3/qB/3/B" id="H791249DA3CBF4D2E9AE45BE0AE974E00" class="bill-dtd-OLC" pagenum="28"><num value="B">“(B)</num><content> any identified measures to address such shortage.</content></subparagraph></paragraph><paragraph identifier="/tIII/s301/a/3/qB/4" id="H9C8C1B8CCBB34ABAB068C7A18C987418" class="bill-dtd-OLC" pagenum="28"><num value="4">“(4)</num><heading> Certain appointments.—</heading><subparagraph identifier="/tIII/s301/a/3/qB/4/A" id="HD76B04818ED74E7FABD4881ABF3314ED" class="bill-dtd-OLC" pagenum="28"><num value="A">“(A)</num><heading> In general.—</heading><content>If the Secretary determines that the number of intermittent disaster response personnel within the National Disaster Medical System under this section is insufficient to address a public health emergency or potential public health emergency, the Secretary may appoint candidates directly to personnel positions for intermittent disaster response within such system. The Secretary shall provide updates on the number of vacant or unfilled positions within such system to the congressional committees of jurisdiction each quarter for which this authority is in effect.</content></subparagraph><subparagraph identifier="/tIII/s301/a/3/qB/4/B" id="HA88872FF07B34E009BD47F99ABE16D8C" class="bill-dtd-OLC" pagenum="28"><num value="B">“(B)</num><heading> Sunset.—</heading><content>The authority under this paragraph shall expire on September 30, 2021.”</content></subparagraph></paragraph></quotedContent>. </content></paragraph><paragraph identifier="/tIII/s301/a/4" id="H6EF9FCA402AE47FBA769EDC2DB9193D4" class="bill-dtd-OLC" pagenum="28"><num value="4">(4)</num><heading> Authorization of appropriations.—</heading><content>Section 2812(g) (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11(g)</ref>) is amended by striking “<quotedText>$52,700,000 for each of fiscal years 2014 through 2018</quotedText>” and inserting “<quotedText>$57,400,000 for each of fiscal years 2019 through 2023</quotedText>”.</content></paragraph></subsection><subsection identifier="/tIII/s301/b" id="H28FFE43BC5664DB7B869FBC7FA974399" class="bill-dtd-OLC" pagenum="28"><num value="b">(b)</num><heading> Volunteer medical reserve corps.—</heading><paragraph identifier="/tIII/s301/b/1" id="H7F33A54F76004077B7EC8F491168FEE3" class="bill-dtd-OLC" pagenum="28"><num value="1">(1)</num><heading> In general.—</heading><content>Section 2813(a) (<ref href="/us/usc/42/42">42 U.S.C. 42</ref> U.S.C. 300hh–15(a)) is amended by striking the second sentence and inserting “<quotedText>The Secretary may appoint a Director to head the Corps and oversee the activities of the Corps chapters that exist at the State, local, Tribal, and territorial levels.</quotedText>”.</content></paragraph><paragraph identifier="/tIII/s301/b/2" id="HA88B99FA093C4A978BD7F559810879F7" class="bill-dtd-OLC" pagenum="28"><num value="2">(2)</num><heading> Authorization of appropriations.—</heading><content>Section 2813(i) (<ref href="/us/usc/42/300hh-15">42 U.S.C. 300hh–15(i)</ref>) is amended by striking “<quotedText>2014 through 2018</quotedText>” and inserting “<quotedText>2019 through 2023</quotedText>”.</content></paragraph></subsection><subsection identifier="/tIII/s301/c" id="H69BC3DDF8B474AD686271A8805CDF7F5" class="bill-dtd-OLC" pagenum="28"><num value="c">(c)</num><heading> Strengthening the Epidemic Intelligence Service.—</heading><chapeau>Section 317F (42 U.S.C. Sec. 247b–7) is amended—</chapeau><paragraph identifier="/tIII/s301/c/1" id="HC1B9B95CA5E249E3AE9D866CF6042230" class="bill-dtd-OLC" pagenum="28"><num value="1">(1)</num><chapeau> in subsection (a)—</chapeau><subparagraph identifier="/tIII/s301/c/1/A" id="H91E2C5A0B8E14826AB6CD32D67ACCFFD" class="bill-dtd-OLC" pagenum="28"><num value="A">(A)</num><chapeau> in paragraph (1)—</chapeau><clause identifier="/tIII/s301/c/1/A/i" id="H49FFCD897C2E413C96C456B9FB57B03F" class="bill-dtd-OLC" pagenum="28"><num value="i">(i)</num><content> by inserting “<quotedText>or preparedness and response activities, including rapid response to public health emergencies and significant public health threats</quotedText>” after “<quotedText>conduct prevention activities</quotedText>”; and</content></clause><clause identifier="/tIII/s301/c/1/A/ii" id="H9AEFE2378333434AB2094304DF210F68" class="bill-dtd-OLC" pagenum="28"><num value="ii">(ii)</num><content> by striking “<quotedText>$35,000</quotedText>” and inserting “<quotedText>$50,000</quotedText>”; and</content></clause></subparagraph><subparagraph identifier="/tIII/s301/c/1/B" id="H6E7AA2F647C3461E9D04A328446C507E" class="bill-dtd-OLC" pagenum="28"><num value="B">(B)</num><content> in paragraph (2)(B), by striking “<quotedText>3 years</quotedText>” and inserting “<quotedText>2 years</quotedText>”; and</content></subparagraph></paragraph><paragraph identifier="/tIII/s301/c/2" id="H9543077A148246ECAA76D04FC932E2D5" class="bill-dtd-OLC" pagenum="28"><num value="2">(2)</num><chapeau> in subsection (c)—</chapeau><?page 29?><subparagraph identifier="/tIII/s301/c/2/A" id="HB6CA26A5790D4CDF99E4342C33A4CA90" class="bill-dtd-OLC" pagenum="29"><num value="A">(A)</num><content> by striking “<quotedText>For the purpose of carrying out this section</quotedText>” and inserting the following:<quotedContent id="HC20E756D508B41D08E2CFEBEC0E34281"><paragraph identifier="/tIII/s301/c/2/A/qB/1" id="H21D650D592B94E6281C240352B981C71" class="bill-dtd-OLC" pagenum="29"><num value="1">“(1)</num><heading> In general.—</heading><content>For the purpose of carrying out this section, except as described in paragraph (2)”</content></paragraph></quotedContent>; and</content></subparagraph><subparagraph identifier="/tIII/s301/c/2/B" id="H45DBEF6D9E264B90A7AE0D1EAFE117ED" class="bill-dtd-OLC" pagenum="29"><num value="B">(B)</num><content> by adding at the end the following:<quotedContent id="H881D952E32AF4CF09C100112CED9B4E2"><paragraph identifier="/tIII/s301/c/2/B/qB/2" id="HBB173CDFF6E241A58AC235B4622BE404" class="bill-dtd-OLC" pagenum="29"><num value="2">“(2)</num><heading> Epidemic Intelligence Service Program.—</heading><content>For purposes of carrying out this section with respect to qualified health professionals serving in the Epidemic Intelligence Service, as authorized under section 317G, there is authorized to be appropriated $1,000,000 for each of fiscal years 2019 through 2023.”</content></paragraph></quotedContent>.</content></subparagraph></paragraph></subsection><subsection identifier="/tIII/s301/d" id="HFDF29492A63E4661BBAAFCBBCA56B531" class="bill-dtd-OLC" pagenum="29"><num value="d">(d)</num><heading> Service benefit for National Disaster Medical System volunteers.—</heading><paragraph identifier="/tIII/s301/d/1" id="H8F2D85874DE6422887A6B9CAE627371C" class="bill-dtd-OLC" pagenum="29"><num value="1">(1)</num><heading> In general.—</heading><content>Section 2812(c) (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11(c)</ref>), as amended by subsection (a)(3), is further amended by adding at the end the following:<quotedContent id="HF529E77AE1BD4045B5288E5602B06486"><paragraph identifier="/tIII/s301/d/1/qB/5" id="H717F8261A908490394EB8465EDF07E4B" class="bill-dtd-OLC" pagenum="29"><num value="5">“(5)</num><heading> Service benefit.—</heading><content>Individuals appointed to serve under this subsection shall be considered eligible for benefits under part L of title I of the Omnibus Crime Control and Safe Streets Act of 1968. The Secretary shall provide notification to any eligible individual of any effect such designation may have on other benefits for which such individual is eligible, including benefits from private entities.”</content></paragraph></quotedContent>.</content></paragraph><paragraph identifier="/tIII/s301/d/2" id="HA9E4B5EC0BC6490FBCF981347A553543" class="bill-dtd-OLC" pagenum="29"><num value="2">(2)</num><heading> Public safety officer benefits.—</heading><chapeau>Section 1204(9) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (<ref href="/us/usc/34/10284">34 U.S.C. 10284(9)</ref>) is amended—</chapeau><subparagraph identifier="/tIII/s301/d/2/A" id="H59AF993F65F64560867F48EE173E6FB6" class="bill-dtd-OLC" pagenum="29"><num value="A">(A)</num><content> in subparagraph (C)(ii), by striking “<quotedText>or</quotedText>” at the end;</content></subparagraph><subparagraph identifier="/tIII/s301/d/2/B" id="HC66299E2949443EE9A91A42AA11B34E7" class="bill-dtd-OLC" pagenum="29"><num value="B">(B)</num><content> in subparagraph (D), by striking the period and inserting “<quotedText>; or</quotedText>”; and</content></subparagraph><subparagraph identifier="/tIII/s301/d/2/C" id="HC4A2BE0721FB4B3186D96C27BB87E01E" class="bill-dtd-OLC" pagenum="29"><num value="C">(C)</num><content> by inserting after subparagraph (D) the following:<quotedContent id="H6371E81F549D4FDA9E2B421F85BF360A"><subparagraph identifier="/tIII/s301/d/2/C/qB/E" id="HD542C15CC54E408895F122A2E7655B9D" class="bill-dtd-OLC" pagenum="29"><num value="E">“(E)</num><chapeau> an individual appointed to the National Disaster Medical System under section 2812 of the Public Health Service Act (<ref href="/us/usc/42/300hh-11">42 U.S.C. 300hh–11</ref>) who is performing official duties of the Department of Health and Human Services, if those official duties are—</chapeau><clause identifier="/tIII/s301/d/2/C/qB/E/i" id="HD85F26F48816407DAD20888B9D38BFE3" class="bill-dtd-OLC" pagenum="29"><num value="i">“(i)</num><content> related to responding to a public health emergency or potential public health emergency, or other activities for which the Secretary of Health and Human Services has activated such National Disaster Medical System; and</content></clause><clause identifier="/tIII/s301/d/2/C/qB/E/ii" id="HB9C8836CCDBD45739F8E9F6CB316119D" class="bill-dtd-OLC" pagenum="29"><num value="ii">“(ii)</num><content> determined by the Secretary of Health and Human Services to be hazardous.”</content></clause></subparagraph></quotedContent>.</content></subparagraph></paragraph><paragraph identifier="/tIII/s301/d/3" id="HCB46EB5662134279B37849D4FE425C5E" class="bill-dtd-OLC" pagenum="29"><num value="3">(3)</num><heading> Sunset.—</heading><content>The amendments made by paragraphs (1) and (2) shall cease to have force or effect on October 1, 2021.</content></paragraph></subsection><subsection identifier="/tIII/s301/e" id="HE75038D2DF544B64B853BC45CAE154D5" class="bill-dtd-OLC" pagenum="29"><num value="e">(e)</num><heading> Mission readiness report to Congress.—</heading><paragraph identifier="/tIII/s301/e/1" id="HB84F4335D1674D4189A22EBA72249D51" class="bill-dtd-OLC" pagenum="29"><num value="1">(1)</num><heading> Report.—</heading><content>Not later than one year after the date of enactment of this section, the Comptroller General of the United States (referred to in this subsection as the “<quotedText>Comptroller General</quotedText>”) shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, a report on the medical surge capacity of the United States in the event of a public health emergency, including the capacity and capability of the current health care workforce to prepare for, and respond to, the full range of public health emergencies <?page 30?>or potential public health emergencies, and recommendations to address any gaps identified in such workforce.</content></paragraph><paragraph identifier="/tIII/s301/e/2" id="HE12426CF70BB40C198FD864E26A31146" class="bill-dtd-OLC" pagenum="30"><num value="2">(2)</num><heading> Contents.—</heading><chapeau>The Comptroller General shall include in the report under paragraph (1)—</chapeau><subparagraph identifier="/tIII/s301/e/2/A" id="H0B698E30424A40108EEB832FC51E1826" class="bill-dtd-OLC" pagenum="30"><num value="A">(A)</num><content> the number of health care providers who have volunteered to provide health care services during a public health emergency, including members of the National Disaster Medical System, the Disaster Medical Assistant Teams, the Medical Reserve Corps, and other volunteer health care professionals in the verification network pursuant to section 319I of the Public Health Service Act (<ref href="/us/usc/42/247d-7b">42 U.S.C. 247d–7b</ref>);</content></subparagraph><subparagraph identifier="/tIII/s301/e/2/B" id="H6A92F2D47F674AE987EF44DBBB5AB740" class="bill-dtd-OLC" pagenum="30"><num value="B">(B)</num><content> the capacity of the workforce described in subparagraph (A) to respond to a public health emergency or potential public health emergency, including the capacity to respond to multiple concurrent public health emergencies and the capacity to respond to a nationwide public health emergency;</content></subparagraph><subparagraph identifier="/tIII/s301/e/2/C" id="H247C8D91AE424108A3C763260B586747" class="bill-dtd-OLC" pagenum="30"><num value="C">(C)</num><content> the preparedness and response capabilities and mission readiness of the workforce described in subparagraph (A) taking into account areas of health care expertise and considerations for at-risk individuals (as defined in section 2802(b)(4)(B) of the Public Health Service Act (<ref href="/us/usc/42/300hh-1">42 U.S.C. 300hh–1(b)(4)(B)</ref>));</content></subparagraph><subparagraph identifier="/tIII/s301/e/2/D" id="HDB5BE44252084400A5B199EE4D14ADF0" class="bill-dtd-OLC" pagenum="30"><num value="D">(D)</num><content> an assessment of the effectiveness of efforts to recruit, retain, and train such workforce; and</content></subparagraph><subparagraph identifier="/tIII/s301/e/2/E" id="H6D304A0472A1472F87AF04F375B52A8E" class="bill-dtd-OLC" pagenum="30"><num value="E">(E)</num><content> identification of gaps that may exist in such workforce and recommendations for addressing such gaps, the extent to which the Assistant Secretary for Preparedness and Response plans to address such gaps, and any recommendations from the Comptroller General to address such gaps.</content></subparagraph></paragraph></subsection></section><section identifier="/tIII/s302" id="HDB4451B7F0D54DF8BED66A5A68E8E9B3" class="bill-dtd-OLC" pagenum="30"><num value="302">Sec. 302.</num><heading> Health system infrastructure to improve preparedness and response.</heading><subsection identifier="/tIII/s302/a" id="H50CA8EE02BED458DAEDEF298577C1425" class="bill-dtd-OLC" pagenum="30"><num value="a">(a)</num><heading> Coordination of preparedness.—</heading><content>Section 2811(b)(5) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(b)(5)</ref>) is amended by adding at the end the following: “<quotedText>Such logistical support shall include working with other relevant Federal, State, local, Tribal, and territorial public health officials and private sector entities to identify the critical infrastructure assets, systems, and networks needed for the proper functioning of the health care and public health sectors that need to be maintained through any emergency or disaster, including entities capable of assisting with, responding to, and mitigating the effect of a public health emergency, including a public health emergency determined by the Secretary pursuant to section 319(a) or an emergency or major disaster declared by the President under the Robert T. Stafford Disaster Relief and Emergency Assistance Act or the National Emergencies Act, including by establishing methods to exchange critical information and deliver products consumed or used to preserve, protect, or sustain life, health, or safety, and sharing of specialized expertise.</quotedText>”.</content></subsection><subsection identifier="/tIII/s302/b" id="HADBB740D23D64B19B541618F45AD3331" class="bill-dtd-OLC" pagenum="30"><num value="b">(b)</num><heading> Manufacturing capacity.—</heading><content>Section 2811(d)(2)(C) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(d)(2)(C)</ref>) is amended by inserting “<quotedText>, and ancillary medical supplies to assist with the utilization of such countermeasures or products,</quotedText>” after “<quotedText>products</quotedText>”.</content></subsection><?page 31?><subsection identifier="/tIII/s302/c" id="H93234FF67B7743FAB9DE114B73C1EC85" class="bill-dtd-OLC" pagenum="31"><num value="c">(c)</num><heading> Evaluation of barriers to rapid delivery of medical countermeasures.—</heading><paragraph identifier="/tIII/s302/c/1" id="H69E05D2585A1435D9ECD732A9066D0D0" class="bill-dtd-OLC" pagenum="31"><num value="1">(1)</num><heading> Rapid delivery study.—</heading><content>The Assistant Secretary for Preparedness and Response may conduct a study on issues that have the potential to adversely affect the handling and rapid delivery of medical countermeasures to individuals during public health emergencies occurring in the United States.</content></paragraph><paragraph identifier="/tIII/s302/c/2" id="H42B995F988B94887B8B71549251214B2" class="bill-dtd-OLC" pagenum="31"><num value="2">(2)</num><heading> Notice to Congress.—</heading><content>Not later than 9 months after the date of the enactment of this Act, the Assistant Secretary for Preparedness and Response shall notify the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate if the Assistant Secretary for Preparedness and Response does not plan to conduct the study under paragraph (1) and shall provide such committees a summary explanation for such decision.</content></paragraph><paragraph identifier="/tIII/s302/c/3" id="HA4EBED6BD9864391A064EE281598D345" class="bill-dtd-OLC" pagenum="31"><num value="3">(3)</num><heading> Report to Congress.—</heading><content>Not later than 1 year after the Assistant Secretary for Preparedness and Response conducts the study under paragraph (1), such Assistant Secretary shall submit a report to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate containing the findings of such study.</content></paragraph></subsection></section><section identifier="/tIII/s303" id="H54BC8F5E97484C6E85DAABC19AB702DE" class="bill-dtd-OLC" pagenum="31"><num value="303">Sec. 303.</num><heading> Considerations for at-risk individuals.</heading><subsection identifier="/tIII/s303/a" id="H200EEF601EDB4B629C8B60D770C7104C" class="bill-dtd-OLC" pagenum="31"><num value="a">(a)</num><heading> At-Risk individuals in the National Health Security Strategy.—</heading><chapeau>Section 2802(b)(4)(B) (<ref href="/us/usc/42/300hh-1">42 U.S.C. 300hh–1(b)(4)(B)</ref>) is amended—</chapeau><paragraph identifier="/tIII/s303/a/1" id="H6F97544DABB0459199EE3E165A8900DC" class="bill-dtd-OLC" pagenum="31"><num value="1">(1)</num><content> by striking “<quotedText>this section and sections 319C–1, 319F, and 319L,</quotedText>” and inserting “<quotedText>this Act,</quotedText>”; and</content></paragraph><paragraph identifier="/tIII/s303/a/2" id="H19AE7718C00D4019864696CE3C06912C" class="bill-dtd-OLC" pagenum="31"><num value="2">(2)</num><content> by striking “<quotedText>special</quotedText>” and inserting “<quotedText>access or functional</quotedText>”.</content></paragraph></subsection><subsection identifier="/tIII/s303/b" id="HF9494839B411491D9EF658A7D3D51375" class="bill-dtd-OLC" pagenum="31"><num value="b">(b)</num><heading> Countermeasure considerations.—</heading><chapeau>Section 319L(c)(6) (42 U.S.C. 247d–7e(c)(6)) is amended—</chapeau><paragraph identifier="/tIII/s303/b/1" id="H258106B4A9B946069439826E150FA6E5" class="bill-dtd-OLC" pagenum="31"><num value="1">(1)</num><content> by striking “<quotedText>elderly</quotedText>” and inserting “<quotedText>older adults</quotedText>”; and</content></paragraph><paragraph identifier="/tIII/s303/b/2" id="H45F6574939EF4728B430CB58AFEC1B6C" class="bill-dtd-OLC" pagenum="31"><num value="2">(2)</num><content> by inserting “<quotedText>with relevant characteristics that warrant consideration during the process of researching and developing such countermeasures and products</quotedText>” before the period.</content></paragraph></subsection><subsection identifier="/tIII/s303/c" id="H9C2D1569380344E5A7142B82BD684FE7" class="bill-dtd-OLC" pagenum="31"><num value="c">(c)</num><heading> Biosurveillance of emerging public health threats.—</heading><chapeau>Section 2814 is amended—</chapeau><paragraph identifier="/tIII/s303/c/1" id="H7F75C46A40F54A7C85B9FCCBA803ADB0" class="bill-dtd-OLC" pagenum="31"><num value="1">(1)</num><content> in paragraph (7), by striking “<quotedText>; and</quotedText>” and inserting a semicolon;</content></paragraph><paragraph identifier="/tIII/s303/c/2" id="H9A90D3193E674C7F844ACA5AE6A35594" class="bill-dtd-OLC" pagenum="31"><num value="2">(2)</num><content> in paragraph (8), by striking the period and inserting “<quotedText>; and</quotedText>”; and</content></paragraph><paragraph identifier="/tIII/s303/c/3" id="H9D4F15BD9F34462EB07743172E603544" class="bill-dtd-OLC" pagenum="31"><num value="3">(3)</num><content> by adding at the end the following:<quotedContent id="H1E27175E97304B3E8E130BC72407DA40"><paragraph identifier="/tIII/s303/c/3/qB/9" id="H5098108EBEFF4C0EB70DE5781C4AB3BA" class="bill-dtd-OLC" pagenum="31"><num value="9">“(9)</num><content> facilitate coordination to ensure that, in implementing the situational awareness and biosurveillance network under section 319D, the Secretary considers incorporating data and information from Federal, State, local, Tribal, and territorial public health officials and entities relevant to detecting emerging public health threats that may affect at-risk individuals, such as pregnant and postpartum women and infants, including adverse health outcomes of such populations related to such emerging public health threats.”</content></paragraph></quotedContent>.</content></paragraph></subsection></section><section identifier="/tIII/s304" id="H3857715C9AED473D9C32E256F7873E60" class="bill-dtd-OLC" pagenum="31"><num value="304">Sec. 304.</num><heading> Improving emergency preparedness and response considerations for children.</heading><content><p class="indent0">Part B of title III (<ref href="/us/usc/42/243">42 U.S.C. 243</ref> et seq.) is amended by inserting after section 319D the following:</p><?page 32?><quotedContent id="H8792038A034C49179C53AD6CDFAA6227"><section identifier="/tIII/s304/qB/s319D–1" id="H8A2A4545B8654F048C812D7D5434D358" class="bill-dtd-OLC" pagenum="32"><num value="319D–1">“Sec. 319D–1.</num><heading> Children’s preparedness unit.</heading><subsection identifier="/tIII/s304/qB/s319D–1/a" id="H0BC4114039FE41C7B40F9A919AA6777D" class="bill-dtd-OLC" pagenum="32"><num value="a">“(a)</num><heading> Enhancing emergency preparedness for children.—</heading><content>The Secretary, acting through the Director of the Centers for Disease Control and Prevention (referred to in this subsection as the ‘<quotedText>Director</quotedText>’), shall maintain an internal team of experts, to be known as the Children's Preparedness Unit (referred to in this subsection as the ‘<quotedText>Unit</quotedText>’), to work collaboratively to provide guidance on the considerations for, and the specific needs of, children before, during, and after public health emergencies. The Unit shall inform the Director regarding emergency preparedness and response efforts pertaining to children at the Centers for Disease Control and Prevention.</content></subsection><subsection identifier="/tIII/s304/qB/s319D–1/b" id="HC825522A811E43EB9F461A99CEC8D4C6" class="bill-dtd-OLC" pagenum="32"><num value="b">“(b)</num><heading> Expertise.—</heading><content>The team described in subsection (a) shall include one or more pediatricians, which may be a developmental-behavioral pediatrician, and may also include behavioral scientists, child psychologists, epidemiologists, biostatisticians, health communications staff, and individuals with other areas of expertise, as the Secretary determines appropriate.</content></subsection><subsection identifier="/tIII/s304/qB/s319D–1/c" id="H6A7C705C72434DBDAADA56D083766175" class="bill-dtd-OLC" pagenum="32"><num value="c">“(c)</num><heading> Duties.—</heading><chapeau>The team described in subsection (a) may—</chapeau><paragraph identifier="/tIII/s304/qB/s319D–1/c/1" id="H06589D04E18A4F3CBCDB8768A6E75DF5" class="bill-dtd-OLC" pagenum="32"><num value="1">“(1)</num><content> assist State, local, Tribal, and territorial emergency planning and response activities related to children, which may include developing, identifying, and sharing best practices;</content></paragraph><paragraph identifier="/tIII/s304/qB/s319D–1/c/2" id="HD4219B7C25F94E51BD6BAA9EABA63707" class="bill-dtd-OLC" pagenum="32"><num value="2">“(2)</num><content> provide technical assistance, training, and consultation to Federal, State, local, Tribal, and territorial public health officials to improve preparedness and response capabilities with respect to the needs of children, including providing such technical assistance, training, and consultation to eligible entities in order to support the achievement of measurable evidence-based benchmarks and objective standards applicable to sections 319C–1 and 319C–2;</content></paragraph><paragraph identifier="/tIII/s304/qB/s319D–1/c/3" id="H089C9C43B2414A0CAB59A3649EBB6017" class="bill-dtd-OLC" pagenum="32"><num value="3">“(3)</num><content> improve the utilization of methods to incorporate the needs of children in planning for and responding to a public health emergency, including public awareness of such methods;</content></paragraph><paragraph identifier="/tIII/s304/qB/s319D–1/c/4" id="HF5DEDE117B4A4B7A82E945C6DEBD0C03" class="bill-dtd-OLC" pagenum="32"><num value="4">“(4)</num><content> coordinate with, and improve, public-private partnerships, such as health care coalitions pursuant to sections 319C–2 and 319C–3, to address gaps and inefficiencies in emergency preparedness and response efforts for children;</content></paragraph><paragraph identifier="/tIII/s304/qB/s319D–1/c/5" id="HCE14A41135224FAF80090E043A3CB5E3" class="bill-dtd-OLC" pagenum="32"><num value="5">“(5)</num><content> provide expertise and input during the development of guidance and clinical recommendations to address the needs of children when preparing for, and responding to, public health emergencies, including pursuant to section 319C–3; and</content></paragraph><paragraph identifier="/tIII/s304/qB/s319D–1/c/6" id="H87CBE727014742738B1CF2C90D6FF5B9" class="bill-dtd-OLC" pagenum="32"><num value="6">“(6)</num><content> carry out other duties related to preparedness and response activities for children, as the Secretary determines appropriate.”</content></paragraph></subsection></section></quotedContent>.</content></section><section identifier="/tIII/s305" id="H45AFBE1BB8C543768B08D52DEA3037B7" class="bill-dtd-OLC" pagenum="32"><num value="305">Sec. 305.</num><heading> National advisory committees on disasters.</heading><subsection identifier="/tIII/s305/a" id="H20098221494C4BC09DEF6D5982B44C51" class="bill-dtd-OLC" pagenum="32"><num value="a">(a)</num><heading> Reauthorizing the National Advisory Committee on Children and Disasters.—</heading><chapeau>Section 2811A (<ref href="/us/usc/42/300hh-10a">42 U.S.C. 300hh–10a</ref>) is amended—</chapeau><paragraph identifier="/tIII/s305/a/1" id="H50E784904E84497294AC790D7219E208" class="bill-dtd-OLC" pagenum="32"><num value="1">(1)</num><content> in subsection (b)(2), by inserting “<quotedText>, mental and behavioral,</quotedText>” after “<quotedText>medical</quotedText>”;</content></paragraph><paragraph identifier="/tIII/s305/a/2" id="H5673EECE056E4CE194DA4E57A05EBB1D" class="bill-dtd-OLC" pagenum="32"><num value="2">(2)</num><chapeau> in subsection (d)—</chapeau><subparagraph identifier="/tIII/s305/a/2/A" id="HEC0F393172AD4783A019562056BBBADE" class="bill-dtd-OLC" pagenum="32"><num value="A">(A)</num><content> in paragraph (1), by striking “<quotedText>15</quotedText>” and inserting “<quotedText>25</quotedText>”; and</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B" id="H1B5D4960BE484DF6B21A3B27566F817D" class="bill-dtd-OLC" pagenum="32"><num value="B">(B)</num><content> by striking paragraph (2) and inserting the following:<?page 33?><quotedContent id="H0FB617E55ADA4B0FB15CB588F0F9BB89"><paragraph identifier="/tIII/s305/a/2/B/qB/2" id="H10B59CABB2704EAB88CEC8D82C334CAF" class="bill-dtd-OLC" pagenum="33"><num value="2">“(2)</num><heading> Required non-Federal members.—</heading><chapeau>The Secretary, in consultation with such other heads of Federal agencies as may be appropriate, shall appoint to the Advisory Committee under paragraph (1) at least 13 individuals, including—</chapeau><subparagraph identifier="/tIII/s305/a/2/B/qB/2/A" id="HBC65D42AB8DE444380D87AB23171D6F2" class="bill-dtd-OLC" pagenum="33"><num value="A">“(A)</num><content> at least 2 non-Federal professionals with expertise in pediatric medical disaster planning, preparedness, response, or recovery;</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/2/B" id="H0A09B15099B0485D91A3DEA05AD6DAC5" class="bill-dtd-OLC" pagenum="33"><num value="B">“(B)</num><content> at least 2 representatives from State, local, Tribal, or territorial agencies with expertise in pediatric disaster planning, preparedness, response, or recovery;</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/2/C" id="HA9B53200E56046A8B3ABC89B12FFD572" class="bill-dtd-OLC" pagenum="33"><num value="C">“(C)</num><content> at least 4 members representing health care professionals, which may include members with expertise in pediatric emergency medicine; pediatric trauma, critical care, or surgery; the treatment of pediatric patients affected by chemical, biological, radiological, or nuclear agents, including emerging infectious diseases; pediatric mental or behavioral health related to children affected by a public health emergency; or pediatric primary care; and</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/2/D" id="HF96C28C180AF45FFA195D03F07B25271" class="bill-dtd-OLC" pagenum="33"><num value="D">“(D)</num><chapeau> other members as the Secretary determines appropriate, of whom—</chapeau><clause identifier="/tIII/s305/a/2/B/qB/2/D/i" id="H8F1C5D8255BE494DB11970985F79E06B" class="bill-dtd-OLC" pagenum="33"><num value="i">“(i)</num><content> at least one such member shall represent a children’s hospital;</content></clause><clause identifier="/tIII/s305/a/2/B/qB/2/D/ii" id="H779B5D0A75004363955BEA2024A4C7C3" class="bill-dtd-OLC" pagenum="33"><num value="ii">“(ii)</num><content> at least one such member shall be an individual with expertise in schools or child care settings;</content></clause><clause identifier="/tIII/s305/a/2/B/qB/2/D/iii" id="HCC169D32459D409BA5EAE7C7876F15CF" class="bill-dtd-OLC" pagenum="33"><num value="iii">“(iii)</num><content> at least one such member shall be an individual with expertise in children and youth with special health care needs; and</content></clause><clause identifier="/tIII/s305/a/2/B/qB/2/D/iv" id="H8260E53E7F3341289342B4AD6809811D" class="bill-dtd-OLC" pagenum="33"><num value="iv">“(iv)</num><content> at least one such member shall be an individual with expertise in the needs of parents or family caregivers, including the parents or caregivers of children with disabilities.</content></clause></subparagraph></paragraph><paragraph identifier="/tIII/s305/a/2/B/qB/3" id="HBA9A7CDA2ABB44AE8D62DB48BB023413" class="bill-dtd-OLC" pagenum="33"><num value="3">“(3)</num><heading> Federal members.—</heading><chapeau>The Advisory Committee under paragraph (1) shall include the following Federal members or their designees (who may be nonvoting members, as determined by the Secretary):</chapeau><subparagraph identifier="/tIII/s305/a/2/B/qB/3/A" id="H0971679C7DA8464D95E20C4AEDC88EAA" class="bill-dtd-OLC" pagenum="33"><num value="A">“(A)</num><content> The Assistant Secretary for Preparedness and Response.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/B" id="HD852C890C9884802BCDC02149C108B98" class="bill-dtd-OLC" pagenum="33"><num value="B">“(B)</num><content> The Director of the Biomedical Advanced Research and Development Authority.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/C" id="HB21EC31AC82947B0A7BEF217E3DC21A7" class="bill-dtd-OLC" pagenum="33"><num value="C">“(C)</num><content> The Director of the Centers for Disease Control and Prevention.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/D" id="H88605BA7B66D4913BEF46611401C5031" class="bill-dtd-OLC" pagenum="33"><num value="D">“(D)</num><content> The Commissioner of Food and Drugs.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/E" id="H3EAE686834A1434D88895CD9E2F65BB2" class="bill-dtd-OLC" pagenum="33"><num value="E">“(E)</num><content> The Director of the National Institutes of Health.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/F" id="HA26096350B874FB68F5A482AE6318A17" class="bill-dtd-OLC" pagenum="33"><num value="F">“(F)</num><content> The Assistant Secretary of the Administration for Children and Families.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/G" id="H5A4A4073945140C9A7E603761D979448" class="bill-dtd-OLC" pagenum="33"><num value="G">“(G)</num><content> The Administrator of the Health Resources and Services Administration.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/H" id="H6EF00E0C16F243B9B249E40AF8B9F166" class="bill-dtd-OLC" pagenum="33"><num value="H">“(H)</num><content> The Administrator of the Federal Emergency Management Agency.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/I" id="H6B768DA3D13942578FB43CF3CE1821A8" class="bill-dtd-OLC" pagenum="33"><num value="I">“(I)</num><content> The Administrator of the Administration for Community Living.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/J" id="H9D6FC1655D9344F194F33DE0FF0EF5E5" class="bill-dtd-OLC" pagenum="33"><num value="J">“(J)</num><content> The Secretary of Education.</content></subparagraph><subparagraph identifier="/tIII/s305/a/2/B/qB/3/K" id="H565F8406FB6F41E4AFFA8B640CB6C654" class="bill-dtd-OLC" pagenum="33"><num value="K">“(K)</num><content> Representatives from such Federal agencies (such as the Substance Abuse and Mental Health Services Administration and the Department of Homeland Security) as the Secretary determines appropriate to fulfill the duties of the Advisory Committee under subsections (b) and (c).</content></subparagraph></paragraph><?page 34?><paragraph identifier="/tIII/s305/a/2/B/qB/4" id="H51FCCFC61D054463990D488675DB4DF3" class="bill-dtd-OLC" pagenum="34"><num value="4">“(4)</num><heading> Term of appointment.—</heading><content>Each member of the Advisory Committee appointed under paragraph (2) shall serve for a term of 3 years, except that the Secretary may adjust the terms of the Advisory Committee appointees serving on the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, or appointees who are initially appointed after such date of enactment, in order to provide for a staggered term of appointment for all members.</content></paragraph><paragraph identifier="/tIII/s305/a/2/B/qB/5" id="H6005502C0F25456C88E9B8B722A4916F" class="bill-dtd-OLC" pagenum="34"><num value="5">“(5)</num><heading> Consecutive appointments; maximum terms.—</heading><content>A member appointed under paragraph (2) may serve not more than 3 terms on the Advisory Committee, and not more than two of such terms may be served consecutively.”</content></paragraph></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tIII/s305/a/3" id="H204C5C939F584C1190B6B506BDEB82F2" class="bill-dtd-OLC" pagenum="34"><num value="3">(3)</num><content> in subsection (e), by adding at the end “<quotedText>At least one meeting per year shall be an in-person meeting.</quotedText>”;</content></paragraph><paragraph identifier="/tIII/s305/a/4" id="HBF52BB71D78645CDAE2D15BC29F6D9FD" class="bill-dtd-OLC" pagenum="34"><num value="4">(4)</num><content> by redesignating subsection (f) as subsection (g);</content></paragraph><paragraph identifier="/tIII/s305/a/5" id="H91B9F542C79B4FCABBDED1340DCC718B" class="bill-dtd-OLC" pagenum="34"><num value="5">(5)</num><content> by inserting after subsection (e) the following:<quotedContent id="HE362D95F4D3142ECB51F06A0DC8750BB"><subsection identifier="/tIII/s305/a/5/qB/f" id="H3350FDAA3CC242C2A52EC78601AACDCB" class="bill-dtd-OLC" pagenum="34"><num value="f">“(f)</num><heading> Coordination.—</heading><content>The Secretary shall coordinate duties and activities authorized under this section in accordance with section 2811D.”</content></subsection></quotedContent>; and</content></paragraph><paragraph identifier="/tIII/s305/a/6" id="H00134986B81448A6A679C17C17F1489D" class="bill-dtd-OLC" pagenum="34"><num value="6">(6)</num><content> in subsection (g), as so redesignated, by striking “<quotedText>2018</quotedText>” and inserting “<quotedText>2023</quotedText>”.</content></paragraph></subsection><subsection identifier="/tIII/s305/b" id="H720548FAE655464384A7664DAF1EE75B" class="bill-dtd-OLC" pagenum="34"><num value="b">(b)</num><heading> Authorizing the National Advisory Committee on Seniors and Disasters.—</heading><content>Subtitle B of title XXVIII (<ref href="/us/usc/42/300hh">42 U.S.C. 300hh</ref> et seq.) is amended by inserting after section 2811A the following:<quotedContent id="H9E1588525CB84436AD0702959B4189BC"><section identifier="/tIII/s305/b/qB/s2811B" id="H225CC7F382974315A77B846797AD35E4" class="bill-dtd-OLC" pagenum="34"><num value="2811B">“Sec. 2811B.</num><heading> National Advisory Committee on Seniors and Disasters.</heading><subsection identifier="/tIII/s305/b/qB/s2811B/a" id="H025DE874084243C29ED419839B17D84D" class="bill-dtd-OLC" pagenum="34"><num value="a">“(a)</num><heading> Establishment.—</heading><content>The Secretary, in consultation with the Secretary of Homeland Security and the Secretary of Veterans Affairs, shall establish an advisory committee to be known as the National Advisory Committee on Seniors and Disasters (referred to in this section as the ‘<quotedText>Advisory Committee</quotedText>’).</content></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/b" id="H4F30CE0A2F6A40AEA0CF7BA5751BEFE5" class="bill-dtd-OLC" pagenum="34"><num value="b">“(b)</num><heading> Duties.—</heading><chapeau>The Advisory Committee shall—</chapeau><paragraph identifier="/tIII/s305/b/qB/s2811B/b/1" id="HC72E3FCD00DD425580252CEDC630C0EF" class="bill-dtd-OLC" pagenum="34"><num value="1">“(1)</num><content> provide advice and consultation with respect to the activities carried out pursuant to section 2814, as applicable and appropriate;</content></paragraph><paragraph identifier="/tIII/s305/b/qB/s2811B/b/2" id="HE34DF46A54004351A35CE2DE9C90EEC9" class="bill-dtd-OLC" pagenum="34"><num value="2">“(2)</num><content> evaluate and provide input with respect to the medical and public health needs of seniors related to preparation for, response to, and recovery from all-hazards emergencies; and</content></paragraph><paragraph identifier="/tIII/s305/b/qB/s2811B/b/3" id="H3DFD1E2BD5694A8587DAB84DB580538C" class="bill-dtd-OLC" pagenum="34"><num value="3">“(3)</num><content> provide advice and consultation with respect to State emergency preparedness and response activities relating to seniors, including related drills and exercises pursuant to the preparedness goals under section 2802(b).</content></paragraph></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/c" id="HCE7F4B4A09F34DEC9329BB5C88C9DE36" class="bill-dtd-OLC" pagenum="34"><num value="c">“(c)</num><heading> Additional duties.—</heading><content>The Advisory Committee may provide advice and recommendations to the Secretary with respect to seniors and the medical and public health grants and cooperative agreements as applicable to preparedness and response activities under this title and title III.</content></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/d" id="H35B5837C094F4CC9831B426E39CF7E8E" class="bill-dtd-OLC" pagenum="34"><num value="d">“(d)</num><heading> Membership.—</heading><paragraph identifier="/tIII/s305/b/qB/s2811B/d/1" id="H6483BC1713F8453193DC6F663875F42D" class="bill-dtd-OLC" pagenum="34"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary, in consultation with such other heads of agencies as appropriate, shall appoint not more than 17 members to the Advisory Committee. In appointing such members, the Secretary shall ensure that the total membership of the Advisory Committee is an odd number.</content></paragraph><?page 35?><paragraph identifier="/tIII/s305/b/qB/s2811B/d/2" id="H4952BDDE109242D3AB2747FC0F751C19" class="bill-dtd-OLC" pagenum="35"><num value="2">“(2)</num><heading> Required members.—</heading><chapeau>The Advisory Committee shall include Federal members or their designees (who may be nonvoting members, as determined by the Secretary) and non-Federal members, as follows:</chapeau><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/A" id="H105020BDE7D2433794BBB5F56DB59C5D" class="bill-dtd-OLC" pagenum="35"><num value="A">“(A)</num><content> The Assistant Secretary for Preparedness and Response.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/B" id="HE6C99850ED9946F4A2EC7D7C775906C1" class="bill-dtd-OLC" pagenum="35"><num value="B">“(B)</num><content> The Director of the Biomedical Advanced Research and Development Authority.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/C" id="HC28143DA6F704E20A05707105DD02A15" class="bill-dtd-OLC" pagenum="35"><num value="C">“(C)</num><content> The Director of the Centers for Disease Control and Prevention.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/D" id="H2F7A8478DA2E417CA1A19885A5910982" class="bill-dtd-OLC" pagenum="35"><num value="D">“(D)</num><content> The Commissioner of Food and Drugs.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/E" id="H121C704601BE45549E5D4F8BF069E9E4" class="bill-dtd-OLC" pagenum="35"><num value="E">“(E)</num><content> The Director of the National Institutes of Health.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/F" id="HFAA1F58DC40A4E8EA26E7FE777A237BE" class="bill-dtd-OLC" pagenum="35"><num value="F">“(F)</num><content> The Administrator of the Centers for Medicare &amp; Medicaid Services.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/G" id="H9499E54681664E72AF1821E64C7E2C92" class="bill-dtd-OLC" pagenum="35"><num value="G">“(G)</num><content> The Administrator of the Administration for Community Living.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/H" id="HC21D4A0A50904D8F8B07165B64B3AF12" class="bill-dtd-OLC" pagenum="35"><num value="H">“(H)</num><content> The Administrator of the Federal Emergency Management Agency.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/I" id="HF28BB9A29C7244679DBE60B6C337BA31" class="bill-dtd-OLC" pagenum="35"><num value="I">“(I)</num><content> The Under Secretary for Health of the Department of Veterans Affairs.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/J" id="HCACBE5790A014915BB39B71B17674B3E" class="bill-dtd-OLC" pagenum="35"><num value="J">“(J)</num><content> At least 2 non-Federal health care professionals with expertise in geriatric medical disaster planning, preparedness, response, or recovery.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/K" id="HC1E0389C6C9845BA8186305FA7D46E37" class="bill-dtd-OLC" pagenum="35"><num value="K">“(K)</num><content> At least 2 representatives of State, local, Tribal, or territorial agencies with expertise in geriatric disaster planning, preparedness, response, or recovery.</content></subparagraph><subparagraph identifier="/tIII/s305/b/qB/s2811B/d/2/L" id="HD99613FA935048218511A24E6FC3A2F5" class="bill-dtd-OLC" pagenum="35"><num value="L">“(L)</num><content> Representatives of such other Federal agencies (such as the Department of Energy and the Department of Homeland Security) as the Secretary determines necessary to fulfill the duties of the Advisory Committee.</content></subparagraph></paragraph></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/e" id="H3DB2238ABB394A178B03D4C79411D34D" class="bill-dtd-OLC" pagenum="35"><num value="e">“(e)</num><heading> Meetings.—</heading><content>The Advisory Committee shall meet not less frequently than biannually. At least one meeting per year shall be an in-person meeting.</content></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/f" id="H536FA8026F7C42ABB7E67CFEEF508800" class="bill-dtd-OLC" pagenum="35"><num value="f">“(f)</num><heading> Coordination.—</heading><content>The Secretary shall coordinate duties and activities authorized under this section in accordance with section 2811D.</content></subsection><subsection identifier="/tIII/s305/b/qB/s2811B/g" id="HED6A32477D4441739B620A6466A90538" class="bill-dtd-OLC" pagenum="35"><num value="g">“(g)</num><heading> Sunset.—</heading><paragraph identifier="/tIII/s305/b/qB/s2811B/g/1" id="H20F205C842684E34A32786EABDFE8526" class="bill-dtd-OLC" pagenum="35"><num value="1">“(1)</num><heading> In general.—</heading><content>The Advisory Committee shall terminate on September 30, 2023.</content></paragraph><paragraph identifier="/tIII/s305/b/qB/s2811B/g/2" id="H47C07DA81F814AA6AF01570FF1EB7C30" class="bill-dtd-OLC" pagenum="35"><num value="2">“(2)</num><heading> Extension of committee.—</heading><content>Not later than October 1, 2022, the Secretary shall submit to Congress a recommendation on whether the Advisory Committee should be extended.”</content></paragraph></subsection></section></quotedContent>. </content></subsection><subsection identifier="/tIII/s305/c" id="HF2F646063FDA48ACAC65B01E4D2980E9" class="bill-dtd-OLC" pagenum="35"><num value="c">(c)</num><heading> National Advisory Committee on Individuals with Disabilities and Disasters.—</heading><content>Subtitle B of title XXVIII (<ref href="/us/usc/42/300hh">42 U.S.C. 300hh</ref> et seq.), as amended by subsection (b), is further amended by inserting after section 2811B the following:<quotedContent id="H64F218F5A8DE48EAA0FAA4D2136436E2"><section identifier="/tIII/s305/c/qB/s2811C" id="H79523A9F72DA482092A7CB792AB967F9" class="bill-dtd-OLC" pagenum="35"><num value="2811C">“Sec. 2811C.</num><heading> National Advisory Committee on Individuals with Disabilities and Disasters.</heading><subsection identifier="/tIII/s305/c/qB/s2811C/a" id="H0B99745B16B943C282DB98C4AE2E1430" class="bill-dtd-OLC" pagenum="35"><num value="a">“(a)</num><heading> Establishment.—</heading><content>The Secretary, in consultation with the Secretary of Homeland Security, shall establish a national advisory committee to be known as the National Advisory Committee on Individuals with Disabilities and Disasters (referred to in this section as the ‘<quotedText>Advisory Committee</quotedText>’).</content></subsection><subsection identifier="/tIII/s305/c/qB/s2811C/b" id="HCB02DB609A6443EDBDDB9CCA7C8C466B" class="bill-dtd-OLC" pagenum="35"><num value="b">“(b)</num><heading> Duties.—</heading><chapeau>The Advisory Committee shall—</chapeau><?page 36?><paragraph identifier="/tIII/s305/c/qB/s2811C/b/1" id="H0E55EAC7292B4D5792E211BBFDCD9568" class="bill-dtd-OLC" pagenum="36"><num value="1">“(1)</num><content> provide advice and consultation with respect to activities carried out pursuant to section 2814, as applicable and appropriate;</content></paragraph><paragraph identifier="/tIII/s305/c/qB/s2811C/b/2" id="HAC2762C67F59408DB321644B58A91B5C" class="bill-dtd-OLC" pagenum="36"><num value="2">“(2)</num><content> evaluate and provide input with respect to the medical, public health, and accessibility needs of individuals with disabilities related to preparation for, response to, and recovery from all-hazards emergencies; and</content></paragraph><paragraph identifier="/tIII/s305/c/qB/s2811C/b/3" id="H290240C30347442F88E128A3FF5EF853" class="bill-dtd-OLC" pagenum="36"><num value="3">“(3)</num><content> provide advice and consultation with respect to State emergency preparedness and response activities, including related drills and exercises pursuant to the preparedness goals under section 2802(b).</content></paragraph></subsection><subsection identifier="/tIII/s305/c/qB/s2811C/c" id="H4513D6BF8F0B49CFBCF290333CADD271" class="bill-dtd-OLC" pagenum="36"><num value="c">“(c)</num><heading> Membership.—</heading><paragraph identifier="/tIII/s305/c/qB/s2811C/c/1" id="H0B0E16F2D4B0469786C081B6165E3702" class="bill-dtd-OLC" pagenum="36"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary, in consultation with such other heads of agencies and departments as appropriate, shall appoint not more than 17 members to the Advisory Committee. In appointing such members, the Secretary shall ensure that the total membership of the Advisory Committee is an odd number.</content></paragraph><paragraph identifier="/tIII/s305/c/qB/s2811C/c/2" id="HD978A89984964BF5A3D9BAF06302195C" class="bill-dtd-OLC" pagenum="36"><num value="2">“(2)</num><heading> Required members.—</heading><chapeau>The Advisory Committee shall include Federal members or their designees (who may be nonvoting members, as determined by the Secretary) and non-Federal members, as follows:</chapeau><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/A" id="H8A58CFF784B24728829E5951684E1302" class="bill-dtd-OLC" pagenum="36"><num value="A">“(A)</num><content> The Assistant Secretary for Preparedness and Response.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/B" id="H38F24D67509044CD93FC776DA27C5EAF" class="bill-dtd-OLC" pagenum="36"><num value="B">“(B)</num><content> The Administrator of the Administration for Community Living.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/C" id="H75D555B0D0A64A978F8C2A60FCDAC72F" class="bill-dtd-OLC" pagenum="36"><num value="C">“(C)</num><content> The Director of the Biomedical Advanced Research and Development Authority.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/D" id="H0A796B6B87764728A26F446AD6566866" class="bill-dtd-OLC" pagenum="36"><num value="D">“(D)</num><content> The Director of the Centers for Disease Control and Prevention.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/E" id="H347B62DC6A644C65A2C589931B9C48A9" class="bill-dtd-OLC" pagenum="36"><num value="E">“(E)</num><content> The Commissioner of Food and Drugs.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/F" id="H72FEE191E04242D99E92C00146214A6C" class="bill-dtd-OLC" pagenum="36"><num value="F">“(F)</num><content> The Director of the National Institutes of Health.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/G" id="H69338BE93D90486290C3594E10653C17" class="bill-dtd-OLC" pagenum="36"><num value="G">“(G)</num><content> The Administrator of the Federal Emergency Management Agency.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/H" id="HA15A9FF76D2441A1B8908AEF2326FA8C" class="bill-dtd-OLC" pagenum="36"><num value="H">“(H)</num><content> The Chair of the National Council on Disability.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/I" id="HCEAAC266360F40CBBDD469E5970B5743" class="bill-dtd-OLC" pagenum="36"><num value="I">“(I)</num><content> The Chair of the United States Access Board.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/J" id="H5401E67F9BED4F5FB81E61716E9616C2" class="bill-dtd-OLC" pagenum="36"><num value="J">“(J)</num><content> The Under Secretary for Health of the Department of Veterans Affairs.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/K" id="HDD483362E70640E0BF4A81587A538016" class="bill-dtd-OLC" pagenum="36"><num value="K">“(K)</num><content> At least 2 non-Federal health care professionals with expertise in disability accessibility before, during, and after disasters, medical and mass care disaster planning, preparedness, response, or recovery.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/L" id="H60F7AD873F3840BAAF22152A5600A8C3" class="bill-dtd-OLC" pagenum="36"><num value="L">“(L)</num><content> At least 2 representatives from State, local, Tribal, or territorial agencies with expertise in disaster planning, preparedness, response, or recovery for individuals with disabilities.</content></subparagraph><subparagraph identifier="/tIII/s305/c/qB/s2811C/c/2/M" id="H9F3E24FBE048460A905208D0BFDF2260" class="bill-dtd-OLC" pagenum="36"><num value="M">“(M)</num><content> At least 2 individuals with a disability with expertise in disaster planning, preparedness, response, or recovery for individuals with disabilities.</content></subparagraph></paragraph></subsection><subsection identifier="/tIII/s305/c/qB/s2811C/d" id="HE10C973B1CD74465A32085CB79255453" class="bill-dtd-OLC" pagenum="36"><num value="d">“(d)</num><heading> Meetings.—</heading><content>The Advisory Committee shall meet not less frequently than biannually. At least one meeting per year shall be an in-person meeting.</content></subsection><subsection identifier="/tIII/s305/c/qB/s2811C/e" id="H4A055DB6F41B47399F5470C73232EB74" class="bill-dtd-OLC" pagenum="36"><num value="e">“(e)</num><heading> Disability defined.—</heading><content>For purposes of this section, the term ‘<term>disability</term>’ has the meaning given such term in section 3 of the Americans with Disabilities Act of 1990.</content></subsection><?page 37?><subsection identifier="/tIII/s305/c/qB/s2811C/f" id="H4AD65FD18BE04BC9BFB3A333BE295EE6" class="bill-dtd-OLC" pagenum="37"><num value="f">“(f)</num><heading> Coordination.—</heading><content>The Secretary shall coordinate duties and activities authorized under this section in accordance with section 2811D.</content></subsection><subsection identifier="/tIII/s305/c/qB/s2811C/g" id="H2C9E8CEF1AE24D56850B3EC0D9EDD67F" class="bill-dtd-OLC" pagenum="37"><num value="g">“(g)</num><heading> Sunset.—</heading><paragraph identifier="/tIII/s305/c/qB/s2811C/g/1" id="HAE65029594384681907AB5B2B68E9B18" class="bill-dtd-OLC" pagenum="37"><num value="1">“(1)</num><heading> In general.—</heading><content>The Advisory Committee shall terminate on September 30, 2023.</content></paragraph><paragraph identifier="/tIII/s305/c/qB/s2811C/g/2" id="HF14250C895D14057B7C6B308333AAE64" class="bill-dtd-OLC" pagenum="37"><num value="2">“(2)</num><heading> Recommendation.—</heading><content>Not later than October 1, 2022, the Secretary shall submit to Congress a recommendation on whether the Advisory Committee should be extended.”</content></paragraph></subsection></section></quotedContent>.</content></subsection><subsection identifier="/tIII/s305/d" id="HC5B30B0688264E3084AB654A0FACC8D4" class="bill-dtd-OLC" pagenum="37"><num value="d">(d)</num><heading> Advisory committee coordination.—</heading><content>Subtitle B of title XXVIII (<ref href="/us/usc/42/300hh">42 U.S.C. 300hh</ref> et seq.), as amended by subsection (c), is further amended by inserting after section 2811C the following:<quotedContent id="H923A2F4B8DFD42838867109CA6507271"><section identifier="/tIII/s305/d/qB/s2811D" id="HFCAF881759004B379AD4A34AC2C30D3F" class="bill-dtd-OLC" pagenum="37"><num value="2811D">“Sec. 2811D.</num><heading> Advisory committee coordination.</heading><subsection identifier="/tIII/s305/d/qB/s2811D/a" id="HEC27FF1CFDAB4BAFB0FC01DA55BD4DDC" class="bill-dtd-OLC" pagenum="37"><num value="a">“(a)</num><heading> In general.—</heading><content>The Secretary shall coordinate duties and activities authorized under sections 2811A, 2811B, and 2811C, and make efforts to reduce unnecessary or duplicative reporting, or unnecessary duplicative meetings and recommendations under such sections, as practicable. Members of the advisory committees authorized under such sections, or their designees, shall annually meet to coordinate any recommendations, as appropriate, that may be similar, duplicative, or overlapping with respect to addressing the needs of children, seniors, and individuals with disabilities during public health emergencies. If such coordination occurs through an in-person meeting, it shall not be considered the required in-person meetings under any of sections 2811A(e), 2811B(e), or 2811C(d).</content></subsection><subsection identifier="/tIII/s305/d/qB/s2811D/b" id="H99A312DDEDB64C838D15D87A25176518" class="bill-dtd-OLC" pagenum="37"><num value="b">“(b)</num><heading> Coordination and alignment.—</heading><content>The Secretary, acting through the employee designated pursuant to section 2814, shall align preparedness and response programs or activities to address similar, dual, or overlapping needs of children, seniors, and individuals with disabilities, and any challenges in preparing for and responding to such needs.</content></subsection><subsection identifier="/tIII/s305/d/qB/s2811D/c" id="HFC5051B2822A49869299C00100036C64" class="bill-dtd-OLC" pagenum="37"><num value="c">“(c)</num><heading> Notification.—</heading><content>The Secretary shall annually notify the congressional committees of jurisdiction regarding the steps taken to coordinate, as appropriate, the recommendations under this section, and provide a summary description of such coordination.”</content></subsection></section></quotedContent>.</content></subsection></section><section identifier="/tIII/s306" id="HE84903B8AA4542E4B1A1DB9806C6D841" class="bill-dtd-OLC" pagenum="37"><num value="306">Sec. 306.</num><heading> Guidance for participation in exercises and drills.</heading><content class="indent0">Not later than 2 years after the date of enactment of this Act, the Secretary of Health and Human Services shall issue final guidance regarding the ability of personnel funded by programs authorized under this Act (including the amendments made by this Act) to participate in drills and operational exercises related to all-hazards medical and public health preparedness and response. Such drills and operational exercises may include activities that incorporate medical surge capacity planning, medical countermeasure distribution and administration, and preparing for and responding to identified threats for that region. Such personnel may include State, local, Tribal, and territorial public health department or agency personnel funded under this Act (including the amendments made by this Act). The Secretary shall consult with the Department of Homeland Security, the Department of Defense, the Department of Veterans Affairs, and other applicable Federal departments and agencies as necessary and appropriate in the development of such guidance. The Secretary shall make the guidance available on the internet website of the Department of Health and Human Services.</content></section></title><?page 38?><title identifier="/tIV" id="H60FE95B474BC424DBCB3AEE9DC1A1DE9" class="bill-dtd-OLC" pagenum="38"><num value="IV">Title IV—</num><heading>Prioritizing a Threat-Based Approach </heading><section identifier="/tIV/s401" id="H9AC515DEC02240F28005F056E1AC3F3B" class="bill-dtd-OLC" pagenum="38"><num value="401">Sec. 401.</num><heading> Assistant Secretary for Preparedness and Response.</heading><chapeau class="block">Section 2811(b) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(b)</ref>) is amended—</chapeau><paragraph identifier="/tIV/s401/1" id="HC1B068B886964BA188F40D5F6EAD42EF" class="bill-dtd-OLC" pagenum="38"><num value="1">(1)</num><content> in the matter preceding paragraph (1), by inserting “<quotedText>utilize experience related to public health emergency preparedness and response, biodefense, medical countermeasures, and other relevant topics to</quotedText>” after “<quotedText>shall</quotedText>”; and</content></paragraph><paragraph identifier="/tIV/s401/2" id="H0D2CDCB4BEB24E568358BC5648AEFAC7" class="bill-dtd-OLC" pagenum="38"><num value="2">(2)</num><content> in paragraph (4), by adding at the end the following:<quotedContent id="H1985BEE4425140C99FE194D06099E550"><subparagraph identifier="/tIV/s401/2/qB/I" id="HC218CC34FFD14BE3B5E03910AD914A5C" class="bill-dtd-OLC" pagenum="38"><num value="I">“(I)</num><heading> Threat awareness.—</heading><content>Coordinate with the Director of the Centers for Disease Control and Prevention, the Director of National Intelligence, the Secretary of Homeland Security, the Assistant to the President for National Security Affairs, the Secretary of Defense, and other relevant Federal officials, such as the Secretary of Agriculture, to maintain a current assessment of national security threats and inform preparedness and response capabilities based on the range of the threats that have the potential to result in a public health emergency.”</content></subparagraph></quotedContent>.</content></paragraph></section><section identifier="/tIV/s402" id="H7481C347809A42B58639F8CC0F727536" class="bill-dtd-OLC" pagenum="38"><num value="402">Sec. 402.</num><heading> Public Health Emergency Medical Countermeasures Enterprise.</heading><subsection identifier="/tIV/s402/a" id="H2D139F3F602F465289E03AC6F4CBACAA" class="bill-dtd-OLC" pagenum="38"><num value="a">(a)</num><heading> In general.—</heading><content>Title XXVIII is amended by inserting after section 2811 (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10</ref>) the following:<quotedContent id="HCFB36C6486574F828DD502BA4B6D4373"><section identifier="/tIV/s402/a/qB/s2811–1" id="H23C587DD257A47E7985B4C42DC72D089" class="bill-dtd-OLC" pagenum="38"><num value="2811–1">“Sec. 2811–1.</num><heading> Public Health Emergency Medical Countermeasures Enterprise.</heading><subsection identifier="/tIV/s402/a/qB/s2811–1/a" id="H66094A32FBD14E469DFAA3521BECCC6E" class="bill-dtd-OLC" pagenum="38"><num value="a">“(a)</num><heading> In general.—</heading><content>The Secretary shall establish the Public Health Emergency Medical Countermeasures Enterprise (referred to in this section as the ‘<quotedText>PHEMCE</quotedText>’). The Assistant Secretary for Preparedness and Response shall serve as chair of the PHEMCE.</content></subsection><subsection identifier="/tIV/s402/a/qB/s2811–1/b" id="H5E1766D361F2471E9AC76D04CB0D57CE" class="bill-dtd-OLC" pagenum="38"><num value="b">“(b)</num><heading> Members.—</heading><chapeau>The PHEMCE shall include each of the following members, or the designee of such members:</chapeau><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/1" id="H89D4ADF7C6E748A89C3A20C36F90C92E" class="bill-dtd-OLC" pagenum="38"><num value="1">“(1)</num><content> The Assistant Secretary for Preparedness and Response.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/2" id="HB3FA1719867A49F7856B1E29ADC4AC06" class="bill-dtd-OLC" pagenum="38"><num value="2">“(2)</num><content> The Director of the Centers for Disease Control and Prevention.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/3" id="H11F92D0D0F7A437EBD520687199F451B" class="bill-dtd-OLC" pagenum="38"><num value="3">“(3)</num><content> The Director of the National Institutes of Health.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/4" id="H0BF3043386094BB3AF09C2A19C58F2C8" class="bill-dtd-OLC" pagenum="38"><num value="4">“(4)</num><content> The Commissioner of Food and Drugs.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/5" id="H2D18C840C8E24E27A45A51CF13F87ADA" class="bill-dtd-OLC" pagenum="38"><num value="5">“(5)</num><content> The Secretary of Defense.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/6" id="H8DC40481114D42A89185A0C6D1213520" class="bill-dtd-OLC" pagenum="38"><num value="6">“(6)</num><content> The Secretary of Homeland Security.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/7" id="H1C25E20C1F9E49A99C69AD8B0FB60948" class="bill-dtd-OLC" pagenum="38"><num value="7">“(7)</num><content> The Secretary of Agriculture.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/8" id="HB696D87CE55642EE881C2C9D68CA43D6" class="bill-dtd-OLC" pagenum="38"><num value="8">“(8)</num><content> The Secretary of Veterans Affairs.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/9" id="HE7393F43D9634BFC8E73C90B2D684FF7" class="bill-dtd-OLC" pagenum="38"><num value="9">“(9)</num><content> The Director of National Intelligence.</content></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/b/10" id="H35A47A1F18F5408C8AF35AD8C0084E26" class="bill-dtd-OLC" pagenum="38"><num value="10">“(10)</num><content> Representatives of any other Federal agency, which may include the Director of the Biomedical Advanced Research and Development Authority, the Director of the Strategic National Stockpile, the Director of the National Institute of Allergy and Infectious Diseases, and the Director of the Office of Public Health Preparedness and Response, as the Secretary determines appropriate.</content></paragraph></subsection><subsection identifier="/tIV/s402/a/qB/s2811–1/c" id="HD4FCAB71C6A44CBA889A253CA9D0C911" class="bill-dtd-OLC" pagenum="38"><num value="c">“(c)</num><heading> Functions.—</heading><paragraph identifier="/tIV/s402/a/qB/s2811–1/c/1" id="H2D7AAFB4C80B48E585FD7AE6B50EC5D8" class="bill-dtd-OLC" pagenum="38"><num value="1">“(1)</num><heading> In general.—</heading><chapeau>The functions of the PHEMCE shall include the following:</chapeau><?page 39?><subparagraph identifier="/tIV/s402/a/qB/s2811–1/c/1/A" id="H3F0902C3010A4A038B14369F17105A9E" class="bill-dtd-OLC" pagenum="39"><num value="A">“(A)</num><content> Utilize a process to make recommendations to the Secretary regarding research, advanced research, development, procurement, stockpiling, deployment, distribution, and utilization with respect to countermeasures, as defined in section 319F–2(c), including prioritization based on the health security needs of the United States. Such recommendations shall be informed by, when available and practicable, the National Health Security Strategy pursuant to section 2802, the Strategic National Stockpile needs pursuant to section 319F–2, and assessments of current national security threats, including chemical, biological, radiological, and nuclear threats, including emerging infectious diseases. In the event that members of the PHEMCE do not agree upon a recommendation, the Secretary shall provide a determination regarding such recommendation.</content></subparagraph><subparagraph identifier="/tIV/s402/a/qB/s2811–1/c/1/B" id="HD4173728AD694C02938B79AF33815B69" class="bill-dtd-OLC" pagenum="39"><num value="B">“(B)</num><content> Identify national health security needs, including gaps in public health preparedness and response related to countermeasures and challenges to addressing such needs (including any regulatory challenges), and support alignment of countermeasure procurement with recommendations to address such needs under subparagraph (A).</content></subparagraph><subparagraph identifier="/tIV/s402/a/qB/s2811–1/c/1/C" id="H4BD2A309BCD24A49AA1C3096E4E72D0C" class="bill-dtd-OLC" pagenum="39"><num value="C">“(C)</num><content> Assist the Secretary in developing strategies related to logistics, deployment, distribution, dispensing, and use of countermeasures that may be applicable to the activities of the strategic national stockpile under section 319F–2(a).</content></subparagraph><subparagraph identifier="/tIV/s402/a/qB/s2811–1/c/1/D" id="H91CAE5C786224C52999A2DB4DC8432FD" class="bill-dtd-OLC" pagenum="39"><num value="D">“(D)</num><content> Provide consultation for the development of the strategy and implementation plan under section 2811(d).</content></subparagraph></paragraph><paragraph identifier="/tIV/s402/a/qB/s2811–1/c/2" id="H4A71EBE8277843B08C52BFBF2470EA09" class="bill-dtd-OLC" pagenum="39"><num value="2">“(2)</num><heading> Input.—</heading><content>In carrying out subparagraphs (B) and (C) of paragraph (1), the PHEMCE shall solicit and consider input from State, local, Tribal, and territorial public health departments or officials, as appropriate.”</content></paragraph></subsection></section></quotedContent>.</content></subsection><subsection identifier="/tIV/s402/b" id="H142F04A825E3490C84C948399825140C" class="bill-dtd-OLC" pagenum="39"><num value="b">(b)</num><heading> Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan.—</heading><chapeau>Section 2811(d) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(d)</ref>) is amended—</chapeau><paragraph identifier="/tIV/s402/b/1" id="HEB078AB6F1D6435B8DD5CD62E513B5CE" class="bill-dtd-OLC" pagenum="39"><num value="1">(1)</num><chapeau> in paragraph (1)—</chapeau><subparagraph identifier="/tIV/s402/b/1/A" id="H71D332C7C14741AC8DECE38CB1A9A2C6" class="bill-dtd-OLC" pagenum="39"><num value="A">(A)</num><content> by striking “<quotedText>Not later than 180 days after the date of enactment of this subsection, and every year thereafter</quotedText>” and inserting “<quotedText>Not later than March 15, 2020, and biennially thereafter</quotedText>”; and</content></subparagraph><subparagraph identifier="/tIV/s402/b/1/B" id="H853B007D36C44B73810F1E6F103FDA36" class="bill-dtd-OLC" pagenum="39"><num value="B">(B)</num><content> by striking “<quotedText>Director of the Biomedical</quotedText>” and all that follows through “<quotedText>Food and Drugs</quotedText>” and inserting “<quotedText>Public Health Emergency Medical Countermeasures Enterprise established under section 2811–1</quotedText>”; and</content></subparagraph></paragraph><paragraph identifier="/tIV/s402/b/2" id="H92F76E0312594F2991E603FEE1C261BA" class="bill-dtd-OLC" pagenum="39"><num value="2">(2)</num><content> in paragraph (2)(J)(v), by striking “<quotedText>one-year period</quotedText>” and inserting “<quotedText>2-year period</quotedText>”.</content></paragraph></subsection></section><section identifier="/tIV/s403" id="H786FB102DE174A7A87ECC275FA44DF0A" class="bill-dtd-OLC" pagenum="39"><num value="403">Sec. 403.</num><heading> Strategic National Stockpile.</heading><subsection identifier="/tIV/s403/a" id="H4156FBCDD57A49B0A2F3178BF8B5D72B" class="bill-dtd-OLC" pagenum="39"><num value="a">(a)</num><heading> In general.—</heading><chapeau>Section 319F–2(a) (42 U.S.C. 247d–6b(a)) is amended—</chapeau><paragraph identifier="/tIV/s403/a/1" id="H97A674FDEEA049F3B43F456BD7E402F7" class="bill-dtd-OLC" pagenum="39"><num value="1">(1)</num><content> by redesignating paragraphs (2) and (3) as paragraphs (3) and (4), respectively; and</content></paragraph><paragraph identifier="/tIV/s403/a/2" id="H75A3E8BC231C4F91A9A0D35A57D8FD7E" class="bill-dtd-OLC" pagenum="39"><num value="2">(2)</num><chapeau> in paragraph (1)—</chapeau><subparagraph identifier="/tIV/s403/a/2/A" id="H9DA16341EC3942958D2C0B1F97E6BB44" class="bill-dtd-OLC" pagenum="39"><num value="A">(A)</num><content> by inserting “<quotedText>the Assistant Secretary for Preparedness and Response and</quotedText>” after “<quotedText>collaboration with</quotedText>”;</content></subparagraph><?page 40?><subparagraph identifier="/tIV/s403/a/2/B" id="H9D611E215EDB4D7180D93A3B757C6116" class="bill-dtd-OLC" pagenum="40"><num value="B">(B)</num><content> by inserting “<quotedText>and optimize</quotedText>” after “<quotedText>provide for</quotedText>”;</content></subparagraph><subparagraph identifier="/tIV/s403/a/2/C" id="HB34396BC4F6A411E99532B2842A3CE40" class="bill-dtd-OLC" pagenum="40"><num value="C">(C)</num><content> by inserting “<quotedText>and, as informed by existing recommendations of, or consultations with, the Public Health Emergency Medical Countermeasure Enterprise established under section 2811–1, make necessary additions or modifications to the contents of such stockpile or stockpiles based on the review conducted under paragraph (2)</quotedText>” before the period of the first sentence; and</content></subparagraph><subparagraph identifier="/tIV/s403/a/2/D" id="HD3EDE0BECB114F669B1CD0B28DBFDE47" class="bill-dtd-OLC" pagenum="40"><num value="D">(D)</num><content> by striking the second sentence;</content></subparagraph></paragraph><paragraph identifier="/tIV/s403/a/3" id="HCB9CD12A7D754ED5BA5C57CF4BD76965" class="bill-dtd-OLC" pagenum="40"><num value="3">(3)</num><content> by inserting after paragraph (1) the following:<quotedContent id="HFE52CF0FC5C94614990F7ACEB6742EE8"><paragraph identifier="/tIV/s403/a/3/qB/2" id="H6FB97419A80840EEABF77339948DD3E1" class="bill-dtd-OLC" pagenum="40"><num value="2">“(2)</num><heading> Threat-based review.—</heading><subparagraph identifier="/tIV/s403/a/3/qB/2/A" id="H9E3E3C6386B249BDB7BD36BAD45EA3CA" class="bill-dtd-OLC" pagenum="40"><num value="A">“(A)</num><heading> In general.—</heading><content>The Secretary shall conduct an annual threat-based review (taking into account at-risk individuals) of the contents of the stockpile under paragraph (1), including non-pharmaceutical supplies, and, in consultation with the Public Health Emergency Medical Countermeasures Enterprise established under section 2811–1, review contents within the stockpile and assess whether such contents are consistent with the recommendations made pursuant to section 2811–1(c)(1)(A). Such review shall be submitted on June 15, 2019, and on March 15 of each year thereafter, to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, in a manner that does not compromise national security.</content></subparagraph><subparagraph identifier="/tIV/s403/a/3/qB/2/B" id="H78FEE1CAD5974B918742A0C75482498C" class="bill-dtd-OLC" pagenum="40"><num value="B">“(B)</num><heading> Additions, modifications, and replenishments.—</heading><chapeau>Each annual threat-based review under subparagraph (A) shall, for each new or modified countermeasure procurement or replenishment, provide—</chapeau><clause identifier="/tIV/s403/a/3/qB/2/B/i" id="HD18352DD9E53493EA59EF731FD90A5A3" class="bill-dtd-OLC" pagenum="40"><num value="i">“(i)</num><chapeau> information regarding—</chapeau><subclause identifier="/tIV/s403/a/3/qB/2/B/i/I" id="H6FB269517EDB4D64A4E4370DC6E185B5" class="bill-dtd-OLC" pagenum="40"><num value="I">“(I)</num><content> the quantities of the additional or modified countermeasure procured for, or contracted to be procured for, the stockpile;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/II" id="HFFDA594BE45D4F34AD5793019E8E5068" class="bill-dtd-OLC" pagenum="40"><num value="II">“(II)</num><content> planning considerations for appropriate manufacturing capacity and capability to meet the goals of such additions or modifications (without disclosing proprietary information), including consideration of the effect such additions or modifications may have on the availability of such products and ancillary medical supplies in the health care system;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/III" id="H1A14B30393304A2DB2906820CA9F5F70" class="bill-dtd-OLC" pagenum="40"><num value="III">“(III)</num><content> the presence or lack of a commercial market for the countermeasure at the time of procurement;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/IV" id="H3ED756D1811A4F97A07C76D61F562B25" class="bill-dtd-OLC" pagenum="40"><num value="IV">“(IV)</num><content> the emergency health security threat or threats such countermeasure procurement is intended to address, including whether such procurement is consistent with meeting emergency health security needs associated with such threat or threats;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/V" id="H7D6E0AF282E84A5C9FF065CAFC8FBB69" class="bill-dtd-OLC" pagenum="40"><num value="V">“(V)</num><content> an assessment of whether the emergency health security threat or threats described in subclause (IV) could be addressed in a manner that better utilizes the resources of the stockpile and permits the greatest possible increase in the level <?page 41?>of emergency preparedness to address such threats;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/VI" id="H48F4025111E64004BE3289ECFC3918F6" class="bill-dtd-OLC" pagenum="41"><num value="VI">“(VI)</num><content> whether such countermeasure is replenishing an expiring or expired countermeasure, is a different countermeasure with the same indication that is replacing an expiring or expired countermeasure, or is a new addition to the stockpile;</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/VII" id="HDBD61A291CC4417F8A4FE3E81CD4506B" class="bill-dtd-OLC" pagenum="41"><num value="VII">“(VII)</num><content> a description of how such additions or modifications align with projected investments under previous countermeasures budget plans under section 2811(b)(7), including expected life-cycle costs, expenditures related to countermeasure procurement to address the threat or threats described in subclause (IV), replenishment dates (including the ability to extend the maximum shelf life of a countermeasure), and the manufacturing capacity required to replenish such countermeasure; and</content></subclause><subclause identifier="/tIV/s403/a/3/qB/2/B/i/VIII" id="H1B51FEAB4EE9443F8A13FBC7CDD39990" class="bill-dtd-OLC" pagenum="41"><num value="VIII">“(VIII)</num><content> appropriate protocols and processes for the deployment, distribution, or dispensing of the countermeasure at the State and local level, including plans for relevant capabilities of State and local entities to dispense, distribute, and administer the countermeasure; and</content></subclause></clause><clause identifier="/tIV/s403/a/3/qB/2/B/ii" id="H8C71C38846FB4CCC97DA728008ED9E4E" class="bill-dtd-OLC" pagenum="41"><num value="ii">“(ii)</num><content> an assurance, which need not be provided in advance of procurement, that for each countermeasure procured or replenished under this subsection, the Secretary completed a review addressing each item listed under this subsection in advance of such procurement or replenishment.”</content></clause></subparagraph></paragraph></quotedContent>;</content></paragraph><paragraph identifier="/tIV/s403/a/4" id="HE6F63E0762F24A83A5BAA4AD23C1A36E" class="bill-dtd-OLC" pagenum="41"><num value="4">(4)</num><chapeau> in paragraph (3), as so redesignated—</chapeau><subparagraph identifier="/tIV/s403/a/4/A" id="H1B566FA48BE54C34A88CE01CB5AEAB0C" class="bill-dtd-OLC" pagenum="41"><num value="A">(A)</num><content> in subparagraph (A), by inserting “<quotedText>and the Public Health Emergency Medical Countermeasures Enterprise established under section 2811–1</quotedText>” before the semicolon;</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/B" id="HC045488D644A42C0BE18CFEBD4A3432B" class="bill-dtd-OLC" pagenum="41"><num value="B">(B)</num><content> in subparagraph (C), by inserting “<quotedText>, and the availability, deployment, dispensing, and administration of countermeasures</quotedText>” before the semicolon;</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/C" id="H2238DCEE35DD4752AA9C5B2B9F6E337A" class="bill-dtd-OLC" pagenum="41"><num value="C">(C)</num><content> by amending subparagraph (E) to read as follows:<quotedContent id="H6AD1BEB0D6694FD29B0B5FD228EC5AFF"><subparagraph identifier="/tIV/s403/a/4/C/qB/E" id="HD4F6C00FB8BA4D959D467A59EA91444E" class="bill-dtd-OLC" pagenum="41"><num value="E">“(E)</num><content> devise plans for effective and timely supply-chain management of the stockpile, in consultation with the Director of the Centers for Disease Control and Prevention, the Assistant Secretary for Preparedness and Response, the Secretary of Transportation, the Secretary of Homeland Security, the Secretary of Veterans Affairs, and the heads of other appropriate Federal agencies; State, local, Tribal, and territorial agencies; and the public and private health care infrastructure, as applicable, taking into account the manufacturing capacity and other available sources of products and appropriate alternatives to supplies in the stockpile;”</content></subparagraph></quotedContent>;</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/D" id="H928328AD3C2047DAAECA3678E279D90E" class="bill-dtd-OLC" pagenum="41"><num value="D">(D)</num><content> in subparagraph (G), by striking “<quotedText>; and</quotedText>” and inserting a semicolon;</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/E" id="HB9A0E3DE7A614C4885602AE9ACA0D916" class="bill-dtd-OLC" pagenum="41"><num value="E">(E)</num><content> in subparagraph (H), by striking the period and inserting a semicolon; and</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/F" id="HBB625CF7253C4D7F9859C84CFE1CA377" class="bill-dtd-OLC" pagenum="41"><num value="F">(F)</num><content> by adding at the end the following:<?page 42?><quotedContent id="HB1A87485EB4B49E296C30EDB4C257B52"><subparagraph identifier="/tIV/s403/a/4/F/qB/I" id="H34CB71E91832444680E8B0BEC795135A" class="bill-dtd-OLC" pagenum="42"><num value="I">“(I)</num><content> ensure that each countermeasure or product under consideration for procurement pursuant to this subsection receives the same consideration regardless of whether such countermeasure or product receives or had received funding under section 319L, including with respect to whether the countermeasure or product is most appropriate to meet the emergency health security needs of the United States; and</content></subparagraph><subparagraph identifier="/tIV/s403/a/4/F/qB/J" id="HCB0A98597FF14E7EA155ECFF33E001F3" class="bill-dtd-OLC" pagenum="42"><num value="J">“(J)</num><content> provide assistance, including technical assistance, to maintain and improve State and local public health preparedness capabilities to distribute and dispense medical countermeasures and products from the stockpile, as appropriate.”</content></subparagraph></quotedContent>; and</content></subparagraph></paragraph><paragraph identifier="/tIV/s403/a/5" id="HEAACCA4C8A6C427BBB9C330B1B2D7254" class="bill-dtd-OLC" pagenum="42"><num value="5">(5)</num><content> by adding at the end the following:<quotedContent id="H104D3B2089DD4D28ACBA3D9937C32ACE"><paragraph identifier="/tIV/s403/a/5/qB/5" id="HF997DA18C3D14FF09A9307819D4F82C1" class="bill-dtd-OLC" pagenum="42"><num value="5">“(5)</num><heading> GAO report.—</heading><subparagraph identifier="/tIV/s403/a/5/qB/5/A" id="H1FA0CCB279EC4225A400D58F350041F1" class="bill-dtd-OLC" pagenum="42"><num value="A">“(A)</num><heading> In general.—</heading><chapeau>Not later than 3 years after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, and every 5 years thereafter, the Comptroller General of the United States shall conduct a review of any changes to the contents or management of the stockpile since January 1, 2015. Such review shall include—</chapeau><clause identifier="/tIV/s403/a/5/qB/5/A/i" id="H895B5873CB374B369CE49B338C800A34" class="bill-dtd-OLC" pagenum="42"><num value="i">“(i)</num><content> an assessment of the comprehensiveness and completeness of each annual threat-based review under paragraph (2), including whether all newly procured or replenished countermeasures within the stockpile were described in each annual review, and whether, consistent with paragraph (2)(B), the Secretary conducted the necessary internal review in advance of such procurement or replenishment;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/ii" id="HAFE02F3B04B14A588CDBD3DE1EB8E27F" class="bill-dtd-OLC" pagenum="42"><num value="ii">“(ii)</num><content> an assessment of whether the Secretary established health security and science-based justifications, and a description of such justifications for procurement decisions related to health security needs with respect to the identified threat, for additions or modifications to the stockpile based on the information provided in such reviews under paragraph (2)(B), including whether such review was conducted prior to procurement, modification, or replenishment;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/iii" id="H0ECB95F553CD47B4BAF162A73540E2F3" class="bill-dtd-OLC" pagenum="42"><num value="iii">“(iii)</num><content> an assessment of the plans developed by the Secretary for the deployment, distribution, and dispensing of countermeasures procured, modified, or replenished under paragraph (1), including whether such plans were developed prior to procurement, modification, or replenishment;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/iv" id="H59475255672D4D3295BD79BEDFD719B1" class="bill-dtd-OLC" pagenum="42"><num value="iv">“(iv)</num><content> an accounting of countermeasures procured, modified, or replenished under paragraph (1) that received advanced research and development funding from the Biomedical Advanced Research and Development Authority;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/v" id="H75C8907C075B407788E987B922113F04" class="bill-dtd-OLC" pagenum="42"><num value="v">“(v)</num><content> an analysis of how such procurement decisions made progress toward meeting emergency health security needs related to the identified threats for countermeasures added, modified, or replenished under paragraph (1);</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/vi" id="H482F6CA287AB4683AED902A8EA301C4D" class="bill-dtd-OLC" pagenum="42"><num value="vi">“(vi)</num><content> a description of the resources expended related to the procurement of countermeasures <?page 43?>(including additions, modifications, and replenishments) in the stockpile, and how such expenditures relate to the ability of the stockpile to meet emergency health security needs;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/vii" id="H30218B1D2D474688BD163531824A1C01" class="bill-dtd-OLC" pagenum="43"><num value="vii">“(vii)</num><content> an assessment of the extent to which additions, modifications, and replenishments reviewed under paragraph (2) align with previous relevant reports or reviews by the Secretary or the Comptroller General;</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/viii" id="H688C567AFCDA4885AF4F45D243963E8B" class="bill-dtd-OLC" pagenum="43"><num value="viii">“(viii)</num><content> with respect to any change in the Federal organizational management of the stockpile, an assessment and comparison of the processes affected by such change, including planning for potential countermeasure deployment, distribution, or dispensing capabilities and processes related to procurement decisions, use of stockpiled countermeasures, and use of resources for such activities; and</content></clause><clause identifier="/tIV/s403/a/5/qB/5/A/ix" id="H0226915C39DF4E8C94FB9CF8C9D3C168" class="bill-dtd-OLC" pagenum="43"><num value="ix">“(ix)</num><content> an assessment of whether the processes and procedures described by the Secretary pursuant to section 403(b) of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle> are sufficient to ensure countermeasures and products under consideration for procurement pursuant to subsection (a) receive the same consideration regardless of whether such countermeasures and products receive or had received funding under section 319L, including with respect to whether such countermeasures and products are most appropriate to meet the emergency health security needs of the United States.</content></clause></subparagraph><subparagraph identifier="/tIV/s403/a/5/qB/5/B" id="H7BAC8DFEC5294B629B785E593A53EDF8" class="bill-dtd-OLC" pagenum="43"><num value="B">“(B)</num><heading> Submission.—</heading><content>Not later than 6 months after completing a classified version of the review under subparagraph (A), the Comptroller General shall submit an unclassified version of the review to the congressional committees of jurisdiction.”</content></subparagraph></paragraph></quotedContent>. </content></paragraph></subsection><subsection identifier="/tIV/s403/b" id="H2B6579DBA1BD4533B587F39D9F3199D9" class="bill-dtd-OLC" pagenum="43"><num value="b">(b)</num><heading> Additional reporting.—</heading><content>In the first threat-based review submitted after the date of enactment of this Act pursuant to paragraph (2) of section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)), as amended by subsection (a), the Secretary shall include a description of the processes and procedures through which the Director of the Strategic National Stockpile and the Director of the Biomedical Advanced Research and Development Authority coordinate with respect to countermeasures and products procured under such section 319F–2(a), including such processes and procedures in place to ensure countermeasures and products under consideration for procurement pursuant to such section 319F–2(a) receive the same consideration regardless of whether such countermeasures or products receive or had received funding under section 319L of the Public Health Service Act (<ref href="/us/usc/42/247d-7e">42 U.S.C. 247d–7e</ref>), and whether such countermeasures and products are the most appropriate to meet the emergency health security needs of the United States.</content></subsection><subsection identifier="/tIV/s403/c" id="H2D44E25081C1400E99A8064FA8199B0C" class="bill-dtd-OLC" pagenum="43"><num value="c">(c)</num><heading> Authorization of appropriations, strategic national stockpile.—</heading><content>Section 319F–2(f)(1) (42 U.S.C. 247d–6b(f)(1)) is amended by striking “<quotedText>$533,800,000 for each of fiscal years 2014 through 2018</quotedText>” and inserting “<quotedText>$610,000,000 for each of fiscal years 2019 through 2023, to remain available until expended</quotedText>”.</content></subsection></section><?page 44?><section identifier="/tIV/s404" id="HA26BB6BF682F4DF4BB8BABC8C6CA51D6" class="bill-dtd-OLC" pagenum="44"><num value="404">Sec. 404.</num><heading> Preparing for pandemic influenza, antimicrobial resistance, and other significant threats.</heading><subsection identifier="/tIV/s404/a" id="H229316623DD545AD8B9BA095CA234F7C" class="bill-dtd-OLC" pagenum="44"><num value="a">(a)</num><heading> Strategic initiatives.—</heading><content>Section 319L(c)(4) (247d–7e(c)(4)) is amended by adding at the end the following:<quotedContent id="HDB6BE264BD3D44E98E421FECE1CD012F"><subparagraph identifier="/tIV/s404/a/qB/F" id="H397B3CA2FB0B4BECA9EDE73BEF3DE4BD" class="bill-dtd-OLC" pagenum="44"><num value="F">“(F)</num><heading> Strategic initiatives.—</heading><chapeau>The Secretary, acting through the Director of BARDA, may implement strategic initiatives, including by building on existing programs and by awarding contracts, grants, and cooperative agreements, or entering into other transactions, to support innovative candidate products in preclinical and clinical development that address priority, naturally occurring and man-made threats that, as determined by the Secretary, pose a significant level of risk to national security based on the characteristics of a chemical, biological, radiological or nuclear threat, or existing capabilities to respond to such a threat (including medical response and treatment capabilities and manufacturing infrastructure). Such initiatives shall accelerate and support the advanced research, development, and procurement of countermeasures and products, as applicable, to address areas including—</chapeau><clause identifier="/tIV/s404/a/qB/F/i" id="H24981FD0BA024C908F23BAE82162B95D" class="bill-dtd-OLC" pagenum="44"><num value="i">“(i)</num><content> chemical, biological, radiological, or nuclear threats, including emerging infectious diseases, for which insufficient approved, licensed, or authorized countermeasures exist, or for which such threat, or the result of an exposure to such threat, may become resistant to countermeasures or existing countermeasures may be rendered ineffective;</content></clause><clause identifier="/tIV/s404/a/qB/F/ii" id="H06F6BE38753343DB8A86AD445757FFCE" class="bill-dtd-OLC" pagenum="44"><num value="ii">“(ii)</num><content> threats that consistently exist or continually circulate and have a significant potential to become a pandemic, such as pandemic influenza, which may include the advanced research and development, manufacturing, and appropriate stockpiling of qualified pandemic or epidemic products, and products, technologies, or processes to support the advanced research and development of such countermeasures (including multiuse platform technologies for diagnostics, vaccines, and therapeutics; virus seeds; clinical trial lots; novel virus strains; and antigen and adjuvant material); and</content></clause><clause identifier="/tIV/s404/a/qB/F/iii" id="H07D921EBB47E43819D25342278707ADC" class="bill-dtd-OLC" pagenum="44"><num value="iii">“(iii)</num><content> threats that may result primarily or secondarily from a chemical, biological, radiological, or nuclear agent, or emerging infectious diseases, and which may present increased treatment complications such as the occurrence of resistance to available countermeasures or potential countermeasures, including antimicrobial resistant pathogens.”</content></clause></subparagraph></quotedContent>. </content></subsection><subsection identifier="/tIV/s404/b" id="HC70A0A08811B4FBFB91310CC382FDF71" class="bill-dtd-OLC" pagenum="44"><num value="b">(b)</num><heading> Protection of national security from threats.—</heading><content>Section 2811 (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10</ref>) is amended by adding at the end the following:<quotedContent id="HC4D22755F6504CE9AE23C471752EF5B0"><subsection identifier="/tIV/s404/b/qB/f" id="HA2D9D3069F0141BCB57B8D717EF09258" class="bill-dtd-OLC" pagenum="44"><num value="f">“(f)</num><heading> Protection of national security from threats.—</heading><paragraph identifier="/tIV/s404/b/qB/f/1" id="H53E4A5E818794B12AC131B0CC01A0973" class="bill-dtd-OLC" pagenum="44"><num value="1">“(1)</num><heading> In general.—</heading><chapeau>In carrying out subsection (b)(3), the Assistant Secretary for Preparedness and Response shall implement strategic initiatives or activities to address threats, including pandemic influenza and which may include a chemical, biological, radiological, or nuclear agent (including any such agent with a significant potential to become a pandemic), that pose a significant level of risk to public health and national <?page 45?>security based on the characteristics of such threat. Such initiatives shall include activities to—</chapeau><subparagraph identifier="/tIV/s404/b/qB/f/1/A" id="H44A961E58FC040B6B785B52017CF7E73" class="bill-dtd-OLC" pagenum="45"><num value="A">“(A)</num><content> accelerate and support the advanced research, development, manufacturing capacity, procurement, and stockpiling of countermeasures, including initiatives under section 319L(c)(4)(F);</content></subparagraph><subparagraph identifier="/tIV/s404/b/qB/f/1/B" id="HDC6F9AE711F44C228EAAD1F3B2BF0087" class="bill-dtd-OLC" pagenum="45"><num value="B">“(B)</num><content> support the development and manufacturing of virus seeds, clinical trial lots, and stockpiles of novel virus strains; and</content></subparagraph><subparagraph identifier="/tIV/s404/b/qB/f/1/C" id="H31940DC6DF704DC9B8399CCD418C3599" class="bill-dtd-OLC" pagenum="45"><num value="C">“(C)</num><content> maintain or improve preparedness activities, including for pandemic influenza.</content></subparagraph></paragraph><paragraph identifier="/tIV/s404/b/qB/f/2" id="H44EFB34D756C43E1ACBD6C423BF252E6" class="bill-dtd-OLC" pagenum="45"><num value="2">“(2)</num><heading> Authorization of appropriations.—</heading><subparagraph identifier="/tIV/s404/b/qB/f/2/A" id="H92A79DA0E858492688DFCF07218C611C" class="bill-dtd-OLC" pagenum="45"><num value="A">“(A)</num><heading> In general.—</heading><content>To carry out this subsection, there is authorized to be appropriated $250,000,000 for each of fiscal years 2019 through 2023.</content></subparagraph><subparagraph identifier="/tIV/s404/b/qB/f/2/B" id="HE7F688D6FD9D4E3A8116E5080E281DF3" class="bill-dtd-OLC" pagenum="45"><num value="B">“(B)</num><heading> Supplement, not supplant.—</heading><content>Amounts appropriated under this paragraph shall be used to supplement and not supplant funds provided under sections 319L(d) and 319F–2(g).</content></subparagraph><subparagraph identifier="/tIV/s404/b/qB/f/2/C" id="H92F8BF975B5540EA95F0F30D78CEBDA3" class="bill-dtd-OLC" pagenum="45"><num value="C">“(C)</num><heading> Documentation required.—</heading><content>The Assistant Secretary for Preparedness and Response, in accordance with subsection (b)(7), shall document amounts expended for purposes of carrying out this subsection, including amounts appropriated under the heading ‘<quotedText>Public Health and Social Services Emergency Fund</quotedText>’ under the heading ‘<quotedText>Office of the Secretary</quotedText>’ under title II of division H of the Consolidated Appropriations Act, 2018 (<ref href="/us/pl/115/141">Public Law 115–141</ref>) and allocated to carrying out section 319L(c)(4)(F).”</content></subparagraph></paragraph></subsection></quotedContent>.</content></subsection></section><section identifier="/tIV/s405" id="H963969CB69314CA3ABFB125C0149A249" class="bill-dtd-OLC" pagenum="45"><num value="405">Sec. 405.</num><heading> Reporting on the Federal Select Agent Program.</heading><chapeau class="block">Section 351A(k) (<ref href="/us/usc/42/262a">42 U.S.C. 262a(k)</ref>) is amended—</chapeau><paragraph identifier="/tIV/s405/1" id="H7E5DC2FDDD1243F7B5D17B12FA7676E0" class="bill-dtd-OLC" pagenum="45"><num value="1">(1)</num><content> by striking “<quotedText>The Secretary</quotedText>” and inserting the following:<quotedContent id="HB95B00A043DF4C2DB177CDA6301AFBA2"><paragraph identifier="/tIV/s405/1/qB/1" id="H4A685DD19B4A4825AAA47D5F38FE11BB" class="bill-dtd-OLC" pagenum="45"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary”</content></paragraph></quotedContent>; and</content></paragraph><paragraph identifier="/tIV/s405/2" id="H835271CD8A6C411C8998FD6BB868E6EE" class="bill-dtd-OLC" pagenum="45"><num value="2">(2)</num><content> by adding at the end the following:<quotedContent id="H33924AC702EB4249A566DC834C1D87C6"><paragraph identifier="/tIV/s405/2/qB/2" id="H944F1CF8F79A46AE9D5802A678591F44" class="bill-dtd-OLC" pagenum="45"><num value="2">“(2)</num><heading> Implementation of recommendations of the Federal Experts Security Advisory Panel and the Fast Track Action Committee on Select Agent Regulations.—</heading><subparagraph identifier="/tIV/s405/2/qB/2/A" id="H965B7DEB586748F2B7D0C4093293A695" class="bill-dtd-OLC" pagenum="45"><num value="A">“(A)</num><heading> In general.—</heading><content>Not later than 1 year after the date of the enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, the Secretary shall report to the congressional committees of jurisdiction on the implementation of recommendations of the Federal Experts Security Advisory Panel concerning the select agent program.</content></subparagraph><subparagraph identifier="/tIV/s405/2/qB/2/B" id="HC31176DDFE1142F49364F958215FF4F0" class="bill-dtd-OLC" pagenum="45"><num value="B">“(B)</num><heading> Continued updates.—</heading><content>The Secretary shall report to the congressional committees of jurisdiction annually following the submission of the report under subparagraph (A) until the recommendations described in such subparagraph are fully implemented, or a justification is provided for the delay in, or lack of, implementation.”</content></subparagraph></paragraph></quotedContent>. </content></paragraph></section></title><?page 46?><title identifier="/tV" id="H3AAEF5881A214C89A16B29C59DA587F2" class="bill-dtd-OLC" pagenum="46"><num value="V">Title V—</num><heading>Increasing Communication in Medical Countermeasure Advanced Research and Development</heading><section identifier="/tV/s501" id="H0F22870BF2F04D4BB1E30561CC81BE84" class="bill-dtd-OLC" pagenum="46"><num value="501">Sec. 501.</num><heading> Medical Countermeasure Budget Plan.</heading><chapeau class="block">Section 2811(b)(7) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(b)(7)</ref>) is amended—</chapeau><paragraph identifier="/tV/s501/1" id="HEFC128C1FFAA449D82D86AC14DF60D2E" class="bill-dtd-OLC" pagenum="46"><num value="1">(1)</num><content> in the matter preceding subparagraph (A), by striking “<quotedText>March 1</quotedText>” and inserting “<quotedText>March 15</quotedText>”;</content></paragraph><paragraph identifier="/tV/s501/2" id="H36A6CC1085AF42749935B27012B11327" class="bill-dtd-OLC" pagenum="46"><num value="2">(2)</num><chapeau> in subparagraph (A)—</chapeau><subparagraph identifier="/tV/s501/2/A" id="HC5287218111643129F96A1201ACCBF5C" class="bill-dtd-OLC" pagenum="46"><num value="A">(A)</num><content> in clause (ii), by striking “<quotedText>; and</quotedText>” and inserting “<quotedText>;</quotedText>”; and</content></subparagraph><subparagraph identifier="/tV/s501/2/B" id="H813488C5D8704B11AB9F9AD80B2C5C12" class="bill-dtd-OLC" pagenum="46"><num value="B">(B)</num><content> by striking clause (iii) and inserting the following:<quotedContent id="H145EC5F14F924D5E8203AB65F2AA606C"><clause identifier="/tV/s501/2/B/qB/iii" id="H201B7446B3F24CB191557DA0A26FCA31" class="bill-dtd-OLC" pagenum="46"><num value="iii">“(iii)</num><content> procurement, stockpiling, maintenance, and potential replenishment (including manufacturing capabilities) of all products in the Strategic National Stockpile;</content></clause><clause identifier="/tV/s501/2/B/qB/iv" id="HBC10278A773D4E93BEC4A8969017B452" class="bill-dtd-OLC" pagenum="46"><num value="iv">“(iv)</num><content> the availability of technologies that may assist in the advanced research and development of countermeasures and opportunities to use such technologies to accelerate and navigate challenges unique to countermeasure research and development; and</content></clause><clause identifier="/tV/s501/2/B/qB/v" id="HA910D59C54444B82814A10B4B12EDF77" class="bill-dtd-OLC" pagenum="46"><num value="v">“(v)</num><content> potential deployment, distribution, and utilization of medical countermeasures; development of clinical guidance and emergency use instructions for the use of medical countermeasures; and, as applicable, potential postdeployment activities related to medical countermeasures;”</content></clause></quotedContent>;</content></subparagraph></paragraph><paragraph identifier="/tV/s501/3" id="H56F0AB97E3464101A2D2C6051C7DD568" class="bill-dtd-OLC" pagenum="46"><num value="3">(3)</num><content> by redesignating subparagraphs (D) and (E) as subparagraphs (E) and (F), respectively; and</content></paragraph><paragraph identifier="/tV/s501/4" id="H604C0E86966F4B5AA6D75BC2D83C1CEC" class="bill-dtd-OLC" pagenum="46"><num value="4">(4)</num><content> by inserting after subparagraph (C), the following:<quotedContent id="HD27D044FC7D94C78A3FC2D08FC4E469D"><subparagraph identifier="/tV/s501/4/qB/D" id="H6A74C3982E9E4805953CC2DF84AC77C6" class="bill-dtd-OLC" pagenum="46"><num value="D">“(D)</num><content> identify the full range of anticipated medical countermeasure needs related to research and development, procurement, and stockpiling, including the potential need for indications, dosing, and administration technologies, and other countermeasure needs as applicable and appropriate;”</content></subparagraph></quotedContent>.</content></paragraph></section><section identifier="/tV/s502" id="H370C043F223148078ED7CED7B2BAD3F9" class="bill-dtd-OLC" pagenum="46"><num value="502">Sec. 502.</num><heading> Material threat and medical countermeasure notifications.</heading><subsection identifier="/tV/s502/a" id="HF410776A5C444286B7894089D41609EF" class="bill-dtd-OLC" pagenum="46"><num value="a">(a)</num><heading> Congressional notification of material threat determination.—</heading><content>Section 319F–2(c)(2)(C) (42 U.S.C. 247d–6b(c)(2)(C)) is amended by striking “<quotedText>The Secretary and the Homeland Security Secretary shall promptly notify the appropriate committees of Congress</quotedText>” and inserting “<quotedText>The Secretary and the Secretary of Homeland Security shall send to Congress, on an annual basis, all current material threat determinations and shall promptly notify the Committee on Health, Education, Labor, and Pensions and the Committee on Homeland Security and Governmental Affairs of the Senate and the Committee on Energy and Commerce and the Committee on Homeland Security of the House of Representatives</quotedText>”.</content></subsection><subsection identifier="/tV/s502/b" id="H73C5CA19CCB24A8CB2464D2AC47A128C" class="bill-dtd-OLC" pagenum="46"><num value="b">(b)</num><heading> Contracting communication.—</heading><content>Section 319F–2(c)(7)(B)(ii)(III) (42 U.S.C. 247d–6b(c)(7)(B)(ii)(III)) is amended by adding at the end the following: “<quotedText>The Secretary shall notify the <?page 47?>vendor within 90 days of a determination by the Secretary to renew, extend, or terminate such contract.</quotedText>”.</content></subsection></section><section identifier="/tV/s503" id="H8F8B2D95A3874513A898A93525D1E92A" class="bill-dtd-OLC" pagenum="47"><num value="503">Sec. 503.</num><heading> Availability of regulatory management plans.</heading><chapeau class="block">Section 565(f) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-4">21 U.S.C. 360bbb–4(f)</ref>) is amended—</chapeau><paragraph identifier="/tV/s503/1" id="H9532CD0FC32C459F8FE0FA16DDE17644" class="bill-dtd-OLC" pagenum="47"><num value="1">(1)</num><content> by redesignating paragraphs (3) through (6) as paragraphs (4) through (7), respectively;</content></paragraph><paragraph identifier="/tV/s503/2" id="H421E4830474A45559360F3A2A574236C" class="bill-dtd-OLC" pagenum="47"><num value="2">(2)</num><content> by inserting after paragraph (2) the following:<quotedContent id="HF90D1E2FE89848519FC5F564F2E7798A"><paragraph identifier="/tV/s503/2/qB/3" id="HD2E95FEA4F5645DAAA7D3F9C1CB77D4D" class="bill-dtd-OLC" pagenum="47"><num value="3">“(3)</num><heading> Publication.—</heading><chapeau>The Secretary shall make available on the internet website of the Food and Drug Administration information regarding regulatory management plans, including—</chapeau><subparagraph identifier="/tV/s503/2/qB/3/A" id="H4BD5521CE1684A59863B0E2AEB1CF183" class="bill-dtd-OLC" pagenum="47"><num value="A">“(A)</num><content> the process by which an applicant may submit a request for a regulatory management plan;</content></subparagraph><subparagraph identifier="/tV/s503/2/qB/3/B" id="HEF54650E5589432CB0EF27A012740E7A" class="bill-dtd-OLC" pagenum="47"><num value="B">“(B)</num><content> the timeframe by which the Secretary is required to respond to such request;</content></subparagraph><subparagraph identifier="/tV/s503/2/qB/3/C" id="H4BD6786F7DBD4413BD312F62608AFE88" class="bill-dtd-OLC" pagenum="47"><num value="C">“(C)</num><content> the information required for the submission of such request;</content></subparagraph><subparagraph identifier="/tV/s503/2/qB/3/D" id="H2B692E7EE59B418290A14EF8AE09A718" class="bill-dtd-OLC" pagenum="47"><num value="D">“(D)</num><content> a description of the types of development milestones and performance targets that could be discussed and included in such plans; and</content></subparagraph><subparagraph identifier="/tV/s503/2/qB/3/E" id="HB5146409E99E474DA200CF3C791AB63B" class="bill-dtd-OLC" pagenum="47"><num value="E">“(E)</num><content> contact information for beginning the regulatory management plan process.”</content></subparagraph></paragraph></quotedContent>;</content></paragraph><paragraph identifier="/tV/s503/3" id="H87F24B7E386A4BA5B6BB6050AD784626" class="bill-dtd-OLC" pagenum="47"><num value="3">(3)</num><chapeau> in paragraph (6), as so redesignated, in the matter preceding subparagraph (A)—</chapeau><subparagraph identifier="/tV/s503/3/A" id="HBF56977B7FE248C8B292BC3AC82F0DCF" class="bill-dtd-OLC" pagenum="47"><num value="A">(A)</num><content> by striking “<quotedText>paragraph (4)(A)</quotedText>” and inserting “<quotedText>paragraph (5)(A)</quotedText>”; and</content></subparagraph><subparagraph identifier="/tV/s503/3/B" id="H78149FC914E6487994C3AE15745A6C14" class="bill-dtd-OLC" pagenum="47"><num value="B">(B)</num><content> by striking “<quotedText>paragraph (4)(B)</quotedText>” and inserting “<quotedText>paragraph (5)(B)</quotedText>”; and</content></subparagraph></paragraph><paragraph identifier="/tV/s503/4" id="HA9D0131D8B1642E791C63BD45FB33B4E" class="bill-dtd-OLC" pagenum="47"><num value="4">(4)</num><content> in paragraph (7)(A), as so redesignated, by striking “<quotedText>paragraph (3)(A)</quotedText>” and inserting “<quotedText>paragraph (4)(A)</quotedText>”.</content></paragraph></section><section identifier="/tV/s504" id="H4205E6DD2C7B43ECBE820E265AAE7D65" class="bill-dtd-OLC" pagenum="47"><num value="504">Sec. 504.</num><heading> The Biomedical Advanced Research and Development Authority and the BioShield Special Reserve Fund.</heading><subsection identifier="/tV/s504/a" id="H187A8FE4110748EBA736F0DB12DB926F" class="bill-dtd-OLC" pagenum="47"><num value="a">(a)</num><heading> BioShield Special Reserve Fund.—</heading><chapeau>Section 319F–2(g)(1) (42 U.S.C. 247d–6b(g)(1)) is amended—</chapeau><paragraph identifier="/tV/s504/a/1" id="HD0949DDE1D15401F8F83B8CDDD8EF884" class="bill-dtd-OLC" pagenum="47"><num value="1">(1)</num><content> by striking “<quotedText>$2,800,000,000 for the period of fiscal years 2014 through 2018</quotedText>” and inserting “<quotedText>$7,100,000,000 for the period of fiscal years 2019 through 2028, to remain available until expended</quotedText>”; and</content></paragraph><paragraph identifier="/tV/s504/a/2" id="H8B54A126E5E94495826DD2E9630EED66" class="bill-dtd-OLC" pagenum="47"><num value="2">(2)</num><content> by striking the second sentence.</content></paragraph></subsection><subsection identifier="/tV/s504/b" id="H79BD9842C97A4AFDA835AACF9A0B2839" class="bill-dtd-OLC" pagenum="47"><num value="b">(b)</num><heading> The Biomedical Advanced Research and Development Authority.—</heading><content>Section 319L(d)(2) (42 U.S.C. 247d–7e(d)(2)) is amended by striking “<quotedText>$415,000,000 for each of fiscal years 2014 through 2018</quotedText>” and inserting “<quotedText>$611,700,000 for each of fiscal years 2019 through 2023</quotedText>”.</content></subsection></section><section identifier="/tV/s505" id="HDC8ADA6672B44340AD814B489275674D" class="bill-dtd-OLC" pagenum="47"><num value="505">Sec. 505.</num><heading> Additional strategies for combating antibiotic resistance.</heading><subsection identifier="/tV/s505/a" id="H2A694D610E1D4007A297C929735FFB4D" class="bill-dtd-OLC" pagenum="47"><num value="a">(a)</num><heading> Advisory council.—</heading><content>The Secretary of Health and Human Services (referred to in this section as the “<quotedText>Secretary</quotedText>”) may continue the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, referred to in this section as the “<quotedText>Advisory Council</quotedText>”.</content></subsection><subsection identifier="/tV/s505/b" id="HCAF89AEBC61D42F7A57E1626E8AD48C6" class="bill-dtd-OLC" pagenum="47"><num value="b">(b)</num><heading> Duties.—</heading><chapeau>The Advisory Council shall advise and provide information and recommendations to the Secretary regarding programs and policies intended to reduce or combat antibiotic-resistant <?page 48?>bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. Such advice, information, and recommendations may be related to improving—</chapeau><paragraph identifier="/tV/s505/b/1" id="HCB30880720224524854B366B52BA4D83" class="bill-dtd-OLC" pagenum="48"><num value="1">(1)</num><content> the effectiveness of antibiotics;</content></paragraph><paragraph identifier="/tV/s505/b/2" id="H700E43CE7F834B0293F4DB9EC3A6CEE1" class="bill-dtd-OLC" pagenum="48"><num value="2">(2)</num><content> research and advanced research on, and the development of, improved and innovative methods for combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities;</content></paragraph><paragraph identifier="/tV/s505/b/3" id="HDAD0EB91F652486E9853EB16C4E21E44" class="bill-dtd-OLC" pagenum="48"><num value="3">(3)</num><content> surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics;</content></paragraph><paragraph identifier="/tV/s505/b/4" id="H509095EA6FA147CC8FC8CCCEB89954E8" class="bill-dtd-OLC" pagenum="48"><num value="4">(4)</num><content> education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals;</content></paragraph><paragraph identifier="/tV/s505/b/5" id="H0F9CDA6B3A31493ABB6E89D329286E0C" class="bill-dtd-OLC" pagenum="48"><num value="5">(5)</num><content> methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections, including stewardship programs; and</content></paragraph><paragraph identifier="/tV/s505/b/6" id="HFA50EC1579B141A5B416FE0354D5C5CE" class="bill-dtd-OLC" pagenum="48"><num value="6">(6)</num><content> coordination with respect to international efforts in order to inform and advance United States capabilities to combat antibiotic resistance.</content></paragraph></subsection><subsection identifier="/tV/s505/c" id="H2E5C03255E33446EBEE69D89F06073A7" class="bill-dtd-OLC" pagenum="48"><num value="c">(c)</num><heading> Meetings and coordination.—</heading><paragraph identifier="/tV/s505/c/1" id="HD91864DFFCA349BC8721237E4348DF19" class="bill-dtd-OLC" pagenum="48"><num value="1">(1)</num><heading> Meetings.—</heading><content>The Advisory Council shall meet not less than biannually and, to the extent practicable, in coordination with meetings of the Antimicrobial Resistance Task Force established in section 319E(a) of the Public Health Service Act.</content></paragraph><paragraph identifier="/tV/s505/c/2" id="H1034C592F8FA4FE186037EE9EC5B35A8" class="bill-dtd-OLC" pagenum="48"><num value="2">(2)</num><heading> Coordination.—</heading><content>The Advisory Council shall, to the greatest extent practicable, coordinate activities carried out by the Council with the Antimicrobial Resistance Task Force established under section 319E(a) of the Public Health Service Act (<ref href="/us/usc/42/247d-5">42 U.S.C. 247d–5(a)</ref>).</content></paragraph></subsection><subsection identifier="/tV/s505/d" id="H154CEBC1AEF0461F830E7965B2B9FB3D" class="bill-dtd-OLC" pagenum="48"><num value="d">(d)</num><heading> FACA.—</heading><content>The Federal Advisory Committee Act (5 U.S.C. App.) shall apply to the activities and duties of the Advisory Council.</content></subsection><subsection identifier="/tV/s505/e" id="H997747ADE2704866985725691E8BBA9E" class="bill-dtd-OLC" pagenum="48"><num value="e">(e)</num><heading> Extension of Advisory Council.—</heading><content>Not later than October 1, 2022, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a recommendation on whether the Advisory Council should be extended, and in addition, identify whether there are other committees, councils, or task forces that have overlapping or similar duties to that of the Advisory Council, and whether such committees, councils, or task forces should be combined, including with respect to section 319E(a) of the Public Health Service Act (<ref href="/us/usc/42/247d-5">42 U.S.C. 247d–5(a)</ref>).</content></subsection></section></title><title identifier="/tVI" id="H3FA03E64B7FC49EAB049D51B121149CA" class="bill-dtd-OLC" pagenum="48"><num value="VI">Title VI—</num><heading>Advancing Technologies for Medical Countermeasures</heading><section identifier="/tVI/s601" id="H89125FDF70034C7680F645CCBAB8BFCD" class="bill-dtd-OLC" pagenum="48"><num value="601">Sec. 601.</num><heading> Administration of countermeasures.</heading><content class="indent0">Section 319L(c)(4)(D)(iii) (42 U.S.C. 247d–7e(c)(4)(D)(iii)) is amended by striking “<quotedText>and platform technologies</quotedText>” and inserting “<quotedText>platform technologies, technologies to administer countermeasures, and technologies to improve storage and transportation of countermeasures</quotedText>”.</content></section><?page 49?><section identifier="/tVI/s602" id="H8A29E30E5CAB4EF58601641121F5DB5D" class="bill-dtd-OLC" pagenum="49"><num value="602">Sec. 602.</num><heading> Updating definitions of other transactions.</heading><chapeau class="block">Section 319L (<ref href="/us/usc/42/247d-7e">42 U.S.C. 247d–7e</ref>) is amended—</chapeau><paragraph identifier="/tVI/s602/1" id="H30787224D02C46EAB368784EC8744D3A" class="bill-dtd-OLC" pagenum="49"><num value="1">(1)</num><content> in subsection (a)(3), by striking “<quotedText>, such as</quotedText>” and all that follows through “<quotedText>Code</quotedText>”; and</content></paragraph><paragraph identifier="/tVI/s602/2" id="H1DBC9777CF1A49768E377AE9569FE0A7" class="bill-dtd-OLC" pagenum="49"><num value="2">(2)</num><chapeau> in subsection (c)(5)(A)—</chapeau><subparagraph identifier="/tVI/s602/2/A" id="HC3B3F703CFAC45F39251DFDD26A82B0F" class="bill-dtd-OLC" pagenum="49"><num value="A">(A)</num><content> in clause (i), by striking “<quotedText>under this subsection</quotedText>” and all that follows through “<quotedText>Code</quotedText>” and inserting “<quotedText>(as defined in subsection (a)(3)) under this subsection</quotedText>”; and</content></subparagraph><subparagraph identifier="/tVI/s602/2/B" id="HCB5BAA4CD92B4C1B98AF7A5D7BED3C0A" class="bill-dtd-OLC" pagenum="49"><num value="B">(B)</num><chapeau> in clause (ii)—</chapeau><clause identifier="/tVI/s602/2/B/i" id="H99C12C07C774464BAB4E5CDBC08EDB65" class="bill-dtd-OLC" pagenum="49"><num value="i">(i)</num><content> by amending subclause (I) to read as follows:<quotedContent id="HC997867FEA2643BCB89F84DEAE912B09"><subclause identifier="/tVI/s602/2/B/i/qB/I" id="HA6B4B768EA52432EAEFD966FCC715849" class="bill-dtd-OLC" pagenum="49"><num value="I">“(I)</num><heading> In general.—</heading><content>To the maximum extent practicable, competitive procedures shall be used when entering into transactions to carry out projects under this subsection.”</content></subclause></quotedContent>; and</content></clause><clause identifier="/tVI/s602/2/B/ii" id="H2B53754DF0B8439ABD0EAA3A8039E9C0" class="bill-dtd-OLC" pagenum="49"><num value="ii">(ii)</num><chapeau> in subclause (II)—</chapeau><subclause identifier="/tVI/s602/2/B/ii/I" id="H0ADF7BA9A51F4975B9152F231D08FF57" class="bill-dtd-OLC" pagenum="49"><num value="I">(I)</num><content> by striking “<quotedText>$20,000,000</quotedText>” and inserting “<quotedText>$100,000,000</quotedText>”;</content></subclause><subclause identifier="/tVI/s602/2/B/ii/II" id="H1DCF305373E44AE2911DFB4C786BFDFA" class="bill-dtd-OLC" pagenum="49"><num value="II">(II)</num><content> by striking “<quotedText>senior procurement executive for the Department (as designated for purpose of section 16(c) of the Office of Federal Procurement Policy Act (<ref href="/us/usc/41/414">41 U.S.C. 414(c)</ref>))</quotedText>” and inserting “<quotedText>Assistant Secretary for Financial Resources</quotedText>”; and</content></subclause><subclause identifier="/tVI/s602/2/B/ii/III" id="H5987B9D45F0647C295230673C6E1A081" class="bill-dtd-OLC" pagenum="49"><num value="III">(III)</num><content> by striking “<quotedText>senior procurement executive under</quotedText>” and inserting “<quotedText>Assistant Secretary for Financial Resources under</quotedText>”.</content></subclause></clause></subparagraph></paragraph></section><section identifier="/tVI/s603" id="H294417A5F9C44CC4ADA1232B8FF648C3" class="bill-dtd-OLC" pagenum="49"><num value="603">Sec. 603.</num><heading> Medical countermeasure master files.</heading><subsection identifier="/tVI/s603/a" id="H52E2C6613E804ED5950EED7B909AD962" class="bill-dtd-OLC" pagenum="49"><num value="a">(a)</num><heading> In general.—</heading><content>The purpose of this section (including section 565B of the Federal Food, Drug, and Cosmetic Act, as added by subsection (b)) is to support and advance the development or manufacture of security countermeasures, qualified countermeasures, and qualified pandemic or epidemic products by facilitating and encouraging submission of data and information to support the development of such products, and through clarifying the authority to cross-reference to data and information previously submitted to the Secretary of Health and Human Services (referred to in this section as the “<quotedText>Secretary</quotedText>”), including data and information submitted to medical countermeasure master files or other master files.</content></subsection><subsection identifier="/tVI/s603/b" id="HE466FBCCA2184597B4094439EF336EF0" class="bill-dtd-OLC" pagenum="49"><num value="b">(b)</num><heading> Medical countermeasure master files.—</heading><content>Chapter V of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/351">21 U.S.C. 351</ref> et seq.) is amended by inserting after section 565A the following:<quotedContent id="HD603BFC8DF0F41C1ABA421D67DE68C82"><section identifier="/tVI/s603/b/qB/s565B" id="H50534357BE054153B4912746F34F0D1A" class="bill-dtd-OLC" pagenum="49"><num value="565B">“Sec. 565B.</num><heading> Medical countermeasure master files.</heading><subsection identifier="/tVI/s603/b/qB/s565B/a" id="H73D34DC985F64684AD067C24E41AB4D3" class="bill-dtd-OLC" pagenum="49"><num value="a">“(a)</num><heading> Applicability of reference.—</heading><paragraph identifier="/tVI/s603/b/qB/s565B/a/1" id="H3138D1C11BF146BE83A91B8E301FDC15" class="bill-dtd-OLC" pagenum="49"><num value="1">“(1)</num><heading> In general.—</heading><content>A person may submit data and information in a master file to the Secretary with the intent to reference, or to authorize, in writing, another person to reference, such data or information to support a medical countermeasure submission (including a supplement or amendment to any such submission), without requiring the master file holder to disclose the data and information to any such persons authorized to reference the master file. Such data and information shall be available for reference by the master file holder or by a person authorized by the master file holder, in accordance with applicable privacy and confidentiality protocols and regulations.</content></paragraph><?page 50?><paragraph identifier="/tVI/s603/b/qB/s565B/a/2" id="H51F012B5401D43A4B055E8648FD12BED" class="bill-dtd-OLC" pagenum="50"><num value="2">“(2)</num><heading> Reference of certain master files.—</heading><content>In the case that data or information within a medical countermeasure master file is used only to support the conditional approval of an application filed under section 571, such master file may be relied upon to support the effectiveness of a product that is the subject of a subsequent medical countermeasure submission only if such application is supplemented by additional data or information to support review and approval in a manner consistent with the standards applicable to such review and approval for such countermeasure, qualified countermeasure, or qualified pandemic or epidemic product.</content></paragraph></subsection><subsection identifier="/tVI/s603/b/qB/s565B/b" id="HC19C176F519A4D0EAF7CFBB7798B3267" class="bill-dtd-OLC" pagenum="50"><num value="b">“(b)</num><heading> Medical countermeasure master file content.—</heading><paragraph identifier="/tVI/s603/b/qB/s565B/b/1" id="H3028085113A74D938BB169EF400365BB" class="bill-dtd-OLC" pagenum="50"><num value="1">“(1)</num><heading> In general.—</heading><chapeau>A master file under this section may include data or information to support—</chapeau><subparagraph identifier="/tVI/s603/b/qB/s565B/b/1/A" id="HB3BF83B4FCB5478D8567CB23EDE0B3B4" class="bill-dtd-OLC" pagenum="50"><num value="A">“(A)</num><content> the development of medical countermeasure submissions to support the approval, licensure, classification, clearance, conditional approval, or authorization of one or more security countermeasures, qualified countermeasures, or qualified pandemic or epidemic products; and</content></subparagraph><subparagraph identifier="/tVI/s603/b/qB/s565B/b/1/B" id="H077A260DA5894279904BD02D9B0A7ADB" class="bill-dtd-OLC" pagenum="50"><num value="B">“(B)</num><content> the manufacture of security countermeasures, qualified countermeasures, or qualified pandemic or epidemic products.</content></subparagraph></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/b/2" id="H1F22E84E6A1E49A59C4D6803200B52BE" class="bill-dtd-OLC" pagenum="50"><num value="2">“(2)</num><heading> Required updates.—</heading><content>The Secretary may require, as appropriate, that the master file holder ensure that the contents of such master file are updated during the time such master file is referenced for a medical countermeasure submission.</content></paragraph></subsection><subsection identifier="/tVI/s603/b/qB/s565B/c" id="HBC4BA7A156794F80A1F1E6A6DC3D22CA" class="bill-dtd-OLC" pagenum="50"><num value="c">“(c)</num><heading> Sponsor reference.—</heading><paragraph identifier="/tVI/s603/b/qB/s565B/c/1" id="H814DC3BBD38F4CFBB6CD91D7C96C75E9" class="bill-dtd-OLC" pagenum="50"><num value="1">“(1)</num><heading> In general.—</heading><content>Each incorporation of data or information within a medical countermeasure master file shall describe the incorporated material in a manner in which the Secretary determines appropriate and that permits the review of such information within such master file without necessitating resubmission of such data or information. Master files shall be submitted in an electronic format in accordance with sections 512(b)(4), 571(a)(4), and 745A, as applicable, and as specified in applicable guidance.</content></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/c/2" id="H0BA5337A5A214B678F9ACBE358E9EB6A" class="bill-dtd-OLC" pagenum="50"><num value="2">“(2)</num><heading> Reference by a master file holder.—</heading><content>A master file holder that is the sponsor of a medical countermeasure submission shall notify the Secretary in writing of the intent to reference the medical countermeasure master file as a part of the submission.</content></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/c/3" id="H9ADB8C3AA2BA49F98F65B86BA8CEAE75" class="bill-dtd-OLC" pagenum="50"><num value="3">“(3)</num><heading> Reference by an authorized person.—</heading><content>A person submitting an application for review may, where the Secretary determines appropriate, incorporate by reference all or part of the contents of a medical countermeasure master file, if the master file holder authorizes the incorporation in writing.</content></paragraph></subsection><subsection identifier="/tVI/s603/b/qB/s565B/d" id="HB5082B5DA92E4A10B7E370026819BFD2" class="bill-dtd-OLC" pagenum="50"><num value="d">“(d)</num><heading> Acknowledgment of and reliance upon a master file by the Secretary.—</heading><paragraph identifier="/tVI/s603/b/qB/s565B/d/1" id="H751B2607B0964A09AADD5BA784341863" class="bill-dtd-OLC" pagenum="50"><num value="1">“(1)</num><heading> In general.—</heading><content>The Secretary shall provide the master file holder with a written notification indicating that the Secretary has reviewed and relied upon specified data or information within a master file and the purposes for which such data or information was incorporated by reference if the Secretary has reviewed and relied upon such specified data or information to support the approval, classification, conditional approval, clearance, licensure, or authorization of a security <?page 51?>countermeasure, qualified countermeasure, or qualified pandemic or epidemic product. The Secretary may rely upon the data and information within the medical countermeasure master file for which such written notification was provided in additional applications, as applicable and appropriate and upon the request of the master file holder so notified in writing or by an authorized person of such holder.</content></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/d/2" id="H9E1D7455F26E4E63A742F3B036534D9C" class="bill-dtd-OLC" pagenum="51"><num value="2">“(2)</num><heading> Certain applications.—</heading><content>If the Secretary has reviewed and relied upon specified data or information within a medical countermeasure master file to support the conditional approval of an application under section 571 to subsequently support the approval, clearance, licensure, or authorization of a security countermeasure, qualified countermeasure, or qualified pandemic or epidemic product, the Secretary shall provide a brief written description to the master file holder regarding the elements of the application fulfilled by the data or information within the master file and how such data or information contained in such application meets the standards of evidence under subsection (c) or (d) of section 505, subsection (d) of section 512, or section 351 of the Public Health Service Act (as applicable), which shall not include any trade secret or confidential commercial information.</content></paragraph></subsection><subsection identifier="/tVI/s603/b/qB/s565B/e" id="H0671EBB168B141919E67082881EE3704" class="bill-dtd-OLC" pagenum="51"><num value="e">“(e)</num><heading> Rules of construction.—</heading><chapeau>Nothing in this section shall be construed to—</chapeau><paragraph identifier="/tVI/s603/b/qB/s565B/e/1" id="H3B6C41135FC04C9F9DC96836789E4681" class="bill-dtd-OLC" pagenum="51"><num value="1">“(1)</num><content> limit the authority of the Secretary to approve, license, clear, conditionally approve, or authorize drugs, biological products, or devices pursuant to, as applicable, this Act or section 351 of the Public Health Service Act (as such applicable Act is in effect on the day before the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>), including the standards of evidence, and applicable conditions, for approval under the applicable Act;</content></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/e/2" id="H886C3C38A548491BBA5B699A9F5AFD73" class="bill-dtd-OLC" pagenum="51"><num value="2">“(2)</num><content> alter the standards of evidence with respect to approval, licensure, or clearance, as applicable, of drugs, biological products, or devices under this Act or section 351 of the Public Health Service Act, including, as applicable, the substantial evidence standards under sections 505(d) and 512(d) or this Act and section 351(a) of the Public Health Service Act; or</content></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/e/3" id="HDBB22C5F63AE442794E86F1DF6A5E111" class="bill-dtd-OLC" pagenum="51"><num value="3">“(3)</num><content> alter the authority of the Secretary under this Act or the Public Health Service Act to determine the types of data or information previously submitted by a sponsor or any other person that may be incorporated by reference in an application, request, or notification for a drug, biological product, or device submitted under sections 505(i), 505(b), 505(j), 512(b)(1), 512(b)(2), 512(j), 564, 571, 520(g), 515(c), 513(f)(2), or 510(k) of this Act, or subsection (a) or (k) of section 351 of the Public Health Service Act, including a supplement or amendment to any such submission, and the requirements associated with such reference.</content></paragraph></subsection><subsection identifier="/tVI/s603/b/qB/s565B/f" id="H7AF65E347B2A42DE81203D3351FB0617" class="bill-dtd-OLC" pagenum="51"><num value="f">“(f)</num><heading> Definitions.—</heading><chapeau>In this section:</chapeau><paragraph identifier="/tVI/s603/b/qB/s565B/f/1" id="H180C042D01864CF6AC9331AADA4BF998" class="bill-dtd-OLC" pagenum="51"><num value="1">“(1)</num><content> The term ‘<term>master file holder</term>’ means a person who submits data and information to the Secretary with the intent to reference or authorize another person to reference such data or information to support a medical countermeasure submission, as described in subsection (a).</content></paragraph><?page 52?><paragraph identifier="/tVI/s603/b/qB/s565B/f/2" id="HFD4A5B8A54D0426386D63AE8BC0409E2" class="bill-dtd-OLC" pagenum="52"><num value="2">“(2)</num><chapeau> The term ‘<term>medical countermeasure submission</term>’ means an investigational new drug application under section 505(i), a new drug application under section 505(b), or an abbreviated new drug application under section 505(j) of this Act, a biological product license application under section 351(a) of the Public Health Service Act or a biosimilar biological product license application under section 351(k) of the Public Health Service Act, a new animal drug application under section 512(b)(1) or abbreviated new animal drug application under section 512(b)(2), an application for conditional approval of a new animal drug under section 571, an investigational device application under section 520(g), an application with respect to a device under section 515(c), a request for classification of a device under section 513(f)(2), a notification with respect to a device under section 510(k), or a request for an emergency use authorization under section 564 to support—</chapeau><subparagraph identifier="/tVI/s603/b/qB/s565B/f/2/A" id="HCE6C7B47B1F543BB87A94A4D26721292" class="bill-dtd-OLC" pagenum="52"><num value="A">“(A)</num><content> the approval, licensure, classification, clearance, conditional approval, or authorization of a security countermeasure, qualified countermeasure, or qualified pandemic or epidemic product; or</content></subparagraph><subparagraph identifier="/tVI/s603/b/qB/s565B/f/2/B" id="HBE1BB6BB3B7943B69094E763691F9264" class="bill-dtd-OLC" pagenum="52"><num value="B">“(B)</num><content> a new indication to an approved security countermeasure, qualified countermeasure, or qualified pandemic or epidemic product.</content></subparagraph></paragraph><paragraph identifier="/tVI/s603/b/qB/s565B/f/3" id="HD5CEBC43FF3C4C5893403A4C457EEBF2" class="bill-dtd-OLC" pagenum="52"><num value="3">“(3)</num><content> The terms ‘<term>qualified countermeasure</term>’, ‘<term>security countermeasure</term>’, and ‘<term>qualified pandemic or epidemic product</term>’ have the meanings given such terms in sections 319F–1, 319F–2, and 319F–3, respectively, of the Public Health Service Act.”</content></paragraph></subsection></section></quotedContent>. </content></subsection><subsection identifier="/tVI/s603/c" id="H023A53256B034D57A02946D2FCB539BB" class="bill-dtd-OLC" pagenum="52"><num value="c">(c)</num><heading> Stakeholder Input.—</heading><content>Not later than 18 months after the date of enactment of this Act, the Secretary, acting through the Commissioner of Food and Drugs and in consultation with the Assistant Secretary for Preparedness and Response, shall solicit input from stakeholders, including stakeholders developing security countermeasures, qualified countermeasures, or qualified pandemic or epidemic products, and stakeholders developing technologies to assist in the development of such countermeasures with respect to how the Food and Drug Administration can advance the use of tools and technologies to support and advance the development or manufacture of security countermeasures, qualified countermeasures, and qualified pandemic or epidemic products, including through reliance on cross-referenced data and information contained within master files and submissions previously submitted to the Secretary as set forth in section 565B of the Federal Food, Drug, and Cosmetic Act, as added by subsection (b).</content></subsection><subsection identifier="/tVI/s603/d" id="HD6698C060C47454C9AF567827F1882DD" class="bill-dtd-OLC" pagenum="52"><num value="d">(d)</num><heading> Guidance.—</heading><content>Not later than 2 years after the date of enactment of this Act, the Secretary, acting through the Commissioner of Food and Drugs, shall publish draft guidance about how reliance on cross-referenced data and information contained within master files under section 565B of the Federal Food, Drug, and Cosmetic Act, as added by subsection (b) or submissions otherwise submitted to the Secretary may be used for specific tools or technologies (including platform technologies) that have the potential to support and advance the development or manufacture of security countermeasures, qualified countermeasures, and qualified pandemic or epidemic products. The Secretary, acting through the Commissioner of Food and Drugs, shall publish the final guidance not later than 3 years after the enactment of this Act.</content></subsection></section><?page 53?><section identifier="/tVI/s604" id="H787617A9190C4E689E7BFF7AC4ACB0A2" class="bill-dtd-OLC" pagenum="53"><num value="604">Sec. 604.</num><heading> Animal rule report.</heading><subsection identifier="/tVI/s604/a" id="H1E0248D662B441F8BF3EE5DA519C619C" class="bill-dtd-OLC" pagenum="53"><num value="a">(a)</num><heading> Study.—</heading><chapeau>The Comptroller General of the United States shall conduct a study on the application of the requirements under subsections (c) and (d) of section 565 of the of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-4">21 U.S.C. 360bbb–4</ref>) (referred to in this section as the “<quotedText>animal rule</quotedText>”) as a component of medical countermeasure advanced development under the Biomedical Advanced Research and Development Authority and regulatory review by the Food and Drug Administration. In conducting such study, the Comptroller General shall examine the following:</chapeau><paragraph identifier="/tVI/s604/a/1" id="HEF3DE714C4E94E94B23DEB2C69122BD9" class="bill-dtd-OLC" pagenum="53"><num value="1">(1)</num><content> The extent to which advanced development and review of a medical countermeasure are coordinated between the Biomedical Advanced Research and Development Authority and the Food and Drug Administration, including activities that facilitate appropriate and efficient design of studies to support approval, licensure, and authorization under the animal rule, consistent with the recommendations in the animal rule guidance, issued pursuant to section 565(c) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-4">21 U.S.C. 360bbb–4(c)</ref>) and entitled “<quotedText>Product Development Under the Animal Rule: Guidance for Industry</quotedText>” (issued in October 2015), to resolve discrepancies in the design of adequate and well-controlled efficacy studies conducted in animal models related to the provision of substantial evidence of effectiveness for the product approved, licensed, or authorized under the animal rule.</content></paragraph><paragraph identifier="/tVI/s604/a/2" id="HE13E8C2E8B8148D3A1D31202FE3E44DA" class="bill-dtd-OLC" pagenum="53"><num value="2">(2)</num><content> The consistency of the application of the animal rule among and between review divisions within the Food and Drug Administration.</content></paragraph><paragraph identifier="/tVI/s604/a/3" id="H9E192456E288437EB50343C7038D2DAB" class="bill-dtd-OLC" pagenum="53"><num value="3">(3)</num><content> The flexibility pursuant to the animal rule to address variations in countermeasure development and review processes, including the extent to which qualified animal models are adopted and used within the Food and Drug Administration in regulatory decisionmaking with respect to medical countermeasures.</content></paragraph><paragraph identifier="/tVI/s604/a/4" id="H2B90579C74734A828D50D12638A65C04" class="bill-dtd-OLC" pagenum="53"><num value="4">(4)</num><content> The extent to which the guidance issued under section 565(c) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-4">21 U.S.C. 360bbb–4(c)</ref>), entitled, “<quotedText>Product Development Under the Animal Rule: Guidance for Industry</quotedText>” (issued in October 2015), has assisted in achieving the purposes described in paragraphs (1), (2), and (3).</content></paragraph></subsection><subsection identifier="/tVI/s604/b" id="HD4A551BDEAE7462EA9C23B6437484A50" class="bill-dtd-OLC" pagenum="53"><num value="b">(b)</num><heading> Consultations.—</heading><chapeau>In conducting the study under subsection (a), the Comptroller General of the United States shall consult with—</chapeau><paragraph identifier="/tVI/s604/b/1" id="HF77C32AE58324E1A94FF68A02BE5B082" class="bill-dtd-OLC" pagenum="53"><num value="1">(1)</num><content> the Federal agencies responsible for advancing, reviewing, and procuring medical countermeasures, including the Office of the Assistant Secretary for Preparedness and Response, the Biomedical Advanced Research and Development Authority, the Food and Drug Administration, and the Department of Defense;</content></paragraph><paragraph identifier="/tVI/s604/b/2" id="H0A295EECE8DE489B937ECFF29C6D4525" class="bill-dtd-OLC" pagenum="53"><num value="2">(2)</num><content> manufacturers involved in the research and development of medical countermeasures to address biological, chemical, radiological, or nuclear threats; and</content></paragraph><paragraph identifier="/tVI/s604/b/3" id="H322F39E84E444ADDBD499922A18EA660" class="bill-dtd-OLC" pagenum="53"><num value="3">(3)</num><content> other biodefense stakeholders, as applicable.</content></paragraph></subsection><subsection identifier="/tVI/s604/c" id="HB51EF43185514C079C80010AEC2528DA" class="bill-dtd-OLC" pagenum="53"><num value="c">(c)</num><heading> Report.—</heading><content>Not later than 3 years after the date of enactment of this Act, the Comptroller General of the United States shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of <?page 54?>the House of Representatives a report containing the results of the study conducted under subsection (a) and recommendations to improve the application and consistency of the requirements under subsections (c) and (d) of section 565 of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-4">21 U.S.C. 360bbb–4</ref>) to support and expedite the research and development of medical countermeasures, as applicable.</content></subsection><subsection identifier="/tVI/s604/d" id="H493106318FB64C738CFBDF1F01FA634B" class="bill-dtd-OLC" pagenum="54"><num value="d">(d)</num><heading> Protection of national security.—</heading><content>The Comptroller General of the United States shall conduct the study and issue the assessment and report under this section in a manner that does not compromise national security.</content></subsection></section><section identifier="/tVI/s605" id="H92B6EA998E544D9AB2CF02E60F06E87F" class="bill-dtd-OLC" pagenum="54"><num value="605">Sec. 605.</num><heading> Review of the benefits of genomic engineering technologies and their potential role in national security.</heading><subsection identifier="/tVI/s605/a" id="HB1639BBD6D5349FFAE91E9C8DD2AA7F3" class="bill-dtd-OLC" pagenum="54"><num value="a">(a)</num><heading> Meeting.—</heading><paragraph identifier="/tVI/s605/a/1" id="H2EFBBEFCFDE14D3981110E27B841E3F1" class="bill-dtd-OLC" pagenum="54"><num value="1">(1)</num><heading> In general.—</heading><content>Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “<quotedText>Secretary</quotedText>”) shall convene a meeting to discuss the potential role advancements in genomic engineering technologies (including genome editing technologies) may have in advancing national health security. Such meeting shall be held in a manner that does not compromise national security.</content></paragraph><paragraph identifier="/tVI/s605/a/2" id="H2678F134E7A84680A4E4787FD5D8A4CF" class="bill-dtd-OLC" pagenum="54"><num value="2">(2)</num><heading> Attendees.—</heading><chapeau>The attendees of the meeting under paragraph (1)—</chapeau><subparagraph identifier="/tVI/s605/a/2/A" id="HEB01A007AC62445FB0A939593782D9B1" class="bill-dtd-OLC" pagenum="54"><num value="A">(A)</num><chapeau> shall include—</chapeau><clause identifier="/tVI/s605/a/2/A/i" id="H014567EC19FA4668862A01ADC4F568C4" class="bill-dtd-OLC" pagenum="54"><num value="i">(i)</num><content> representatives from the Office of the Assistant Secretary for Preparedness and Response, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration; and</content></clause><clause identifier="/tVI/s605/a/2/A/ii" id="H6C694418872B428194D74BAD835A5129" class="bill-dtd-OLC" pagenum="54"><num value="ii">(ii)</num><content> representatives from academic, private, and nonprofit entities with expertise in genome engineering technologies, biopharmaceuticals, medicine, or biodefense, and other relevant stakeholders; and</content></clause></subparagraph><subparagraph identifier="/tVI/s605/a/2/B" id="H12D8A963F0C14A87AE0C7575D7B5996B" class="bill-dtd-OLC" pagenum="54"><num value="B">(B)</num><chapeau> may include—</chapeau><clause identifier="/tVI/s605/a/2/B/i" id="H7A901A1B890E41D097F4F0EE95852E5B" class="bill-dtd-OLC" pagenum="54"><num value="i">(i)</num><content> other representatives from the Department of Health and Human Services, as the Secretary determines appropriate; and</content></clause><clause identifier="/tVI/s605/a/2/B/ii" id="H02E55D59A0BA4B6FBE3FE636D760FE7A" class="bill-dtd-OLC" pagenum="54"><num value="ii">(ii)</num><content> representatives from the Department of Homeland Security, the Department of Defense, the Department of Agriculture, and other departments, as the Secretary may request for the meeting.</content></clause></subparagraph></paragraph><paragraph identifier="/tVI/s605/a/3" id="H4D889C853BB34D03A150E5564F89438C" class="bill-dtd-OLC" pagenum="54"><num value="3">(3)</num><heading> Topics.—</heading><chapeau>The meeting under paragraph (1) shall include a discussion of—</chapeau><subparagraph identifier="/tVI/s605/a/3/A" id="H5352AE00B9024C6BA1971D9A04877A45" class="bill-dtd-OLC" pagenum="54"><num value="A">(A)</num><chapeau> the current state of the science of genomic engineering technologies related to national health security, including—</chapeau><clause identifier="/tVI/s605/a/3/A/i" id="H0FCE608A2DAD463CAC24BC28A074428F" class="bill-dtd-OLC" pagenum="54"><num value="i">(i)</num><content> medical countermeasure development, including potential efficiencies in the development pathway and detection technologies; and</content></clause><clause identifier="/tVI/s605/a/3/A/ii" id="H2E70B53B9796471E82DDD9A8EFC1B827" class="bill-dtd-OLC" pagenum="54"><num value="ii">(ii)</num><content> the international and domestic regulation of products utilizing genome editing technologies; and</content></clause></subparagraph><subparagraph identifier="/tVI/s605/a/3/B" id="HB242FF2180154CA5A585477C3944E65E" class="bill-dtd-OLC" pagenum="54"><num value="B">(B)</num><chapeau> national security implications, including—</chapeau><?page 55?><clause identifier="/tVI/s605/a/3/B/i" id="H41B1BFEC76C8457F82715860F265DBF0" class="bill-dtd-OLC" pagenum="55"><num value="i">(i)</num><content> capabilities of the United States to leverage genomic engineering technologies as a part of the medical countermeasure enterprise, including current applicable research, development, and application efforts underway within the Department of Defense;</content></clause><clause identifier="/tVI/s605/a/3/B/ii" id="HA8F5CBD696B74E9EAA0CE5968A93192B" class="bill-dtd-OLC" pagenum="55"><num value="ii">(ii)</num><content> the potential for state and non-state actors to utilize genomic engineering technologies as a national health security threat; and</content></clause><clause identifier="/tVI/s605/a/3/B/iii" id="H1FFD7C7EAF394FE9B09145E76C7A16C5" class="bill-dtd-OLC" pagenum="55"><num value="iii">(iii)</num><content> security measures to monitor and assess the potential threat that may result from utilization of genomic engineering technologies and related technologies for the purpose of compromising national health security.</content></clause></subparagraph></paragraph></subsection><subsection identifier="/tVI/s605/b" id="H625F146900C2449FAF84F3152F8E3667" class="bill-dtd-OLC" pagenum="55"><num value="b">(b)</num><heading> Report.—</heading><content>Not later than 270 days after the meeting described in subsection (a) is held, the Assistant Secretary for Preparedness and Response shall issue a report to the congressional committees of jurisdiction on the topics discussed at such meeting, and provide recommendations, as applicable, to utilize innovations in genomic engineering (including genome editing) and related technologies as a part of preparedness and response activities to advance national health security. Such report shall be issued in a manner that does not compromise national security.</content></subsection></section><section identifier="/tVI/s606" id="H4A34E42718264615AF1AB211A52AEAFB" class="bill-dtd-OLC" pagenum="55"><num value="606">Sec. 606.</num><heading> Report on vaccines development.</heading><content class="indent0">Not later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report describing efforts and activities to coordinate with other countries and international partners during recent public health emergencies with respect to the research and advanced research on, and development of, qualified pandemic or epidemic products (as defined in section 319F–3 of the Public Health Service Act (<ref href="/us/usc/42/247d-6d">42 U.S.C. 247d–6d</ref>)). Such report may include information regarding relevant work carried out under section 319L(c)(5)(E) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(5)(E)), through public-private partnerships, and through collaborations with other countries to assist with or expedite the research and development of qualified pandemic or epidemic products. Such report shall not include information that may compromise national security.</content></section><section identifier="/tVI/s607" id="H6399FC744B6640D58EA7D07FB20D471D" class="bill-dtd-OLC" pagenum="55"><num value="607">Sec. 607.</num><heading> Strengthening mosquito abatement for safety and health.</heading><subsection identifier="/tVI/s607/a" id="H1C5190ACBA794383BDD36C6373FD801B" class="bill-dtd-OLC" pagenum="55"><num value="a">(a)</num><heading> Reauthorization of mosquito abatement for safety and health program.—</heading><chapeau>Section 317S (<ref href="/us/usc/42/247b-21">42 U.S.C. 247b–21</ref>) is amended—</chapeau><paragraph identifier="/tVI/s607/a/1" id="HEBF73F841F1D45FFA7FEF45E9928EDD3" class="bill-dtd-OLC" pagenum="55"><num value="1">(1)</num><chapeau> in subsection (a)(1)(B)—</chapeau><subparagraph identifier="/tVI/s607/a/1/A" id="HD9A759A925AA4A929CCC784BBECBFC7B" class="bill-dtd-OLC" pagenum="55"><num value="A">(A)</num><content> by inserting “<quotedText>including programs to address emerging infectious mosquito-borne diseases,</quotedText>” after “<quotedText>subdivisions for control programs,</quotedText>”; and</content></subparagraph><subparagraph identifier="/tVI/s607/a/1/B" id="H1831DDD6A0AE4D8681D66EFF828EAF4D" class="bill-dtd-OLC" pagenum="55"><num value="B">(B)</num><content> by inserting “<quotedText>or improving existing control programs</quotedText>” before the period at the end;</content></subparagraph></paragraph><paragraph identifier="/tVI/s607/a/2" id="H8C824C5B0E534005B54D5A8C53382899" class="bill-dtd-OLC" pagenum="55"><num value="2">(2)</num><chapeau> in subsection (b)—</chapeau><subparagraph identifier="/tVI/s607/a/2/A" id="H380FEB06282E4CDF967A74259CC965F3" class="bill-dtd-OLC" pagenum="55"><num value="A">(A)</num><content> in paragraph (1), by inserting “<quotedText>, including improvement,</quotedText>” after “<quotedText>operation</quotedText>”;</content></subparagraph><subparagraph identifier="/tVI/s607/a/2/B" id="HD20D15D1F2EE4CAD8D6F8B6748E1EEE3" class="bill-dtd-OLC" pagenum="55"><num value="B">(B)</num><chapeau> in paragraph (2)—</chapeau><clause identifier="/tVI/s607/a/2/B/i" id="H25192F947A36493E8484E4AD7DCBC37D" class="bill-dtd-OLC" pagenum="55"><num value="i">(i)</num><chapeau> in subparagraph (A)—</chapeau><?page 56?><subclause identifier="/tVI/s607/a/2/B/i/I" id="H30777E91B27341BDBFA8EDEF24B4D089" class="bill-dtd-OLC" pagenum="56"><num value="I">(I)</num><content> in clause (ii), by striking “<quotedText>or</quotedText>” at the end;</content></subclause><subclause identifier="/tVI/s607/a/2/B/i/II" id="H48804C6E499B46E38F770154474047F4" class="bill-dtd-OLC" pagenum="56"><num value="II">(II)</num><content> in clause (iii), by striking the semicolon at the end and inserting “<quotedText>, including an emerging infectious mosquito-borne disease that presents a serious public health threat; or</quotedText>”; and</content></subclause><subclause identifier="/tVI/s607/a/2/B/i/III" id="H94BA9BF4D5CF4270919348405242DCC4" class="bill-dtd-OLC" pagenum="56"><num value="III">(III)</num><content> by adding at the end the following:<quotedContent id="HF0E8732B4F794B55A51D200283D21031"><clause identifier="/tVI/s607/a/2/B/i/III/qB/iv" id="H20C801B248AA4DF98DC13B46182F23D2" class="bill-dtd-OLC" pagenum="56"><num value="iv">“(iv)</num><content> a public health emergency due to the incidence or prevalence of a mosquito-borne disease that presents a serious public health threat;”</content></clause></quotedContent>; and</content></subclause></clause><clause identifier="/tVI/s607/a/2/B/ii" id="H1484C4F3BE7145EFA53AB2868D7DB034" class="bill-dtd-OLC" pagenum="56"><num value="ii">(ii)</num><content> by amending subparagraph (D) to read as follows:<quotedContent id="HF92C0B986E514830A3789F2558920ACA"><subparagraph identifier="/tVI/s607/a/2/B/ii/qB/D" id="HEAC8906287894308AB36CB3EEE2B03A0" class="bill-dtd-OLC" pagenum="56"><num value="D">“(D)</num><clause identifier="/tVI/s607/a/2/B/ii/qB/D/i" id="H71EE3F39BC39452BB51199425961AEFC" class="bill-dtd-OLC" pagenum="56"><num value="i">(i)</num><content> is located in a State that has received a grant under subsection (a); or</content></clause><clause identifier="/tVI/s607/a/2/B/ii/qB/D/ii" id="H1A66DBD3F1A74025BD3FA114C6547C89" class="bill-dtd-OLC" pagenum="56"><num value="ii">“(ii)</num><content> that demonstrates to the Secretary that the control program is consistent with existing State mosquito control plans or policies, or other applicable State preparedness plans.”</content></clause></subparagraph></quotedContent>;</content></clause></subparagraph><subparagraph identifier="/tVI/s607/a/2/C" id="H06B815789B1F41698330B68C0C342785" class="bill-dtd-OLC" pagenum="56"><num value="C">(C)</num><content> in paragraph (4)(C), by striking “<quotedText>that extraordinary</quotedText>” and all that follows through the period at the end and inserting the following: “that—<quotedContent id="HBEF3A504B0D24FD6B561863FC53724F5"><clause identifier="/tVI/s607/a/2/C/qB/i" id="H8AFD10DCE9844AB2A6A255538C74CADC" class="bill-dtd-OLC" pagenum="56"><num value="i">“(i)</num><content> extraordinary economic conditions in the political subdivision or consortium of political subdivisions involved justify the waiver; or</content></clause><clause identifier="/tVI/s607/a/2/C/qB/ii" id="H3161EAB20DCC461DB246212395F81B31" class="bill-dtd-OLC" pagenum="56"><num value="ii">“(ii)</num><chapeau> the geographical area covered by a political subdivision or consortium for a grant under paragraph (1) has an extreme mosquito control need due to—</chapeau><subclause identifier="/tVI/s607/a/2/C/qB/ii/I" id="H96A35B2B154244A3AA619FE477229B5E" class="bill-dtd-OLC" pagenum="56"><num value="I">“(I)</num><content> the size or density of the potentially impacted human population;</content></subclause><subclause identifier="/tVI/s607/a/2/C/qB/ii/II" id="H86C70AF0FD5941CB896CD0EE2D2AB163" class="bill-dtd-OLC" pagenum="56"><num value="II">“(II)</num><content> the size or density of a mosquito population that requires heightened control; or</content></subclause><subclause identifier="/tVI/s607/a/2/C/qB/ii/III" id="H6FF80CA2FB234F8B9EE251A0441A95E0" class="bill-dtd-OLC" pagenum="56"><num value="III">“(III)</num><content> the severity of the mosquito-borne disease, such that expected serious adverse health outcomes for the human population justify the waiver.”</content></subclause></clause></quotedContent>; and</content></subparagraph><subparagraph identifier="/tVI/s607/a/2/D" id="H2008219669604707AB1BACDC55F39FA7" class="bill-dtd-OLC" pagenum="56"><num value="D">(D)</num><content> by amending paragraph (6) to read as follows:<quotedContent id="HA860C965578242BEA5335E23A9A88FE2"><paragraph identifier="/tVI/s607/a/2/D/qB/6" id="H86535619555A48B9BB6D6A0CF1B234F3" class="bill-dtd-OLC" pagenum="56"><num value="6">“(6)</num><heading> Number of grants.—</heading><content>A political subdivision or a consortium of political subdivisions may not receive more than one grant under paragraph (1).”</content></paragraph></quotedContent>; and</content></subparagraph></paragraph><paragraph identifier="/tVI/s607/a/3" id="H6829ED6523F741B8A6B5E63D10EF22AE" class="bill-dtd-OLC" pagenum="56"><num value="3">(3)</num><chapeau> in subsection (f)—</chapeau><subparagraph identifier="/tVI/s607/a/3/A" id="HF37052D9B79D48C2852D327AFA14E178" class="bill-dtd-OLC" pagenum="56"><num value="A">(A)</num><content> in paragraph (1) by striking “<quotedText>for fiscal year 2003, and such sums as may be necessary for each of fiscal years 2004 through 2007</quotedText>” and inserting “<quotedText>for each of fiscal years 2019 through 2023</quotedText>”;</content></subparagraph><subparagraph identifier="/tVI/s607/a/3/B" id="HA37FC9D6E6224474AC399E1D7C46310A" class="bill-dtd-OLC" pagenum="56"><num value="B">(B)</num><content> in paragraph (2), by striking “<quotedText>the Public Health Security and Bioterrorism Preparedness and Response Act of 2002</quotedText>” and inserting “<quotedText>this Act and other medical and public health preparedness and response laws</quotedText>”; and</content></subparagraph><subparagraph identifier="/tVI/s607/a/3/C" id="H6EEC93262B2D46D7A74310FD616A4669" class="bill-dtd-OLC" pagenum="56"><num value="C">(C)</num><chapeau> in paragraph (3)—</chapeau><clause identifier="/tVI/s607/a/3/C/i" id="H8523B096402B45F98876C8EE379BCFC2" class="bill-dtd-OLC" pagenum="56"><num value="i">(i)</num><content> in the paragraph heading, by striking “<quotedText><inline class="allCaps"><inline class="noSmallCaps noTextTransform">2004</inline></inline></quotedText>” and inserting “<quotedText><inline class="allCaps"><inline class="noSmallCaps noTextTransform">2019</inline></inline></quotedText>”; and</content></clause><clause identifier="/tVI/s607/a/3/C/ii" id="H3326A1D5A9554D6A8C439D4F7C88DACA" class="bill-dtd-OLC" pagenum="56"><num value="ii">(ii)</num><content> by striking “<quotedText>2004,</quotedText>” and inserting “<quotedText>2019,</quotedText>”.</content></clause></subparagraph></paragraph></subsection><subsection identifier="/tVI/s607/b" id="HA2DD2CFFAD1B408D8ED4DE8F8A130259" class="bill-dtd-OLC" pagenum="56"><num value="b">(b)</num><heading> Epidemiology-Laboratory capacity grants.—</heading><chapeau>Section 2821 (<ref href="/us/usc/42/300hh-31">42 U.S.C. 300hh–31</ref>) is amended—</chapeau><paragraph identifier="/tVI/s607/b/1" id="HF502F636532F4E7BBC6919DD5FBC60A2" class="bill-dtd-OLC" pagenum="56"><num value="1">(1)</num><content> in subsection (a)(1), by inserting “<quotedText>, including mosquito and other vector-borne diseases,</quotedText>” after “<quotedText>infectious diseases</quotedText>”; and</content></paragraph><?page 57?><paragraph identifier="/tVI/s607/b/2" id="H8442F5B1B0F24A4A860FEE9ECDC062DE" class="bill-dtd-OLC" pagenum="57"><num value="2">(2)</num><content> in subsection (b), by striking “<quotedText>2010 through 2013</quotedText>” and inserting “<quotedText>2019 through 2023</quotedText>”.</content></paragraph></subsection></section></title><title identifier="/tVII" id="H46A151F46D61417390689F0327B3380A" class="bill-dtd-OLC" pagenum="57"><num value="VII">Title VII—</num><heading>Miscellaneous Provisions</heading><section identifier="/tVII/s701" id="H2E8A0472175A46288CFBA5B941F9127D" class="bill-dtd-OLC" pagenum="57"><num value="701">Sec. 701.</num><heading> Reauthorizations and extensions.</heading><subsection identifier="/tVII/s701/a" id="H273FD6DD8E2743998C33D68C28726833" class="bill-dtd-OLC" pagenum="57"><num value="a">(a)</num><heading> Veterans Affairs.—</heading><content>Section 8117(g) of title 38, United States Code, is amended by striking “<quotedText>2014 through 2018</quotedText>” and inserting “<quotedText>2019 through 2023</quotedText>”.</content></subsection><subsection identifier="/tVII/s701/b" id="HC218232965164728B5E879491C5E00FB" class="bill-dtd-OLC" pagenum="57"><num value="b">(b)</num><heading> Vaccine tracking and distribution.—</heading><content>Section 319A(e) (<ref href="/us/usc/42/247d-1">42 U.S.C. 247d–1(e)</ref>) is amended by striking “<quotedText>2014 through 2018</quotedText>” and inserting “<quotedText>2019 through 2023</quotedText>”.</content></subsection><subsection identifier="/tVII/s701/c" id="H5C69551622A54B30A4E914B057219B0A" class="bill-dtd-OLC" pagenum="57"><num value="c">(c)</num><heading> Temporary reassignment.—</heading><content>Section 319(e)(8) (<ref href="/us/usc/42/247d">42 U.S.C. 247d(e)(8)</ref>) is amended by striking “<quotedText>2018</quotedText>” and inserting “<quotedText>2023</quotedText>”.</content></subsection><subsection identifier="/tVII/s701/d" id="H3B2B2357AC244A3E911FBDB4220CC88E" class="bill-dtd-OLC" pagenum="57"><num value="d">(d)</num><heading> Strategic Innovation Partner.—</heading><content>Section 319L(c)(4)(E)(ix) (42 U.S.C. 247d–7e(c)(4)(E)(ix)) is amended by striking “<quotedText>2022</quotedText>” and inserting “<quotedText>2023</quotedText>”.</content></subsection><subsection identifier="/tVII/s701/e" id="HDFCE3A41A2B649F88926D2A7766D5189" class="bill-dtd-OLC" pagenum="57"><num value="e">(e)</num><heading> Limited antitrust exemption.—</heading><paragraph identifier="/tVII/s701/e/1" id="H63B0304573EC4ADFB2010C0C0ABB0442" class="bill-dtd-OLC" pagenum="57"><num value="1">(1)</num><heading> In general.—</heading><chapeau>Section 405 of the Pandemic and All-Hazards Preparedness Act (<ref href="/us/pl/109/417">Public Law 109–417</ref>; 42 U.S.C. 247d–6a note) is amended—</chapeau><subparagraph identifier="/tVII/s701/e/1/A" id="H3581F70F8AD94D149C49775D8F1C70FD" class="bill-dtd-OLC" pagenum="57"><num value="A">(A)</num><chapeau> in subsection (a)(1)(A)—</chapeau><clause identifier="/tVII/s701/e/1/A/i" id="H4ACAA76FBC344498B71273BE38C35BB5" class="bill-dtd-OLC" pagenum="57"><num value="i">(i)</num><content> by striking “<quotedText>Secretary of Health and Human Services (referred to in this subsection as the ‘<quotedText>Secretary</quotedText>’)</quotedText>” and inserting “<quotedText>Secretary</quotedText>”;</content></clause><clause identifier="/tVII/s701/e/1/A/ii" id="H0A687717D5A8454CA7926D672CB4B45B" class="bill-dtd-OLC" pagenum="57"><num value="ii">(ii)</num><content> by striking “<quotedText>of the Public Health Service Act (<ref href="/us/usc/42/247d-6b">42 U.S.C. 247d–6b</ref>)) (as amended by this Act</quotedText>”;</content></clause><clause identifier="/tVII/s701/e/1/A/iii" id="H80B34C91CD66411285AE99B01E9A5827" class="bill-dtd-OLC" pagenum="57"><num value="iii">(iii)</num><content> by striking “<quotedText>of the Public Health Service Act (<ref href="/us/usc/42/247d-6a">42 U.S.C. 247d–6a</ref>)) (as amended by this Act</quotedText>”; and</content></clause><clause identifier="/tVII/s701/e/1/A/iv" id="HBD8CB60CA9304CBC830A3E8C52EF10E0" class="bill-dtd-OLC" pagenum="57"><num value="iv">(iv)</num><content> by striking “<quotedText>of the Public Health Service Act (<ref href="/us/usc/42/247d-6d">42 U.S.C. 247d–6d</ref>)</quotedText>”;</content></clause></subparagraph><subparagraph identifier="/tVII/s701/e/1/B" id="HA6EE13BC34CB4B34B972FAFC4FC83547" class="bill-dtd-OLC" pagenum="57"><num value="B">(B)</num><content> in subsection (b), by striking “<quotedText>12-year</quotedText>” and inserting “<quotedText>17-year</quotedText>”;</content></subparagraph><subparagraph identifier="/tVII/s701/e/1/C" id="HDF388919236B480B97BAE293E31E1A7F" class="bill-dtd-OLC" pagenum="57"><num value="C">(C)</num><content> by redesignating such section 405 as section 319L–1; and</content></subparagraph><subparagraph identifier="/tVII/s701/e/1/D" id="H3A71E2DA94E44CD8957C49D494026EBD" class="bill-dtd-OLC" pagenum="57"><num value="D">(D)</num><content> by transferring such section 319L–1, as redesignated, to the Public Health Service Act (<ref href="/us/usc/42/201">42 U.S.C. 201</ref> et seq.), to appear after section 319L of such Act (<ref href="/us/usc/42/247d-7e">42 U.S.C. 247d–7e</ref>).</content></subparagraph></paragraph><paragraph identifier="/tVII/s701/e/2" id="H9D2945052A704E1A8286959E3A616C49" class="bill-dtd-OLC" pagenum="57"><num value="2">(2)</num><heading> Conforming amendments.—</heading><subparagraph identifier="/tVII/s701/e/2/A" id="idAF8D21089A3E4DC5B355855EBA4A12B0" class="bill-dtd-OLC" pagenum="57"><num value="A">(A)</num><heading> Table of contents.—</heading><content>The table of contents in section 1(b) of the Pandemic and All-Hazards Preparedness Act (<ref href="/us/pl/109/417">Public Law 109–417</ref>) is amended by striking the item related to section 405.</content></subparagraph><subparagraph identifier="/tVII/s701/e/2/B" id="id6AC9D564DEEE4608912A5BE42139A36B" class="bill-dtd-OLC" pagenum="57"><num value="B">(B)</num><heading> Reference.—</heading><content>Section 319L(c)(4)(A)(iii) (<ref href="/us/usc/42/247d-7e">42 U.S.C. 247d–7e</ref>) is amended by striking “<quotedText>section 405 of the Pandemic and All-Hazards Preparedness Act</quotedText>” and inserting “<quotedText>section 319L–1</quotedText>”.</content></subparagraph></paragraph></subsection><subsection identifier="/tVII/s701/f" id="H4279BA1669FD434FB601842071B9508C" class="bill-dtd-OLC" pagenum="57"><num value="f">(f)</num><heading> Inapplicability of certain provisions.—</heading><chapeau>Subsection (e)(1) of section 319L (42 U.S.C. 247d–7e(e)(1)) is amended—</chapeau><paragraph identifier="/tVII/s701/f/1" id="HF2A24EC10A8545DAA77B4647E399ADFE" class="bill-dtd-OLC" pagenum="57"><num value="1">(1)</num><content> by amending subparagraph (A) to read as follows:<quotedContent id="H1B87973DA347469BA9C0AC3D0777AEFD"><subparagraph identifier="/tVII/s701/f/1/qB/A" id="HD774B790D16044088BCF2F690DE91F24" class="bill-dtd-OLC" pagenum="57"><num value="A">“(A)</num><heading> Nondisclosure of information.—</heading><clause identifier="/tVII/s701/f/1/qB/A/i" id="HFFC99511DBBD4E54B685B425ECFD9F90" class="bill-dtd-OLC" pagenum="57"><num value="i">“(i)</num><heading> In general.—</heading><content>Information described in clause (ii) shall be deemed to be information described in section 552(b)(3) of title 5, United States Code.</content></clause><?page 58?><clause identifier="/tVII/s701/f/1/qB/A/ii" id="HAE0ACAAECF184940841F2CA14B97D3B3" class="bill-dtd-OLC" pagenum="58"><num value="ii">“(ii)</num><heading> Information described.—</heading><chapeau>The information described in this clause is information relevant to programs of the Department of Health and Human Services that could compromise national security and reveal significant and not otherwise publicly known vulnerabilities of existing medical or public health defenses against chemical, biological, radiological, or nuclear threats, and is comprised of—</chapeau><subclause identifier="/tVII/s701/f/1/qB/A/ii/I" id="H0E633DA16EFC42A39CBE31300215FA48" class="bill-dtd-OLC" pagenum="58"><num value="I">“(I)</num><content> specific technical data or scientific information that is created or obtained during the countermeasure and product advanced research and development carried out under subsection (c);</content></subclause><subclause identifier="/tVII/s701/f/1/qB/A/ii/II" id="H50332B42DB1944D99878FEBC257D47EE" class="bill-dtd-OLC" pagenum="58"><num value="II">“(II)</num><content> information pertaining to the location security, personnel, and research materials and methods of high-containment laboratories conducting research with select agents, toxins, or other agents with a material threat determination under section 319F–2(c)(2); or</content></subclause><subclause identifier="/tVII/s701/f/1/qB/A/ii/III" id="HC981C632CF7A43E2AB2C8819293939D2" class="bill-dtd-OLC" pagenum="58"><num value="III">“(III)</num><content> security and vulnerability assessments.”</content></subclause></clause></subparagraph></quotedContent>;</content></paragraph><paragraph identifier="/tVII/s701/f/2" id="H1E54DB16801B470184A27CC8684BA695" class="bill-dtd-OLC" pagenum="58"><num value="2">(2)</num><content> by redesignating subparagraph (C) as subparagraph (D);</content></paragraph><paragraph identifier="/tVII/s701/f/3" id="HD22C4C6EE08B4648B01F8AEC53CEEE65" class="bill-dtd-OLC" pagenum="58"><num value="3">(3)</num><content> by inserting after subparagraph (B) the following:<quotedContent id="HD68A740FE1EF4ACBB66920428F9AAEBA"><subparagraph identifier="/tVII/s701/f/3/qB/C" id="H5EB7748B36C341FBBC40C0EAD3821818" class="bill-dtd-OLC" pagenum="58"><num value="C">“(C)</num><heading> Reporting.—</heading><content>One year after the date of enactment of the <shortTitle>Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019</shortTitle>, and annually thereafter, the Secretary shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the number of instances in which the Secretary has used the authority under this subsection to withhold information from disclosure, as well as the nature of any request under section 552 of title 5, United States Code that was denied using such authority.”</content></subparagraph></quotedContent>; and</content></paragraph><paragraph identifier="/tVII/s701/f/4" id="H0F0329E0B15D4E0C86147E08542F91DA" class="bill-dtd-OLC" pagenum="58"><num value="4">(4)</num><content> in subparagraph (D), as so redesignated, by striking “<quotedText>12</quotedText>” and inserting “<quotedText>17</quotedText>”.</content></paragraph></subsection></section><section identifier="/tVII/s702" id="H3047AC7DC2E944C3B4FDC8864D11F427" class="bill-dtd-OLC" pagenum="58"><num value="702">Sec. 702.</num><heading> Location of materials in the stockpile.</heading><content><p class="indent0">Subsection (d) of section 319F–2 (<ref href="/us/usc/42/247d-6b">42 U.S.C. 247d–6b</ref>) is amended to read as follows:</p><quotedContent id="H52D73D02B4B249B6A2B499078C3B538E"><subsection identifier="/tVII/s702/qB/d" id="H05A89E230025450C8BA400BC6E75D314" class="bill-dtd-OLC" pagenum="58"><num value="d">“(d)</num><heading> Disclosures.—</heading><content>No Federal agency may disclose under section 552 of title 5, United States Code any information identifying the location at which materials in the stockpile described in subsection (a) are stored, or other information regarding the contents or deployment capability of the stockpile that could compromise national security.”</content></subsection></quotedContent>.</content></section><section identifier="/tVII/s703" id="HE4843EADC74546319110DCF1D3E49433" class="bill-dtd-OLC" pagenum="58"><num value="703">Sec. 703.</num><heading> Cybersecurity.</heading><subsection identifier="/tVII/s703/a" id="H5BA3552310CE4E15A24F7FC2D7E2025A" class="bill-dtd-OLC" pagenum="58"><num value="a">(a)</num><heading> Strategy for public health preparedness and response to cybersecurity threats.—</heading><paragraph identifier="/tVII/s703/a/1" id="HFC5765DE83C24780852C6CC704495F0E" class="bill-dtd-OLC" pagenum="58"><num value="1">(1)</num><heading> Strategy.—</heading><chapeau>Not later than 18 months after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “<quotedText>Secretary</quotedText>”) shall prepare and submit to the relevant committees of Congress a strategy for public health preparedness and response to address cybersecurity threats (as defined in section 102 of Cybersecurity Information Sharing Act of 2015 (<ref href="/us/usc/6/1501">6 U.S.C. 1501</ref>)) that present a threat to national health security. Such strategy shall include—</chapeau><?page 59?><subparagraph identifier="/tVII/s703/a/1/A" id="HABF7EA23C6264DF08E79207253F84703" class="bill-dtd-OLC" pagenum="59"><num value="A">(A)</num><content> identifying the duties, functions, and preparedness goals for which the Secretary is responsible in order to prepare for and respond to such cybersecurity threats, including metrics by which to measure success in meeting preparedness goals;</content></subparagraph><subparagraph identifier="/tVII/s703/a/1/B" id="HCC815822D5164DDE9E3029B21F6C6F55" class="bill-dtd-OLC" pagenum="59"><num value="B">(B)</num><content> identifying gaps in public health capabilities to achieve such preparedness goals; and</content></subparagraph><subparagraph identifier="/tVII/s703/a/1/C" id="H1229ED6CCA4C40279694CE6D37B499DE" class="bill-dtd-OLC" pagenum="59"><num value="C">(C)</num><content> strategies to address identified gaps and strengthen public health emergency preparedness and response capabilities to address such cybersecurity threats.</content></subparagraph></paragraph><paragraph identifier="/tVII/s703/a/2" id="H9798FA8C63A94E1383A62D94C8D7F675" class="bill-dtd-OLC" pagenum="59"><num value="2">(2)</num><heading> Protection of national security.—</heading><content>The Secretary shall make such strategy available to the Committee on Health, Education, Labor, and Pensions of the Senate, the Committee on Energy and Commerce of the House of Representatives, and other congressional committees of jurisdiction, in a manner that does not compromise national security.</content></paragraph></subsection><subsection identifier="/tVII/s703/b" id="HA29468A9F21347949E6CBB0EE5594A85" class="bill-dtd-OLC" pagenum="59"><num value="b">(b)</num><heading> Coordination of preparedness for and response to all-Hazards public health emergencies.—</heading><content>Subparagraph (D) of section 2811(b)(4) (<ref href="/us/usc/42/300hh-10">42 U.S.C. 300hh–10(b)(4)</ref>) is amended to read as follows:<quotedContent id="H5A757D022D154069B13DC764A629C92B"><subparagraph identifier="/tVII/s703/b/qB/D" id="H17B92A675F934FEEBAF3F9218596350B" class="bill-dtd-OLC" pagenum="59"><num value="D">“(D)</num><heading> Policy coordination and strategic direction.—</heading><content>Provide integrated policy coordination and strategic direction, before, during, and following public health emergencies, with respect to all matters related to Federal public health and medical preparedness and execution and deployment of the Federal response for public health emergencies and incidents covered by the National Response Plan described in section 504(a)(6) of the Homeland Security Act of 2002 (<ref href="/us/usc/6/314">6 U.S.C. 314(a)(6)</ref>), or any successor plan; and such Federal responses covered by the National Cybersecurity Incident Response Plan developed under section 228(c) of the Homeland Security Act of 2002 (<ref href="/us/usc/6/149">6 U.S.C. 149(c)</ref>), including public health emergencies or incidents related to cybersecurity threats that present a threat to national health security.”</content></subparagraph></quotedContent>.</content></subsection></section><section identifier="/tVII/s704" id="H0B096551102E4875A89AA8BC4A1EDB48" class="bill-dtd-OLC" pagenum="59"><num value="704">Sec. 704.</num><heading> Strategy and report.</heading><chapeau class="block">Not later than 14 days after the date of the enactment of this Act, the Secretary of Health and Human Services, in coordination with the Assistant Secretary for Preparedness and Response and the Assistant Secretary for the Administration on Children and Families or other appropriate office, and in collaboration with other departments, as appropriate, shall submit to the Committee on Energy and Commerce of the House of Representatives, the Committee on Health, Education, Labor, and Pensions of the Senate, and other relevant congressional committees—</chapeau><paragraph identifier="/tVII/s704/1" id="H3E9D6A1D0A104739ACAF443C0EB70080" class="bill-dtd-OLC" pagenum="59"><num value="1">(1)</num><chapeau> a formal strategy, including interdepartmental actions and efforts to reunify children with their parents or guardians, in all cases in which such children have been separated from their parents or guardians as a result of the initiative announced on April 6, 2018, and due to prosecution under section 275(a) of the Immigration and Nationality Act (<ref href="/us/usc/8/1325">8 U.S.C. 1325(a)</ref>), if the parent or guardian chooses such reunification and the child—</chapeau><subparagraph identifier="/tVII/s704/1/A" id="H5D2FF444C061411598B80139F7F40575" class="bill-dtd-OLC" pagenum="59"><num value="A">(A)</num><content> was separated from a parent or guardian and placed into a facility funded by the Department of Health and Human Services;</content></subparagraph><?page 60?><subparagraph identifier="/tVII/s704/1/B" id="H7AF07C5A3D244BFF8C7E1F872E618B28" class="bill-dtd-OLC" pagenum="60"><num value="B">(B)</num><content> as of the date of the enactment of this Act, remains in the care of the Department of Health and Human Services; and</content></subparagraph><subparagraph identifier="/tVII/s704/1/C" id="H50BB45CB27594B3596B29C1923B62C80" class="bill-dtd-OLC" pagenum="60"><num value="C">(C)</num><content> can be safely reunited with such parent or guardian; and</content></subparagraph></paragraph><paragraph identifier="/tVII/s704/2" id="HABFD8743B11C4FEE8E88646ADA91DA8F" class="bill-dtd-OLC" pagenum="60"><num value="2">(2)</num><content> a report on challenges and deficiencies related to the oversight of, and care for, unaccompanied alien children and appropriately reuniting such children with their parents or guardians, and the actions taken to address any challenges and deficiencies related to unaccompanied alien children in the custody of the Department of Health and Human Services, including deficiencies identified and publicly reported by Congress, the Government Accountability Office, or the inspectors general of the Department of Health and Human Services or other Federal departments.</content></paragraph></section><section identifier="/tVII/s705" id="H3BC143D97CB94EB994B8B4A50C4DBC38" class="bill-dtd-OLC" pagenum="60"><num value="705">Sec. 705.</num><heading> Technical amendments.</heading><subsection identifier="/tVII/s705/a" id="HB0E002BE732C4A5880CBEA6EF05BC573" class="bill-dtd-OLC" pagenum="60"><num value="a">(a)</num><heading> Public Health Service Act.—</heading><chapeau>Title III (<ref href="/us/usc/42/241">42 U.S.C. 241</ref> et seq.) is amended—</chapeau><paragraph identifier="/tVII/s705/a/1" id="H4C22DE86DCA44A74A37CA17FF3EEAE60" class="bill-dtd-OLC" pagenum="60"><num value="1">(1)</num><content> in paragraphs (1) and (5) of section 319F–1(a) (42 U.S.C. 247d–6a(a)), by striking “<quotedText>section 319F(h)</quotedText>” each place such term appears and inserting “<quotedText>section 319F(e)</quotedText>”; and</content></paragraph><paragraph identifier="/tVII/s705/a/2" id="H97A7E9EA54B94F8CB6C1E199A2A14730" class="bill-dtd-OLC" pagenum="60"><num value="2">(2)</num><content> in section 319K(a) (42 U.S.C. 247d–7d(a)), by striking “<quotedText>section 319F(h)(4)</quotedText>” and inserting “<quotedText>section 319F(e)(4)</quotedText>”.</content></paragraph></subsection><subsection identifier="/tVII/s705/b" id="H80892D2A9563414E9F675B9C59CA6DDB" class="bill-dtd-OLC" pagenum="60"><num value="b">(b)</num><heading> Public health security grants.—</heading><chapeau>Section 319C–1(b)(2) (42 U.S.C. 247d–3a(b)(2)) is amended—</chapeau><paragraph identifier="/tVII/s705/b/1" id="HF2A0AB80FDB34F51A2A3C5842AABDD10" class="bill-dtd-OLC" pagenum="60"><num value="1">(1)</num><content> in subparagraph (C), by striking “<quotedText>individuals,,</quotedText>” and inserting “<quotedText>individuals,</quotedText>”; and</content></paragraph><paragraph identifier="/tVII/s705/b/2" id="H034BB39D58D043D08FF1556353A064D4" class="bill-dtd-OLC" pagenum="60"><num value="2">(2)</num><content> in subparagraph (F), by striking “<quotedText>make satisfactory annual improvement and describe</quotedText>” and inserting “<quotedText>makes satisfactory annual improvement and describes</quotedText>”.</content></paragraph></subsection><subsection identifier="/tVII/s705/c" id="H7238CCD45BBD4E78811A043C7A9F869B" class="bill-dtd-OLC" pagenum="60"><num value="c">(c)</num><heading> Emergency use instructions.—</heading><content>Subparagraph (A) of section 564A(e)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3a(e)(2)) is amended by striking “<quotedText>subsection (a)(1)(C)(i)</quotedText>” and inserting “<quotedText>subsection (a)(1)(C)</quotedText>”.</content></subsection><subsection identifier="/tVII/s705/d" id="HC0329922A25545B1BAF6A2A56C6BD7D4" class="bill-dtd-OLC" pagenum="60"><num value="d">(d)</num><heading> Products held for emergency use.—</heading><chapeau>Section 564B(2) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/360bbb-3b">21 U.S.C. 360bbb–3b</ref>) is amended—</chapeau><paragraph identifier="/tVII/s705/d/1" id="H439601A775064CBBAC451CDFD1DB5BF9" class="bill-dtd-OLC" pagenum="60"><num value="1">(1)</num><content> in subparagraph (B), by inserting a comma after “<quotedText>505</quotedText>”; and</content></paragraph><paragraph identifier="/tVII/s705/d/2" id="HED9DE55C89884708B8817C63221D2AD9" class="bill-dtd-OLC" pagenum="60"><num value="2">(2)</num><content> in subparagraph (C), by inserting “<quotedText>or section 564A</quotedText>” before the period at the end.</content></paragraph></subsection><subsection identifier="/tVII/s705/e" id="H131825138E8946EFA88D612B2D6FAB49" class="bill-dtd-OLC" pagenum="60"><num value="e">(e)</num><heading> Transparency.—</heading><chapeau>Section 507(c)(3) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/357">21 U.S.C. 357(c)(3)</ref>) is amended—</chapeau><paragraph identifier="/tVII/s705/e/1" id="HCD63B1BB9CEF4E3FBD41219413EBE29A" class="bill-dtd-OLC" pagenum="60"><num value="1">(1)</num><content> by striking “<quotedText>Nothing in</quotedText>” and inserting the following:<quotedContent id="HBF6ECCADF7F64DD396E2788A51224092"><subparagraph identifier="/tVII/s705/e/1/qB/A" id="HEAF5EBD64E134771A06038C750E0AD69" class="bill-dtd-OLC" pagenum="60"><num value="A">“(A)</num><heading> In general.—</heading><content>Nothing in”</content></subparagraph></quotedContent>;</content></paragraph><paragraph identifier="/tVII/s705/e/2" id="H63181E68251D4DECAF946BED05BBB656" class="bill-dtd-OLC" pagenum="60"><num value="2">(2)</num><content> by inserting “<quotedText>or directing</quotedText>” after “<quotedText>authorizing</quotedText>”;</content></paragraph><paragraph identifier="/tVII/s705/e/3" id="H904F661E2BB6401BAD30AD5A8EF8DDD2" class="bill-dtd-OLC" pagenum="60"><num value="3">(3)</num><content> by striking “<quotedText>disclose any</quotedText>” and inserting “disclose—<quotedContent id="HD491D377AB3841D688F39185BF82B4FE"><clause identifier="/tVII/s705/e/3/qB/i" id="H3A3CCE39B01B45E9AC735D7463157D01" class="bill-dtd-OLC" pagenum="60"><num value="i">“(i)</num><content> any”</content></clause></quotedContent>; </content></paragraph><paragraph identifier="/tVII/s705/e/4" id="H1E5CFFB502024AB0AA512B463EFFE20A" class="bill-dtd-OLC" pagenum="60"><num value="4">(4)</num><content> by striking the period and inserting “<quotedText>; or</quotedText>”; and</content></paragraph><paragraph identifier="/tVII/s705/e/5" id="H6142EB79B3CA4B3097385F8462449BD2" class="bill-dtd-OLC" pagenum="60"><num value="5">(5)</num><content> by adding at the end the following:<quotedContent id="HD8D7F80D802047D6A12C4D1CD1FFCF41"><clause identifier="/tVII/s705/e/5/qB/ii" id="H0EC0209A60B6481082E5E66FDB212EC9" class="bill-dtd-OLC" pagenum="60"><num value="ii">“(ii)</num><content> in the case of a drug development tool that may be used to support the development of a qualified countermeasure, security countermeasure, or qualified pandemic or epidemic product, as defined in sections 319F–1, 319F–2, and 319F–3, respectively, of the Public Health Service Act, any information that the <?page 61?>Secretary determines has a significant potential to affect national security.</content></clause><subparagraph identifier="/tVII/s705/e/5/qB/B" id="H18C657D7DB6B40758E46FF0F0C23FE3D" class="bill-dtd-OLC" pagenum="61"><num value="B">“(B)</num><heading> Public acknowledgment.—</heading><content>In the case that the Secretary, pursuant to subparagraph (A)(ii), does not make information publicly available, the Secretary shall provide on the internet website of the Food and Drug Administration an acknowledgment of the information that has not been disclosed, pursuant to subparagraph (A)(ii).”</content></subparagraph></quotedContent>.</content></paragraph></subsection></section></title></main><signatures><signature><name/><role>Speaker of the House of Representatives</role></signature><signature><name/><role>Vice President of the United States and President of the Senate</role></signature></signatures></bill>